IMMERSION CORP - Quarter Report: 2007 June (Form 10-Q)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2007
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission file number 000-27969
IMMERSION CORPORATION
(Exact name of registrant as specified
in its charter)
Delaware | 94-3180138 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
801 Fox Lane, San
Jose, California 95131
(Address of principal executive
offices)(Zip Code)
(408) 467-1900
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated
filer in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o | Accelerated filer þ | Non-accelerated filero |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o | No þ |
Number of shares of common stock outstanding at August 2, 2007: 28,000,041
IMMERSION CORPORATION
INDEX
Page | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
23 | ||||||||
38 | ||||||||
39 | ||||||||
39 | ||||||||
42 | ||||||||
55 | ||||||||
56 | ||||||||
57 | ||||||||
EXHIBIT 31.1 | ||||||||
EXHIBIT 31.2 | ||||||||
EXHIBIT 32.1 | ||||||||
EXHIBIT 32.2 |
2
Table of Contents
PART I
FINANCIAL INFORMATION
FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
IMMERSION
CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
(In thousands, except share and per share amounts)
(Unaudited)
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 110,630 | $ | 32,012 | ||||
Short-term investments |
24,890 | | ||||||
Accounts receivable (net of allowances for doubtful accounts of: June 30, 2007 $111
and December 31, 2006 $139) |
6,691 | 5,153 | ||||||
Inventories, net |
3,090 | 2,639 | ||||||
Deferred income taxes |
4,267 | | ||||||
Prepaid expenses and other current assets |
912 | 1,179 | ||||||
Total current assets |
150,480 | 40,983 | ||||||
Property and equipment, net |
1,859 | 1,647 | ||||||
Intangibles and other assets, net |
8,864 | 7,385 | ||||||
Total assets |
$ | 161,203 | $ | 50,015 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT) |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 1,971 | $ | 2,334 | ||||
Accrued compensation |
1,697 | 1,526 | ||||||
Income taxes payable |
3,083 | | ||||||
Other current liabilities |
2,056 | 1,750 | ||||||
Deferred revenue and customer advances |
6,763 | 1,716 | ||||||
Total current liabilities |
15,570 | 7,326 | ||||||
Long-term debt |
18,438 | 18,122 | ||||||
Long-term deferred revenue, less current portion |
12,861 | 31,784 | ||||||
Long-term customer advance from Microsoft |
| 15,000 | ||||||
Other long-term liabilities |
792 | 775 | ||||||
Total liabilities |
47,661 | 73,007 | ||||||
Contingencies (Note 15) |
||||||||
Stockholders equity (deficit): |
||||||||
Common stock and additional paid-in capital
$0.001 par value; 100,000,000 shares
authorized; shares issued and outstanding: June 30, 2007 26,873,158 and
December 31, 2006 24,797,572 |
125,206 | 110,501 | ||||||
Warrants |
2,899 | 3,686 | ||||||
Accumulated other comprehensive income |
74 | 67 | ||||||
Accumulated deficit |
(14,637 | ) | (137,246 | ) | ||||
Total stockholders equity (deficit) |
113,542 | (22,992 | ) | |||||
Total liabilities and stockholders equity (deficit) |
$ | 161,203 | $ | 50,015 | ||||
See accompanying Notes to Condensed Consolidated Financial Statements.
3
Table of Contents
IMMERSION CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Revenues: |
||||||||||||||||
Royalty and license |
$ | 2,747 | $ | 1,702 | $ | 4,958 | $ | 3,612 | ||||||||
Product sales |
5,289 | 3,917 | 8,879 | 7,283 | ||||||||||||
Development contracts and other |
559 | 1,034 | 1,172 | 1,790 | ||||||||||||
Total revenues |
8,595 | 6,653 | 15,009 | 12,685 | ||||||||||||
Costs and expenses: |
||||||||||||||||
Cost of product sales (exclusive of amortization of intangibles
shown separately below) |
2,427 | 1,802 | 3,970 | 3,157 | ||||||||||||
Sales and marketing |
3,030 | 3,009 | 5,733 | 6,086 | ||||||||||||
Research and development |
2,513 | 1,802 | 5,056 | 3,531 | ||||||||||||
General and administrative |
3,122 | 2,296 | 6,381 | 5,107 | ||||||||||||
Amortization of intangibles |
242 | 219 | 496 | 429 | ||||||||||||
Litigation conclusions and patent license |
| (400 | ) | (134,900 | ) | (1,050 | ) | |||||||||
Total costs and expenses |
11,334 | 8,728 | (113,264 | ) | 17,260 | |||||||||||
Operating income (loss) |
(2,739 | ) | (2,075 | ) | 128,273 | (4,575 | ) | |||||||||
Interest and other income |
1,820 | 84 | 2,181 | 187 | ||||||||||||
Interest expense |
(407 | ) | (403 | ) | (813 | ) | (810 | ) | ||||||||
Income (loss) before benefit (provision) for income taxes |
(1,326 | ) | (2,394 | ) | 129,641 | (5,198 | ) | |||||||||
Benefit (provision) for income taxes |
1,502 | 15 | (7,032 | ) | (87 | ) | ||||||||||
Net income (loss) |
$ | 176 | $ | (2,379 | ) | $ | 122,609 | $ | (5,285 | ) | ||||||
Basic net income (loss) per share |
$ | 0.01 | $ | (0.10 | ) | $ | 4.75 | $ | (0.22 | ) | ||||||
Shares used in calculating basic net income (loss) per share |
26,297 | 24,546 | 25,822 | 24,483 | ||||||||||||
Diluted net income (loss) per share |
$ | 0.01 | $ | (0.10 | ) | $ | 4.03 | $ | (0.22 | ) | ||||||
Shares used in calculating diluted net income (loss) per share |
28,619 | 24,546 | 30,530 | 24,483 | ||||||||||||
See accompanying Notes to Condensed Consolidated Financial Statements.
4
Table of Contents
IMMERSION CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
(In thousands)
(Unaudited)
Six Months Ended | ||||||||
June 30, | ||||||||
2007 | 2006 | |||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | 122,609 | $ | (5,285 | ) | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
430 | 339 | ||||||
Amortization of intangibles |
496 | 429 | ||||||
Stock-based compensation |
1,243 | 1,417 | ||||||
Excess tax benefits from stock-based compensation |
(1,876 | ) | (18 | ) | ||||
Interest expense accretion on 5% Convertible Debenture |
316 | 316 | ||||||
Fair value adjustment of Put Option and Registration Rights |
(2 | ) | (10 | ) | ||||
Loss on disposal of equipment |
6 | 3 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(1,520 | ) | 332 | |||||
Inventories |
(425 | ) | 237 | |||||
Deferred income taxes |
(5,409 | ) | | |||||
Prepaid expenses and other current assets |
269 | 102 | ||||||
Accounts payable |
(1,188 | ) | (1,221 | ) | ||||
Accrued compensation and other current liabilities |
464 | 607 | ||||||
Income taxes payable |
7,288 | | ||||||
Deferred revenue and customer advances |
(28,877 | ) | 6,157 | |||||
Other long-term liabilities |
20 | | ||||||
Net cash provided by operating activities |
93,844 | 3,405 | ||||||
Cash flows used in investing activities: |
||||||||
Purchases of short-term investments |
(24,913 | ) | | |||||
Intangibles and other assets |
(833 | ) | (643 | ) | ||||
Purchases of property and equipment |
(656 | ) | (701 | ) | ||||
Net cash used in investing activities |
(26,402 | ) | (1,344 | ) | ||||
Cash flows from financing activities: |
||||||||
Issuance of common stock under employee stock purchase plan |
147 | 125 | ||||||
Exercise of stock options and warrants |
8,322 | 433 | ||||||
Excess tax benefits from stock-based compensation |
1,876 | 18 | ||||||
Payments on notes payable and capital leases |
| (5 | ) | |||||
Net cash provided by financing activities |
10,345 | 571 | ||||||
Effect of exchange rates on cash and cash equivalents |
831 | 57 | ||||||
Net increase in cash and cash equivalents |
78,618 | 2,689 | ||||||
Cash and cash equivalents: |
||||||||
Beginning of the period |
32,012 | 28,171 | ||||||
End of the period |
$ | 110,630 | $ | 30,860 | ||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid for taxes |
$ | 5,032 | $ | 27 | ||||
Cash paid for interest |
$ | 500 | $ | 504 | ||||
See accompanying Notes to Condensed Consolidated Financial Statements.
5
Table of Contents
IMMERSION CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2007
(Unaudited)
June 30, 2007
(Unaudited)
1. SIGNIFICANT ACCOUNTING POLICIES
Description
of Business Immersion Corporation (the Company) was incorporated in 1993 in
California and reincorporated in Delaware in 1999 and develops, manufactures, licenses, and
supports a wide range of hardware and software technologies and products that enhance digital
devices with touch interaction.
Principles
of Consolidation and Basis of Presentation The condensed consolidated financial
statements include the accounts of Immersion Corporation and its majority-owned subsidiaries. All
intercompany accounts, transactions, and balances have been eliminated in consolidation.
The accompanying condensed consolidated financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of America (GAAP) for interim
financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X and,
therefore, do not include all information and footnotes necessary for a complete presentation of
the financial position, results of operations, and cash flows, in conformity with accounting
principles generally accepted in the United States of America. These condensed consolidated
financial statements should be read in conjunction with the Companys audited consolidated
financial statements included in the Companys Annual Report on Form 10-K for the fiscal year ended
December 31, 2006. In the opinion of management, all adjustments consisting of only normal
recurring items necessary for the fair presentation of the financial position and results of
operations for the interim periods have been included.
The results of operations for the interim periods ended June 30, 2007 are not necessarily
indicative of the results to be expected for the full year.
Short-term
Investments The Companys short-term investments consist primarily of highly
liquid debt instruments purchased with an original or remaining maturity at the date of purchase of
greater than 90 days. The Company classifies all debt securities with readily determinable market
values as available-for-sale in accordance with Statement of Financial Accounting Standard
(SFAS) No. 115, Accounting for Certain Investments in Debt and Equity Securities. These
investments are carried at fair market value with unrealized gains and losses considered to be
temporary in nature reported as a separate component of other comprehensive income (loss) within
stockholders equity (deficit). The Company reviews all investments for reductions in fair value
that are other-than-temporary. When such reductions occur, the cost of the investment is adjusted
to fair value through loss on investments on the condensed consolidated statement of operations.
Gains and losses on investments are calculated on the basis of specific identification.
Revenue
Recognition The Company recognizes revenues in accordance with applicable accounting
standards, including Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition (SAB No.
104), Emerging Issues Task Force (EITF) No. 00-21, Accounting for Revenue Arrangements with
Multiple Deliverables (EITF No. 00-21), and the American Institute of Certified Public
Accountants (AICPA) Statement of Position (SOP) 97-2, Software Revenue Recognition, as
amended. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has
occurred or service has been rendered, the fee is fixed and determinable, and collectibility is
probable. The Company derives its revenues from three principal sources: royalty and license fees,
product sales, and development contracts.
Royalty
and license revenue The Company recognizes royalty and license revenue based on
royalty reports or related information received from the licensee as well as time-based licenses of
its intellectual property portfolio. Up-front payments under license agreements are deferred and
recognized as revenue based on either the royalty reports received or amortized over the license
period depending on the nature of the agreement. Advance payments under license agreements that
also require the Company to provide future services to the licensee are deferred and recognized
over the service period when vendor-specific objective evidence (VSOE) related to the value of
the services does not exist.
The Company generally recognizes revenue from its licensees under one or a combination of the
following models:
6
Table of Contents
License revenue model | Revenue recognition | |
Perpetual license of intellectual
property portfolio based on per unit
royalties, no services contracted.
|
Based on royalty reports received from licensees. No further obligations to licensee exist. | |
Time-based license of intellectual
property portfolio with up-front
payments and/or annual minimum royalty
requirements, no services contracted.
Licensees have certain rights to
updates to the intellectual property
portfolio during the contract period.
|
Based on straight-line amortization of annual minimum/up-front payment recognized over contract period or annual minimum period. | |
Perpetual license of intellectual
property portfolio or technology
license along with contract for
development work.
|
Based on cost-to-cost percentage-of-completion accounting method over the service period. Obligation to licensee exists until development work is complete. | |
License of software or technology, no
modification necessary, no services
contracted.
|
Up-front revenue recognition based on SOP 97-2 criteria or EITF No. 00-21, as applicable. |
Individual contracts may have characteristics that do not fall within a specific license
model or may have characteristics of a combination of license models. Under those circumstances,
the Company recognizes revenue in accordance with SAB No. 104, EITF No. 00-21, and SOP 97-2, as
amended, to guide the accounting treatment for each individual contract. See also the discussion
regarding Multiple element arrangements below. If the information received from the Companys
licensees regarding royalties is incorrect or inaccurate, the Companys revenues in future periods
may be adversely affected. To date, none of the information the Company has received from its
licensees has caused any material adjustment to period revenues.
Product
sales The Company recognizes revenues from product sales when the product is
shipped, provided that collection is determined to be probable and no significant obligation
remains. The Company sells the majority of its products with warranties ranging from 3 to 24
months. The Company records the estimated warranty costs during the quarter the revenue is
recognized. Historically, warranty-related costs and related accruals have not been significant.
The Company offers a general right of return on the MicroScribe® product line for 14 days after
purchase. The Company recognizes revenue at the time of shipment of a MicroScribe digitizer and
provides an accrual for potential returns based on historical experience. The Company offers no
other general right of return on its products.
Development
contracts and other revenue Development contracts and other revenue is comprised
of professional services (consulting services and/or development contracts), customer support, and
extended warranty contracts. Development contract revenues are recognized under the cost-to-cost
percentage-of-completion accounting method based on physical completion of the work to be
performed. Losses on contracts are recognized when determined. Revisions in estimates are reflected
in the period in which the conditions become known. Customer support and extended warranty contract
revenue is recognized ratably over the contractual period.
Multiple
element arrangements The Company enters into revenue arrangements in which the
customer purchases a combination of patent, technology, and/or software licenses, products,
professional services, support, and extended warranties (multiple element arrangements). When VSOE
of fair value exists for all elements, the Company allocates revenue to each element based on the
relative fair value of each of the elements. The price charged when the element is sold separately
generally determines the fair value or VSOE.
The Companys revenue recognition policies are significant because the Companys revenues are
a key component of its results of operations. In addition, the Companys revenue recognition
policies determine the timing of certain expenses, such as commissions and royalties.
Recent
Accounting Pronouncements In June 2006, the Financial Accounting Standards Board
(FASB) issued Financial Interpretation No. 48, Accounting for Uncertainty in Income Taxes (FIN
48). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an enterprises
financial statements in accordance with Statement No. 109 Accounting for Income Taxes, (SFAS No.
109). FIN 48 prescribes a two-step process to determine the amount of benefit to be recognized.
First, the tax position must be evaluated to determine the likelihood that it will be sustained
upon examination. If the tax position is deemed more-likely-than-not to be sustained, the tax
position is then measured to determine the amount of benefit to recognize in the financial
statements. The tax position is measured at the largest amount of benefit that is greater than 50
percent likely of being realized upon ultimate settlement. The Company adopted the provisions of
FIN 48
7
Table of Contents
resulted in no adjustment to beginning retained earnings as the Company had a full
valuation allowance on the deferred tax assets as of the adoption date. See Note 11.
In September 2006, the FASB issued Statement No. 157, Fair Value Measurements, (SFAS No.
157). SFAS No. 157 establishes a framework for measuring fair value by providing a standard
definition for fair value as it applies to assets and liabilities. SFAS No. 157, which does not
require any new fair value measurements, clarifies the application of other accounting
pronouncements that require or permit fair value measurements. The effective date for the Company
is January 1, 2008. The Company is currently evaluating the effect that the adoption of SFAS No.
157 will have on its financial position and results of operations.
In February 2007, the FASB issued Statement No. 159, The Fair Value Option for Financial
Assets and Financial Liabilities (SFAS No. 159). The new Statement allows entities to choose, at
specified election dates, to measure eligible financial assets and liabilities at fair value in
situations in which they are not otherwise required to be measured at fair value. If a company
elects the fair value option for an eligible item, changes in that items fair value in subsequent
reporting periods must be recognized in current earnings. SFAS No. 159 also establishes
presentation and disclosure requirements designed to draw comparison between entities that elect
different measurement attributes for similar assets and liabilities. SFAS No. 159 is effective for
fiscal years beginning after November 15, 2007. Early adoption is permitted subject to specific
requirements outlined in the new Statement. The Company is currently evaluating the effect that the
adoption of SFAS No. 159 will have on its financial position and results of operations.
2. INVENTORIES
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
(In thousands) | ||||||||
Raw materials and subassemblies |
$ | 2,319 | $ | 2,267 | ||||
Work in process |
80 | 110 | ||||||
Finished goods |
691 | 262 | ||||||
Inventories, net |
$ | 3,090 | $ | 2,639 | ||||
3. PROPERTY AND EQUIPMENT
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
(In thousands) | ||||||||
Computer equipment and purchased software |
$ | 3,168 | $ | 2,980 | ||||
Machinery and equipment |
3,020 | 2,817 | ||||||
Furniture and fixtures |
1,318 | 1,280 | ||||||
Leasehold improvements |
974 | 824 | ||||||
Total |
8,480 | 7,901 | ||||||
Less accumulated depreciation |
(6,621 | ) | (6,254 | ) | ||||
Property and equipment, net |
$ | 1,859 | $ | 1,647 | ||||
4. INTANGIBLES AND OTHER ASSETS
8
Table of Contents
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
(In thousands) | ||||||||
Patents and technology |
$ | 13,833 | $ | 13,011 | ||||
Deferred income taxes |
1,142 | | ||||||
Other assets |
105 | 105 | ||||||
Gross intangibles and other assets |
15,080 | 13,116 | ||||||
Accumulated amortization of patents and technology |
(6,216 | ) | (5,731 | ) | ||||
Intangibles and other assets, net |
$ | 8,864 | $ | 7,385 | ||||
The estimated annual amortization expense for intangible assets as of June 30, 2007 is
$963,000 in 2007, $736,000 in 2008, $872,000 in 2009, $801,000 in 2010, $759,000 in 2011, and $4.0
million in total for all years thereafter.
5. COMPONENTS OF OTHER CURRENT LIABILITIES AND DEFERRED REVENUE AND CUSTOMER ADVANCES
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
(In thousands) | ||||||||
Accrued legal |
$ | 368 | $ | 256 | ||||
Other current liabilities |
1,688 | 1,494 | ||||||
Total other current liabilities |
$ | 2,056 | $ | 1,750 | ||||
Deferred revenue |
$ | 6,716 | $ | 1,646 | ||||
Customer advances |
47 | 70 | ||||||
Total current deferred revenue and customer advances |
$ | 6,763 | $ | 1,716 | ||||
Deferred revenue at June 30, 2007 includes $3.0 million representing the current portion of
deferred revenue from Sony Computer Entertainment. See Note 10 for further discussion.
6. LONG-TERM DEBT
5%
Senior Subordinated Convertible Debenture (5% Convertible
Debenture) On December 23,
2004, the Company issued an aggregate principal amount of $20.0 million of 5% Convertible
Debentures. The 5% Convertible Debentures will mature on December 22, 2009 (see Note 16 for
subsequent event discussion regarding Mandatory Redemption). The amount payable at maturity of each
5% Convertible Debenture is the initial principal plus all accrued but unpaid interest thereon, to
the extent such principal amount and interest have not been converted into common stock or
previously paid in cash. The Company cannot prepay the 5% Convertible Debenture except as described
below in Mandatory Conversion and Mandatory Redemption of 5% Convertible Debentures at the
Companys Option. Interest accrues daily on the principal amount of the 5% Convertible Debenture
at a rate of 5% per year and is payable on the last day of each calendar quarter. Interest will
cease to accrue on that portion of the 5% Convertible Debenture that is converted or paid,
including pursuant to conversion rights or rights of redemption. The holder of a 5% Convertible
Debenture has the right to convert the outstanding principal amount and accrued and unpaid
interest, in whole or in part, into the Companys common stock at a price of $7.0265 per common
share, the Conversion Price. In the event of a change of control, a holder may require the Company
to redeem all or a portion of its 5% Convertible Debenture. This is referred to as the Put Option.
The redeemed portion shall be redeemed at a price equal to the redeemed amount multiplied by 100%
of the principal amount of the 5% Convertible Debenture. The Conversion Price will be reduced in
certain instances when the Company sells, or is deemed to have sold shares of common stock at a
price less than the applicable Conversion Price, including the issuance of certain options, the
issuance of convertible securities, or the change in exercise price or rate of conversion for
options or convertible securities. The Conversion Price will be proportionately adjusted if the
Company subdivides (by stock split, stock dividend, recapitalization, or otherwise) or combines (by
combination, reverse stock split, or otherwise) one or more classes of its common stock. So long
as any 5% Convertible Debentures are outstanding, the Company
9
Table of Contents
will not, nor will the Company permit
any of its subsidiaries to directly or indirectly incur or guarantee, assume or suffer to exist,
any indebtedness other than permitted indebtedness under the 5% Convertible Debenture agreement. If
an event of default occurs, and is continuing with respect to any of the Companys 5% Convertible
Debentures, the holder may, at its option, require the Company to redeem all or a portion of the 5%
Convertible Debenture.
Mandatory Conversion and Mandatory Redemption of 5% Convertible Debentures at the Companys
Option If the closing bid price of the Companys common stock is at or above $14.053 for at
least 20 consecutive trading days and certain other conditions are met, the Company has the right
to (i) require the holder of a 5% Convertible Debenture to convert the 5% Convertible Debenture in
whole, including interest, into shares of the Companys common stock at a price of $7.0265 per
common share, as may be adjusted under the debenture, as set forth and subject to the conditions in
the 5% Convertible Debenture, or (ii) redeem the 5% Convertible Debenture. If the Company makes
either of the foregoing elections with respect to any 5% Convertible Debenture, the Company must
make the same election with respect to all 5% Convertible Debentures. As of July 26, 2007 the
closing bid price of the Companys common stock exceeded $14.053 for 20 consecutive trading days
and on July 27, 2007, the holders of the 5% Convertible Debentures were notified that the Company
intended to effect the Mandatory Redemption (see Note 16).
Warrants
On December 23, 2004, in connection with the issuance of the 5% Convertible
Debentures, the Company issued warrants to purchase an aggregate of 426,951 shares of its common
stock at an exercise price of $7.0265. The warrants may be exercised at any time prior to 5:00 p.m.
Eastern time, on December 23, 2009. Any warrants not exercised prior to such time will expire.
The exercise price will be reduced in certain instances where shares of common stock are sold or
deemed to be sold at a price less than the applicable exercise price, including the issuance of
certain options, the issuance of convertible securities, or the change in exercise price or rate of
conversion for option or convertible securities. The exercise price will be proportionately
adjusted if the Company subdivides (by stock split, stock dividend, recapitalization, or otherwise)
or combines (by combination, reverse stock split, or otherwise) one or more classes of its common
stock.
Registration
Rights On April 18, 2005, the Companys registration statement relating to the
5% Convertible Debentures and the shares of common stock issuable upon conversion of the debentures
and exercise of the warrants was declared effective by the Securities and Exchange Commission
(SEC). The Company expects to keep this registration statement effective until the earlier of (i)
such time as all of the shares covered by the prospectus have been disposed of pursuant to and in
accordance with the registration statement, or (ii) the date on which the shares may be sold
pursuant to Rule 144(k) of the Securities Act.
The Company incurred approximately $1.3 million in issuance costs and other expenses in
connection with the offering. This amount has been deferred and is being amortized to interest
expense over the term of the 5% Convertible Debenture. Additionally, the Company evaluated the
various instruments included in the agreements entered into on December 22, 2004 and allocated the
relative fair values to be as follows: warrants $1.7 million, Put Option $0.1 million,
Registration Rights $0.1 million, issuance costs $1.3 million, 5% Convertible Debenture $16.8
million. The 5% Convertible Debentures will be accreted to $20.0 million over their five-year
life, resulting in additional interest expense. The value of the warrants has been included in
Stockholders Equity (Deficit); the value of the Put Option and Registration Rights have been
recorded as a liability and are subject to future value adjustments; and the value of the 5%
Convertible Debentures has been recorded as long-term debt.
Annual maturities of long-term debt as of June 30, 2007 are $20.0 million due on December 23,
2009 (see Note 16).
7. LONG-TERM DEFERRED REVENUE
On June 30, 2007, long-term deferred revenue was $12.9 million and included approximately $9.6
million of deferred revenue from Sony Computer Entertainment. On December 31, 2006, long-term
deferred revenue was $31.8 million and included approximately $27.9 million of compulsory license
fees and interest from Sony Computer Entertainment pursuant to Court orders dated January 10 and
February 9, 2005. See Note 10 for further discussion.
8. LONG-TERM CUSTOMER ADVANCE FROM MICROSOFT
On July 25, 2003, the Company contemporaneously executed a series of agreements with Microsoft
Corporation (Microsoft) that (1) settled the Companys lawsuit against Microsoft, (2) granted
Microsoft a worldwide royalty-free, irrevocable license to the Companys portfolio of patents (the
License Agreement) in exchange for a payment of $19.9 million, (3) provided Microsoft with
sublicense rights to pursue certain license arrangements directly with third parties including Sony
Computer Entertainment which, if consummated, would result in payments to the Company (the
Sublicense Rights), and conveyed to Microsoft the right to a payment of cash in the event of a
settlement within certain parameters of the Companys patent litigation against Sony Computer
Entertainment of America Inc. and Sony Computer Entertainment Inc. (the Participation
10
Table of Contents
Rights) in
exchange for a payment of $0.1 million, (4) issued Microsoft shares of the Companys Series A
Redeemable Convertible Preferred Stock (Series A Preferred Stock) for a payment of $6.0 million,
and (5) granted the Company the right to sell up to $9.0 million of debentures to Microsoft under
the terms and conditions established in newly authorized 7% Debentures with annual draw down rights
over a 48-month period. The sublicense rights provided to Microsoft to contract directly with Sony
Computer Entertainment expired in July 2005.
Under these agreements, in the event that the Company elects to settle the action in the
United States District Court for the Northern District of California entitled Immersion Corporation
v. Sony Computer Entertainment of America, Inc., Sony Computer Entertainment Inc. and Microsoft
Corporation, Case No. C02-00710 CW (WDB), as such action pertains to Sony Computer Entertainment,
the Company would be obligated to pay Microsoft a minimum of $15.0 million for amounts up to $100.0
million received from Sony Computer Entertainment on account of the Companys granting certain
rights, plus 25% of amounts over $100.0 million up to $150.0 million, and 17.5% of amounts over
$150.0 million. As of December 31, 2006, the Company reflected a liability of $15.0 million in its
financial statements, being the minimum amount the Company would be obliged to pay to Microsoft
upon a settlement with Sony Computer Entertainment.
In March 2007, the Company concluded its patent infringement litigation against Sony Computer
Entertainment at the U.S. Court of Appeals for the Federal Circuit. Additionally, the Company and
Sony Computer Entertainment entered into a new business agreement. The Company has determined that
the conclusion of its litigation with Sony Computer Entertainment does not trigger any payment
obligations under its Microsoft agreements. Accordingly, the liability of $15.0 million that was in
the Companys financial statements at December 31, 2006 has been extinguished and the Company has
accounted for this sum as litigation conclusions and patent license income in the three months
ended March 31, 2007 and for the six months ended June 30, 2007. See Note 15, Contingencies. As the
patent infringement litigation with Sony Computer Entertainment has concluded, the Companys right
to sell 7% Debentures has expired.
9. STOCK-BASED COMPENSATION
On January 1, 2006, the Company adopted the provisions of, and accounted for stock-based
compensation in accordance with, SFAS No. 123revised 2004, Share-Based Payment (SFAS No.
123R) which replaced SFAS No. 123, Accounting for Stock-Based Compensation (SFAS No. 123) and
supersedes Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to
Employees (APB No. 25). Under the fair value recognition provisions of SFAS No. 123R,
stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as expense on a straight-line basis over the requisite service period, which is
the vesting period. The valuation provisions of SFAS No. 123R apply to new grants and to grants
that were outstanding as of the effective date and are subsequently modified. Estimated
compensation for grants that were outstanding as of the effective date will be recognized over the
remaining service period using the compensation cost estimated for the SFAS No. 123 pro forma
disclosures. Prior to the adoption of SFAS No. 123R, the Company used the Black-Scholes-Merton
option-pricing model (Black-Scholes model), multi-option approach to determine the fair value of
stock options and employee stock purchase plan shares for pro forma disclosures.
Stock
Options The Companys stock option program is a long-term retention program that is
intended to attract, retain, and provide incentives for talented employees, officers, and
directors, and to align stockholder and employee interests. The Company considers its option
programs critical to its operation and productivity; essentially all of its employees participate.
Since inception, under the Companys stock option plans, the Company may grant options to purchase
up to 17,577,974 shares of its common stock to employees, directors, and consultants at prices not
less than the fair market value on the date of grant for incentive stock options and not less than
85% of fair market value on the date of grant for nonstatutory stock options. These options
generally vest over 4 years and expire 10 years from the date of grant. At June 30, 2007, options
to purchase 2,777,392 shares of common stock were available for grant, and options to purchase
6,618,465 shares of common stock were outstanding.
On June 6, 2007, the Companys stockholders approved the Immersion Corporation 2007 Equity
Incentive Plan (the 2007 Plan). The 2007 Plan replaces the Companys 1997 Stock Option Plan (the
1997 Plan). Effective June 6, 2007, the 1997 Plan was terminated. Under the 2007 Plan, the
Company may grant stock options, stock appreciation rights, restricted stock, restricted stock
units, performance shares, performance units, and other stock-based or cash-based awards to
employees and consultants. The 2007 Plan also authorizes the grant of awards of stock options,
stock appreciation rights, restricted stock and restricted stock units to non-employee members of
the Companys Board of Directors and deferred compensation awards to officers, directors and
certain management or highly compensated employees. The 2007 Plan authorizes the issuance of
2,303,232 shares of the Companys common stock, and up to an additional 1,000,000 shares subject to
awards that remain outstanding under the 1997 Plan as of June 6, 2007 and which subsequently
terminate without having been exercised or which are forfeited to the Company.
Employee
Stock Purchase Plan The Company has an employee stock purchase plan (ESPP). Under
the ESPP, eligible employees may purchase common stock through payroll deductions at a purchase
price of 85% of the lower of the fair market
11
Table of Contents
value of the Companys stock at the beginning of the
offering period or the purchase date. Participants may not purchase more than 2,000 shares in a
six-month offering period or purchase stock having a value greater than $25,000 in any calendar
year as measured at the beginning of the offering period. A total of 500,000 shares of common stock
are reserved for the issuance under the ESPP plus an automatic annual increase on January 1, 2001
and on each January 1 thereafter through January 1, 2010 by an amount equal to the lesser of
500,000 shares per year or a number of shares determined by the Board of Directors. As of June 30,
2007, 322,367 shares had been purchased under the ESPP. Under SFAS No. 123R, the ESPP is
considered a compensatory plan and the Company is required to recognize compensation cost for sales
made under the ESPP.
The Company did not modify its ESPP in the quarter ended June 30, 2007.
General
Stock Option Information The following table sets forth the summary of option
activity under the Companys stock option program for the six months ended June 30, 2007:
Weighted | ||||||||||||||||
Average | ||||||||||||||||
Weighted | Remaining | Aggregate | ||||||||||||||
Number | Average | Contractual | Intrinsic | |||||||||||||
of Shares | Exercise Price | Term | Value | |||||||||||||
Outstanding at December 31, 2006 (5,403,314 exercisable at a weighted
average price of $7.65 per share) |
7,585,423 | $ | 7.40 | |||||||||||||
Granted (weighted average fair value of $5.48 per share) |
1,051,708 | 8.97 | ||||||||||||||
Exercised |
(1,796,008 | ) | 4.63 | |||||||||||||
Canceled |
(222,658 | ) | 7.13 | |||||||||||||
Outstanding at June 30, 2007 |
6,618,465 | $ | 8.41 | 6.23 | $48.7 million | |||||||||||
Exercisable at June 30, 2007 |
4,231,067 | $ | 8.78 | 4.81 | $31.4 million | |||||||||||
The expected to vest balance as of June 30, 2007 is equal to the outstanding balance at that
date without consideration of forfeitures.
The aggregate intrinsic value is calculated as the difference between the exercise price of
the underlying awards and the quoted price of the Companys common stock for the options that were
in-the-money at June 30, 2007. The aggregate intrinsic value of options exercised under the
Companys stock option plans, determined as of the date of option exercise was $8.2 million for the
quarter ended June 30, 2007.
Additional information regarding options outstanding as of June 30, 2007 is as follows:
Options Outstanding | Options Exercisable | |||||||||||||||||||||||
Weighted | ||||||||||||||||||||||||
Average | Weighted | Weighted | ||||||||||||||||||||||
Range of | Remaining | Average | Average | |||||||||||||||||||||
Exercise | Number | Contractual | Exercise | Number | Exercise | |||||||||||||||||||
Prices | Outstanding | Life (Years) | Price | Exercisable | Price | |||||||||||||||||||
$ | 1.20 - $ 2.35 | 731,342 | 5.22 | $ | 1.68 | 731,342 | $ | 1.68 | ||||||||||||||||
3.20 - 6.11 | 684,269 | 6.39 | 5.50 | 467,738 | 5.48 | |||||||||||||||||||
6.20 - 6.95 | 1,145,957 | 7.97 | 6.77 | 472,796 | 6.69 | |||||||||||||||||||
6.96 - 7.00 | 859,015 | 7.03 | 6.99 | 595,235 | 6.99 | |||||||||||||||||||
7.02 - 8.98 | 1,187,507 | 4.33 | 8.37 | 936,529 | 8.60 | |||||||||||||||||||
9.04 - 9.04 | 881,198 | 9.62 | 9.04 | | | |||||||||||||||||||
9.11 - 15.50 | 724,043 | 4.47 | 10.68 | 622,293 | 10.85 | |||||||||||||||||||
17.13 - 33.50 | 374,747 | 2.43 | 26.60 | 374,747 | 26.60 | |||||||||||||||||||
34.75 - 34.75 | 5,501 | 1.29 | 34.75 | 5,501 | 34.75 | |||||||||||||||||||
43.25 - 43.25 | 24,886 | 2.78 | 43.25 | 24,886 | 43.25 | |||||||||||||||||||
$ | 1.20 - $43.25 | 6,618,465 | 6.23 | $ | 8.41 | 4,231,067 | $ | 8.78 | ||||||||||||||||
Stock-based Compensation
12
Table of Contents
Valuation
and amortization method The Company uses the Black-Scholes model, single-option
approach to determine the fair value of stock options and ESPP shares. All share-based payment
awards are amortized on a straight-line basis over the requisite service periods of the awards,
which are generally the vesting periods. Prior to the adoption of SFAS No. 123R, the Company used
the Black-Scholes model, multiple-option approach to determine the fair value of stock options and
ESPP shares and amortization of resulting stock-based compensation amounts included in its pro
forma disclosures of SFAS No. 123. The determination of the fair value of stock-based payment
awards on the date of grant using an option-pricing model is affected by the Companys stock price
as well as assumptions regarding a number of complex and subjective variables. These variables
include actual and projected employee stock option exercise behaviors, the Companys expected stock
price volatility over the term of the awards, risk-free interest rate, and expected dividends.
Expected
term The Company estimates the expected term of options granted by using the
simplified method as prescribed by SAB No. 107. The expected term of ESPP shares is the length of
the offering period.
Expected
volatility The Company estimates the volatility of its common stock taking into
consideration its historical stock price movement, the volatility of stock prices of companies of
similar size with similar businesses, if any, and its expected future stock price trends based on
known or anticipated events.
Risk-free
interest rate The Company bases the risk-free interest rate that it uses in the
option pricing model on U.S. Treasury zero-coupon issues with remaining terms similar to the
expected term on the options.
Expected
dividend The Company does not anticipate paying any cash dividends in the
foreseeable future and therefore uses an expected dividend yield of zero in the option-pricing
model.
Forfeitures
The Company is required to estimate future forfeitures at the time of grant and
revise those estimates in subsequent periods if actual forfeitures differ from those estimates. The
Company uses historical data to estimate pre-vesting option forfeitures and records stock-based
compensation expense only for those awards that are expected to vest.
The assumptions used to value option grants and shares under the ESPP are as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
Options | 2007 | 2006 | 2007 | 2006 | ||||||||||||
Expected term (in years) |
6.25 | 6.25 | 6.25 | 6.25 | ||||||||||||
Volatility |
59 | % | 62 | % | 60 | % | 62 | % | ||||||||
Interest rate |
5.0 | % | 5.1 | % | 4.6 | % | 4.9 | % | ||||||||
Dividend yield |
| | | |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
Employee Stock Purchase Plan | 2007 | 2006 | 2007 | 2006 | ||||||||||||
Expected term (in years) |
0.5 | 0.5 | 0.5 | 0.5 | ||||||||||||
Volatility |
45 | % | 34 | % | 45 | % | 34 | % | ||||||||
Interest rate |
5.2 | % | 4.6 | % | 5.2 | % | 4.6 | % | ||||||||
Dividend yield |
| | | |
Total stock-based compensation recognized in the condensed consolidated statements of operations is as follows:
13
Table of Contents
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
Income Statement Classifications | 2007 | 2006 | 2007 | 2006 | ||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Cost of product sales |
$ | 26 | $ | 18 | $ | 46 | $ | 37 | ||||||||
Sales and marketing |
217 | 296 | 377 | 582 | ||||||||||||
Research and development |
128 | 121 | 314 | 250 | ||||||||||||
General and administrative |
238 | 259 | 506 | 548 | ||||||||||||
Total |
$ | 609 | $ | 694 | $ | 1,243 | $ | 1,417 | ||||||||
SFAS No. 123R requires the benefits of tax deductions in excess of recognized compensation
expense to be reported as a financing cash flow, rather than as an operating cash flow. This
requirement will reduce net operating cash flows and increase net financing cash flows in periods
after adoption. For the three months and six months ended
June 30, 2007, the Company recorded $791,000
and $1.9 million, respectively, of excess tax benefits from stock-based compensation.
The Company has calculated an additional paid-in capital (APIC) pool pursuant to the
provisions of SFAS No. 123R. The APIC pool represents the excess tax benefits related to
stock-based compensation that are available to absorb future tax deficiencies. The Company includes
only those excess tax benefits that have been realized in accordance with SFAS No. 109, Accounting
for Income Taxes. If the amount of future tax deficiencies is greater than the available APIC
pool, the Company will record the excess as income tax expense in its consolidated statements of
operations.
As of June 30, 2007, there was $5.1 million of unrecognized compensation cost, adjusted for
estimated forfeitures, related to non-vested stock options granted to the Companys employees and
directors. This cost will be recognized over an estimated weighted-average period of approximately
2.6 years. Total unrecognized compensation cost will be adjusted for future changes in estimated
forfeitures.
10. LITIGATION CONCLUSIONS AND PATENT LICENSE
In March 2007, the Companys patent infringement litigation with Sony Computer Entertainment
concluded. Sony Computer Entertainment satisfied the District Court judgment against it, which
included damages, pre-judgment interest, costs and interest totaling $97.3 million, along with
compulsory license fees already paid to the Company of $30.6 million and interest earned on these
fees of $1.8 million. See Note 15 for further discussion of this litigation. As of March 19, 2007,
the Company and Sony Computer Entertainment entered into an agreement whereby the Company granted
Sony Computer Entertainment and its affiliates a worldwide, non-transferable, non-exclusive license
of the Companys patents for the on-going use, development, manufacture, sale, lease, importation,
and distribution of its current and past PlayStation and related products. The license does not
cover adult, foundry, medical, automotive, industrial, mobility, or gambling products. The Company
also granted to Sony Computer Entertainment a license of the Companys patents for the use,
development, manufacture, sale, lease, importation, and distribution, by Sony Computer
Entertainment and through third parties, of haptic game devices for use on those Sony PlayStation
consoles. The Company also granted Sony Computer Entertainment certain other licenses, an option to
obtain licenses in the future with respect to future gaming consoles, products, certain releases
and covenants not to sue. Sony Computer Entertainment granted the Company certain covenants not to
sue and agreed to pay the Company twelve quarterly installments of $1.875 million (for a total of
$22.5 million) beginning on March 31, 2007 and ending on December 31, 2009, and may pay the Company
certain other fees and royalty amounts. In total, the Company will receive a minimum of $152.2
million through the conclusion of the litigation and the business agreement. The Company engaged an
independent firm of financial advisors to assist with the determination of the fair value of all
the elements of both the litigation conclusion and the patent license. In accordance with the
guidance from EITF No. 00-21, the Company has allocated the present value of the total payments,
equal to $149.9 million, between each element based on their relative fair values. Under this
allocation, the Company recorded $119.9 million as litigation conclusions and patent license income
and the remaining $30.0 million is allocated to deferred license revenue. The Company recorded
$749,000 and $856,000, as revenue, respectively, in the three-month and six-month periods ended
June 30, 2007. The Company will record the remaining $29.1 million as revenue, on a straight-line
basis, over the remaining capture period of the patents licensed, ending March 19, 2017. The
Company has accounted for future payments in accordance with APB No. 21 Interest on Receivables
and Payables. Under APB No. 21, the Company determined the present value of the $22.5 million
future payments to equal $20.2 million. The Company is accounting for the difference of $2.3
million as interest income as each $1.875 million payment installment becomes due.
In 2003, the Company executed a series of agreements with Microsoft as described in Note 8
that provided for settlement of its lawsuit against Microsoft as well as various licensing,
sublicensing, and equity and financing arrangements. Under the terms of
14
Table of Contents
these agreements, in the
event that the Company elects to settle the action in the United States District Court for the
Northern District of California entitled Immersion Corporation v. Sony Computer Entertainment of
America, Inc., Sony Computer Entertainment Inc. and Microsoft Corporation, Case No. C02-00710 CW
(WDB), as such action pertains to Sony Computer Entertainment, the Company would be obligated to
pay Microsoft a minimum of $15.0 million for amounts up to $100.0 million received from Sony
Computer Entertainment on account of the Companys granting certain rights, plus 25% of amounts
over $100.0 million up to $150.0 million, and 17.5% of amounts over $150.0 million. The Company has
determined that the conclusion of its litigation with Sony Computer Entertainment does not trigger
any payment obligations under its Microsoft agreements. Accordingly, the liability of $15.0 million
that was in the financial statements at December 31, 2006 has been extinguished, and the Company
has accounted for this sum as litigation conclusions and patent license income in the three-month
period ended March 31, 2007. However, in a letter sent to the Company dated May 1, 2007, Microsoft
disputed the Companys position and stated that it believes the Company owes Microsoft at least
$27.5 million. On June 18, 2007, Microsoft filed a complaint against the Company in the U.S.
District Court for the Western District of Washington alleging one claim for breach of a contract.
The Company disputes Microsofts allegations and intends to vigorously defend itself. See
Contingencies Note 15. The results of any litigation are inherently uncertain, and there can be no
assurance that the Companys position will prevail.
On September 24, 2004, the Company filed in the United States District Court for the Northern
District of California a complaint for patent infringement against Electro Source LLC (Electro
Source). On February 28, 2006, the Company announced that it had settled its legal differences
with Electro Source and the Company and Electro Source agreed to dismiss all claims and
counterclaims relating to this matter. In addition to the Confidential Settlement Agreement,
Electro Source entered into a worldwide license to the Companys patents for vibro-tactile devices
in the consumer gaming peripheral field of use under which Electro Source makes royalty payments to
the Company based on sales by Electro Source of spinning mass vibro-tactile gamepads, steering
wheels, and other game controllers for dedicated gaming consoles. In March 2006 and June 2006,
Electro Source paid the Company $650,000 and $400,000, respectively, and the Company recorded
$400,000 and $1.1 million as litigation conclusions and patent license income during the
three-month and six-month periods ended June 30, 2006, respectively.
11. INCOME TAXES
For the three months and six months ended June 30, 2007, the Company recorded (benefits)
provisions for income taxes of $(1.5) million and $7.0 million, yielding effective tax rates of
113.3% and 5.4%, respectively. For the three months and six months ended June 30, 2006, the Company
recorded (benefits) provisions for income taxes of $(15,000) and $87,000, yielding effective tax
rates or 0.6% and (1.7)%, respectively. During the second quarter of 2007, the Company generated a
$1.3 million taxable loss. During the first six months of 2007, the Company generated $129.6 of
taxable income and based upon these earnings and projected future taxable earnings the Company
released $47.6 million of the valuation allowance previously recorded against the deferred tax
assets. Although the Company incurred pre-tax losses for the six months ended June 30, 2006, sums
received from Sony Computer Entertainment and interest thereon included in long-term deferred
revenue, approximating $6.9 million during the period, created federal and state alternative
minimum taxable income.
On January 1, 2007, the Company adopted FIN 48, Accounting for Uncertainty in Income Taxes.
FIN 48 prescribes a recognition threshold that a tax position is required to meet before
being recognized in the financial statements and provides guidance on derecognition,
measurement, classification, interest and penalties, accounting in interim periods, disclosure and
transition issues.
The application of FIN 48 would have resulted in a decrease in retained earnings of $628,000,
except that the decrease was fully offset by the application of a valuation allowance. Future
changes in the unrecognized tax benefit will have an impact on the effective tax rate due. Accrued
interest on tax positions will be recorded as a component of income tax provision but is not
significant at June 30, 2007. No interest or penalties were recorded upon the adoption of FIN 48
as of January 1, 2007 or in the six months ended June 30, 2007. The Company does not reasonably
estimate that the unrecognized tax benefit will change significantly within the next twelve months.
The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which
it operates. The Company is currently open to audit under the statute of limitations by the
Internal Revenue Service for the years ending December 31, 1993 through 2006. The Company and its
subsidiaries state income tax returns are open to audit under the statute of limitations for the
years ending December 31, 1993 through 2006. The Companys foreign operations in Canada are open to
audit under statute of limitation for the years ending December 31, 1998 through 2006. The
Companys fiscal 2004 income tax return is currently under a routine examination by the Internal
Revenue Service.
Net deferred income taxes were $5.4 million as of June 30, 2007 and are primarily timing
differences between book and tax and federal net operating loss carryforwards of $2.8 million (net
of $1.0 million) that are limited in utilization to approximately $1.1 million annually, which
expire in 2020. During 2005, the Company evaluated ownership changes from 1999 to 2004 and
determined that there were no further limitations on the Companys net operating loss
carryforwards.
15
Table of Contents
12. NET INCOME (LOSS) PER SHARE
The following is a reconciliation of the numerators and denominators used in computing basic
and diluted net income (loss) per share (in thousands, except per share amounts):
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Numerator: |
||||||||||||||||
Net income (loss) used in computing basic net income (loss) per share |
$ | 176 | $ | (2,379 | ) | $ | 122,609 | $ | (5,285 | ) | ||||||
Interest on 5% Convertible Debentures |
| | 295 | | ||||||||||||
Net income (loss) used in computing diluted net income (loss) per
share |
$ | 176 | $ | (2,379 | ) | $ | 122,904 | $ | (5,285 | ) | ||||||
Denominator: |
||||||||||||||||
Shares used in computation of basic net income (loss) per share
(weighted average common shares outstanding) |
26,297 | 24,546 | 25,822 | 24,483 | ||||||||||||
Dilutive potential common shares: |
||||||||||||||||
Stock options |
1,933 | | 1,517 | | ||||||||||||
Warrants |
389 | | 345 | | ||||||||||||
5% Convertible Debentures |
| | 2,846 | | ||||||||||||
Shares used in computation of diluted net income (loss) per share |
28,619 | 24,546 | 30,530 | 24,483 | ||||||||||||
Basic net income (loss) per share |
$ | 0.01 | $ | (0.10 | ) | $ | 4.75 | $ | (0.22 | ) | ||||||
Diluted net income (loss) per share |
$ | 0.01 | $ | (0.10 | ) | $ | 4.03 | $ | (0.22 | ) | ||||||
For the three and six months ended June 30, 2007, options and warrants to purchase
approximately 534,578 and 918,988 shares of common stock, respectively, with exercise prices
greater than the average fair market value of the Companys stock of $11.27 and $9.50,
respectively, were not included in the calculation because the effect would have been
anti-dilutive. Additionally for the three months ended June 30, 2007, securities representing the
conversion of the 5% Convertible Debentures of 2,846,363 were excluded from the calculation because
the effect would have been anti-dilutive.
As of June 30, 2006, the Company had securities outstanding that could potentially dilute
basic earnings per share, but were excluded from the computation of diluted net loss per share
since their effect would have been anti-dilutive. These outstanding securities consisted of the
following:
June 30, | ||||
2006 | ||||
Outstanding stock options |
7,757,382 | |||
Warrants |
808,762 | |||
5% Senior Subordinated Convertible Debentures |
2,846,363 |
13. COMPREHENSIVE INCOME (LOSS)
The following table sets forth the components of comprehensive income (loss):
16
Table of Contents
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Net income (loss) |
$ | 176 | $ | (2,379 | ) | $ | 122,609 | $ | (5,285 | ) | ||||||
Change in unrealized gains (losses) on
short-term investments |
(25 | ) | | (25 | ) | | ||||||||||
Foreign currency translation adjustment |
32 | 21 | 32 | 21 | ||||||||||||
Total comprehensive income (loss) |
$ | 183 | $ | (2,358 | ) | $ | 122,616 | $ | (5,264 | ) | ||||||
14. SEGMENT REPORTING, GEOGRAPHIC INFORMATION, AND SIGNIFICANT CUSTOMERS
The Company develops, manufactures, licenses, and supports a wide range of hardware and
software technologies that more fully engage users sense of touch when operating digital devices.
The Company focuses on five application areas gaming, mobility, 3D, touch interface, and
medical. The Company manages these application areas under two operating and reportable segments:
1) Immersion Computing, Entertainment, and Industrial, and 2) Immersion Medical. The Company
determines its reporting segments in accordance with criteria outlined in SFAS No. 131,
Disclosures about Segments of an Enterprise and Related Information. The gaming, mobile devices,
3D, and touch interface areas do not individually meet the criteria for segment reporting as set
out in SFAS No. 131.
The Companys chief operating decision maker (CODM) is the Chief Executive Officer. The CODM
allocates resources to and assesses the performance of each operating segment using information
about its revenue and operating profit before interest and taxes. A description of the types of
products and services provided by each operating segment is as follows:
Immersion Computing, Entertainment, and Industrial develops and markets touch feedback
technologies that enable software and hardware developers to enhance realism and usability in their
computing, entertainment, and industrial applications. Immersion Medical develops, manufactures,
and markets medical training simulators that recreate realistic healthcare environments.
The following tables display information about the Companys reportable segments:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Revenues: |
||||||||||||||||
Immersion Computing, Entertainment, and Industrial |
$ | 4,474 | $ | 3,229 | $ | 8,232 | $ | 6,677 | ||||||||
Immersion Medical |
4,147 | 3,475 | 6,804 | 6,076 | ||||||||||||
Intersegment eliminations |
(26 | ) | (51 | ) | (27 | ) | (68 | ) | ||||||||
Total |
$ | 8,595 | $ | 6,653 | $ | 15,009 | $ | 12,685 | ||||||||
Net Income (Loss): |
||||||||||||||||
Immersion Computing, Entertainment, and Industrial |
$ | 152 | $ | (2,464 | ) | $ | 123,442 | $ | (5,103 | ) | ||||||
Immersion Medical |
23 | 95 | (839 | ) | (183 | ) | ||||||||||
Intersegment eliminations |
1 | (10 | ) | 6 | 1 | |||||||||||
Total |
$ | 176 | $ | (2,379 | ) | $ | 122,609 | $ | (5,285 | ) | ||||||
17
Table of Contents
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
(In thousands) | ||||||||
Total Assets: |
||||||||
Immersion Computing, Entertainment, and Industrial |
$ | 175,453 | $ | 64,280 | ||||
Immersion Medical |
6,414 | 7,494 | ||||||
Intersegment eliminations |
(20,664 | ) | (21,759 | ) | ||||
Total |
$ | 161,203 | $ | 50,015 | ||||
Intersegment eliminations represent eliminations for intercompany sales and cost of sales
and intercompany receivables and payables between Immersion Computing, Entertainment, and
Industrial and Immersion Medical segments.
The Company operates primarily in the United States and in Canada where it operates through
its wholly owned subsidiary, Immersion Canada, Inc. Segment assets and expenses relating to the
Companys corporate operations are not allocated but are included in Immersion Computing,
Entertainment, and Industrial as that is how they are considered for management evaluation
purposes. As a result, the segment information may not be indicative of the financial position or
results of operations that would have been achieved had these segments operated as unaffiliated
entities. Management measures the performance of each segment based on several metrics, including
net income (loss). These results are used, in part, to evaluate the performance of, and allocate resources
to, each of the segments.
Revenue
by Product Lines Information regarding revenue from external customers by product
lines is as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Revenues: |
||||||||||||||||
Consumer, Computing, and Entertainment |
$ | 1,716 | $ | 1,019 | $ | 3,490 | $ | 2,427 | ||||||||
3D |
1,097 | 1,182 | 2,088 | 2,359 | ||||||||||||
Touch Interface Products |
1,635 | 977 | 2,627 | 1,823 | ||||||||||||
Subtotal Immersion Computing,
Entertainment, and Industrial |
4,448 | 3,178 | 8,205 | 6,609 | ||||||||||||
Immersion Medical |
4,147 | 3,475 | 6,804 | 6,076 | ||||||||||||
Total |
$ | 8,595 | $ | 6,653 | $ | 15,009 | $ | 12,685 | ||||||||
Revenue
by Region The following is a summary of revenues by geographic areas. Revenues
are broken out geographically by the ship-to location of the customer. Geographic revenue as a
percentage of total revenue was as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
North America |
60 | % | 73 | % | 63 | % | 72 | % | ||||||||
Europe |
18 | % | 17 | % | 17 | % | 17 | % | ||||||||
Far East |
17 | % | 8 | % | 16 | % | 9 | % | ||||||||
Rest of the world |
5 | % | 2 | % | 4 | % | 2 | % | ||||||||
Total |
100 | % | 100 | % | 100 | % | 100 | % | ||||||||
18
Table of Contents
The Company derived 58% and 70% of its total revenues from the United States of America
for the three months ended June 30, 2007 and 2006, respectively. The Company derived 11% of its
total revenues from Japan for the three months ended June 30, 2007. The Company derived 10% and
11% of its total revenues from Germany for the three months ended June 30, 2007 and 2006,
respectively. The Company derived 62% and 70% of its total revenues from the United States of
America for the six months ended June 30, 2007 and 2006, respectively. The Company derived 11% of
its total revenues from Japan for the six months ended June 30, 2007. The Company derived 11% of
its total revenues from Germany for the six months ended June 30, 2006. Revenues from other
countries represented less than 10% individually for the periods presented.
The majority of the Companys long-lived assets are located in the United States of America.
Long-lived assets include net property and equipment and long-term investments and other assets.
Long-lived assets that were outside the United States of America constituted less than 10% of the
total on June 30, 2007 and December 31, 2006.
Significant Customers Customers comprising 10% or greater of the Companys net revenues are
summarized as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Customer A |
12 | % | * | 12 | % | * | ||||||||||
Customer B |
11 | % | * | * | * | |||||||||||
Total |
23 | % | * | 12 | % | * | ||||||||||
* | Revenue derived from customer represented less than 10% for the period. |
Customer B and two other customers accounted for 11%, 22%, and 10%, respectively, of the
Companys accounts receivable at June 30, 2007. Customer B accounted for 49% of the Companys
accounts receivable at December 31, 2006. No other customer accounted for more than 10% of the
Companys accounts receivable at December 31, 2006.
15. CONTINGENCIES
In re Immersion Corporation
The Company is involved in legal proceedings relating to a class action lawsuit filed on
November 9, 2001, In re Immersion Corporation Initial Public Offering Securities Litigation, No.
Civ. 01-9975 (S.D.N.Y.), related to In re Initial Public Offering Securities Litigation, No. 21 MC
92 (S.D.N.Y.). The named defendants are the Company and three of its current or former officers or
directors (the Immersion Defendants), and certain underwriters of the Companys November 12, 1999
initial public offering (IPO). Subsequently, two of the individual defendants stipulated to a
dismissal without prejudice.
The operative amended complaint is brought on purported behalf of all persons who purchased
the Companys common stock from the date of the Companys IPO through December 6, 2000. It alleges
liability under Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934, on the grounds that the registration statement for the IPO did
not disclose that: (1) the underwriters agreed to allow certain customers to purchase shares in the
IPO in exchange for excess commissions to be paid to the underwriters; and (2) the underwriters
arranged for certain customers to purchase additional shares in the aftermarket at predetermined
prices. The complaint also appears to allege that false or misleading analyst reports were issued.
The complaint does not claim any specific amount of damages.
Similar allegations were made in other lawsuits challenging over 300 other initial public
offerings and follow-on offerings conducted in 1999 and 2000. The cases were consolidated for
pretrial purposes. On February 19, 2003, the Court ruled on all defendants motions to dismiss. The
motion was denied as to claims under the Securities Act of 1933 in the case involving Immersion as
well as in all other cases (except for 10 cases). The motion was denied as to the claim under
Section 10(b) as to the Company, on the basis that the complaint alleged that the Company had made
acquisition(s) following the IPO. The motion was granted as to the claim under Section 10(b), but denied as to the claim under Section 20(a),
as to the remaining individual defendant.
The Company and most of the issuer defendants have settled with the plaintiffs. In this
settlement, plaintiffs have dismissed and released all claims against the Immersion Defendants, in
exchange for a contingent payment by the insurance companies
19
Table of Contents
collectively responsible for insuring the issuers in all of the IPO cases, and for the assignment or surrender of certain claims the
Company may have against the underwriters. The Immersion Defendants will not be required to make
any cash payments in the settlement, unless the pro rata amount paid by the insurers in the
settlement exceeds the amount of the insurance coverage, a circumstance which the Company believes
is remote. The settlement will require approval of the Court, which cannot be assured, after class
members are given the opportunity to object to the settlement or opt out of the settlement.
In September 2005, the Court granted preliminary approval of the settlement. The Court held a
hearing to consider final approval of the settlement on April 24, 2006, and took the matter under
submission. Before the Court issued a final decision on the settlement, on December 5, 2006 the
United States Court of Appeals for the Second Circuit vacated the class certification of
plaintiffs claims against the underwriters in six cases designated as focus or test cases. Miles
v. Merrill Lynch & Co. (In re Initial Public Offering Securities Litigation). Thereafter, on
December 14, 2006, the Court ordered a stay of all proceedings in all of the lawsuits pending the
outcome of plaintiffs petition to the Second Circuit Court of Appeals for a rehearing en banc and
resolution of the class certification issue. On April 6, 2007, the Second Circuit Court of Appeals
denied plaintiffs petition for a rehearing, but clarified that the plaintiffs may seek to certify
a more limited class. Accordingly, the plaintiffs and issuers have stated that they are prepared
to discuss how the settlement might be amended or renegotiated to comply with the decision of the
Second Circuit Court of Appeals. On April 30, 2007, Plaintiffs stated that they intend to present
a proposed redefined class to the Court. If the settlement is not amended or renegotiated and then
approved by the Court, the Company cannot assure that it will prevail in the lawsuit.
Immersion Corporation vs. Microsoft Corporation, Sony Computer Entertainment Inc. and Sony
Computer Entertainment of America, Inc.
On February 11, 2002, the Company filed a complaint against Microsoft Corporation, Sony
Computer Entertainment, Inc., and Sony Computer Entertainment of America, Inc. in the U.S. District
Court for the Northern District Court of California alleging infringement of U.S. Patent Nos.
5,889,672 and 6,275,213. On July 28, 2003, the Company announced that it had settled its legal
differences with Microsoft, and both parties agreed to dismiss all claims and counterclaims
relating to this matter as well as assume financial responsibility for their respective legal costs
with respect to the lawsuit between the Company and Microsoft.
On September 21, 2004, after a trial, the jury returned its verdict in favor of the Company.
The jury found all the asserted claims of the patents valid and infringed. The jury awarded the
Company damages in the amount of $82.0 million. On March 24, 2005, Judge Wilken entered judgment in
the Companys favor and awarded the Company $82.0 million in past damages, and pre-judgment
interest in the amount of $8.9 million, for a total of $90.9 million. The Company was also awarded
certain court costs. Court costs do not include attorneys fees. Additionally, the Court issued a
permanent injunction against the manufacture, use, sale, or import into the United States of the
infringing Sony PlayStation system consisting of the PlayStation consoles, Dual Shock controllers,
and the 47 games found by the jury to infringe the Companys patents. The Court stayed the
permanent injunction pending appeal to the United States Court of Appeals for the Federal Circuit.
The Court further ordered Sony Computer Entertainment to pay a compulsory license fee at the rate
of 1.37% for the duration of the stay of the permanent injunction at the same rate and conditions
as previously awarded in its interim January 10, 2005 and February 9, 2005 Orders. On April 7,
2005, pursuant to a stipulation of the parties, the Court entered an Amended Judgment to clarify
that the Judgment in favor of the Company and against Sony Computer Entertainment also encompassed
Sony Computer Entertainments counterclaims for declaratory relief on invalidity and
unenforceability, as well as non-infringement.
On March 1, 2007, Sony Computer Entertainment withdrew and moved to dismiss its appeals from
the District Courts April 7, 2005 Amended Judgment (and all interlocutory orders merged in the
Amended Judgment). On March 2, 2007, Sony Computer Entertainment withdrew and moved to dismiss its
appeal from the District Courts March 8, 2006 order denying Sony Computer Entertainments motion
for relief from final judgment under Rule 60(b) of the Federal Rules of Civil Procedure. On March
8, 2007, the Federal Circuit dismissed the Sony Computer Entertainment Rule 60(b) appeal. On March
14, 2007 the Federal Circuit dismissed the Sony Computer Entertainment appeal of Amended Judgment
(and all interlocutory orders merged in the Amended Judgment). In accordance with the Amended
Judgment, the Company received funds totaling $97.3 million in satisfaction of the judgment for
past damages for sales and other activities with respect to the infringing Sony PlayStation system
consisting of the PlayStation consoles, Dual Shock controllers, and the 47 games found by the jury
to infringe the Companys patents, pre-judgment interest and costs, and post-judgment interest.
Additionally, the Company retained $32.4 million of compulsory license fees and interest thereon
previously paid to the Company by Sony Computer Entertainment ($27.9 million in long-term deferred
revenue on December 31, 2006 and $4.5 million received subsequent to year end.) On March 19, 2007,
the Company lodged with the court a Notice of Satisfaction of Judgment, indicating that Sony
Computer Entertainment had satisfied and discharged the judgment that the court had entered. On March 19, 2007, pursuant to a Stipulation lodged with
the court, Judge Wilken entered an order dissolving the permanent injunction.
On May 17, 2005, Sony Computer Entertainment filed a Request for Inter Partes Reexamination of
the 333 Patent with the United States Patent and Trademark Office (PTO). On May 19, 2005, Sony
Computer Entertainment filed a similar Request for
20
Table of Contents
reexamination of the 213 Patent. On March 27, 2007, the Company filed a petition to terminate the inter partes reexamination on the grounds that
the District Court judgment was final and non-appealable. On June 5, 2007, the USPTO granted the
Companys petition to terminate the inter partes proceedings.
Internet Services LLC Litigation
On October 20, 2004, Internet Services LLC (ISLLC) filed claims against the Company in its
lawsuit against Sony Computer Entertainment, alleging that the Company breached a contract with
ISLLC by suing Sony Computer Entertainment for patent infringement relating to haptically-enabled
software whose topics or images are allegedly age-restricted, for judicial apportionment of damages
between ISLLC and the Company of the damages awarded by the jury, and for a judicial declaration
with respect to ISLLCs rights and duties under agreements with the Company. On December 29, 2004,
the Court issued an order dismissing ISLLCs claims against Sony Computer Entertainment with
prejudice and dismissing ISLLCs claims against the Company without prejudice to ISLLC filing a new
complaint if it can do so in good faith without contradicting, or repeating the deficiency of, its
complaint.
On January 12, 2005, ISLLC filed Amended Cross-Claims and Counterclaims against the Company
that contained similar claims. ISLLC also realleged counterclaims against Sony Computer
Entertainment. On January 28, 2005, the Company filed a motion to dismiss ISLLCs Amended
Cross-Claims and a motion to strike ISLLCs Counterclaims against Sony Computer Entertainment. On
March 24, 2005 the Court issued an order dismissing ISLLCs claims with prejudice as to ISLLCs
claim seeking a declaratory judgment that it is an exclusive licensee under the 213 and 333
patents and as to ISLLCs claim seeking judicial apportionment of the damages verdict in the Sony
Computer Entertainment case. The Courts order further dismissed ISLLCs claims without prejudice
as to ISLLCs breach of contract and unjust enrichment claims.
ISLLC filed a notice of appeal of the District Court orders with the United States Court of
Appeals for the Federal Circuit on April 18, 2005. On April 4, 2007, the Federal Circuit issued its
opinion, affirming the District Court orders.
On February 8, 2006, ISLLC filed a lawsuit against the Company in the Superior Court of Santa
Clara County. ISLLCs complaint seeks a share of the damages awarded to the Company in the March
24, 2005 Judgment and of the Microsoft settlement proceeds, and generally restates the claims
already adjudicated by the District Court. On March 16, 2006, the Company answered the complaint,
cross claimed for breach of contract by ISLLC and rescission of the contract, and removed the
lawsuit to federal court. The case was assigned to Judge Wilken as a case related to the previous
proceedings involving Sony Computer Entertainment and ISLLC. ISLLC filed its answer to the
Companys cross claims on April 27, 2006. ISLLC also moved to remand the case to Superior Court. On
July 10, 2006, Judge Wilken issued an order denying ISLLCs motion to remand. On September 5, 2006,
Judge Wilken granted the stipulated request by the parties to stay discovery and other proceedings
in the case pending the disposition of ISLLCs appeal from the Courts previous orders. The case
was stayed from December 1, 2006 pending the Federal Circuits disposition on the appeal. As noted
above, the Federal Circuit issued its opinion on April 4, 2007, and entered a judgment affirming
the District Courts previous orders. On April 23, 2007, ISLLC filed in the Federal Circuit a
Petition for Panel Rehearing and a Motion to Extend Time. ISLLC argued that the Court should rehear
the matter or correct and/or clarify the April 4, 2007 opinion. On May 7, 2007, the Federal Circuit
denied ISLLCs petition.
On May 10, 2007, ISLLC filed a motion in the District Court to remand its latest action to the
Superior Court or in the alternative for leave to file an amended complaint to remove the
declaratory relief claim. The Company opposed ISLLCs motion, and cross-moved for judgment on the
pleadings on the grounds that ISLLCs claims are barred by res judicata and collateral estoppel.
On June 26, 2007, the Court ruled on the motions, denying ISLLCs motion to remand or for leave to
file an amended complaint, and granting in part the Companys motion for judgment on the pleadings.
The Court dismissed ISLLCs claim for declaratory relief. ISLLCs claims for breach of contract,
promissory fraud, and constructive trust, to the extent not inconsistent with the Courts previous
rulings, remain.
The Company intends to defend itself vigorously against ISLLCs allegations. The parties
participated in a court ordered mediation on March 12, 2007, but were unsuccessful in resolving the
matter.
Immersion Corporation vs. Thorner
On March 24, 2006, the Company filed a lawsuit against Mr. Craig Thorner in Santa Clara County
Superior Court. The complaint alleges claims for breach of contract with respect to Thorners
license to a third party of U.S. Patent No. 5,684,722, which the Company has alleged is in violation of contractual obligations to it. The case was
removed to federal court by Mr. Thorner, and has been assigned to Judge Jeremy Fogel. On May 1,
2006, Mr. Thorner filed an answer to the Companys claims and asserted counterclaims against the
Company seeking, among other things, a portion of the proceeds from the Companys license with
Microsoft, under theories of alleged breach of contract, breach of the implied covenant of good
faith and fair dealing, fraud, promissory fraud, breach of fiduciary duty, and negligent
misrepresentation. On July 28, 2006, the Company filed a motion for judgment on the pleadings
seeking the dismissal of Mr. Thorners breach of contract and fraud claims which allege a right to
a
21
Table of Contents
portion of the proceeds from the Companys license with Microsoft. On September 1, 2006, the
Court held a hearing on the Companys motion. On September 12, 2006, the Court issued an order
granting the Companys motion for judgment on the pleadings as to Mr. Thorners alleged claims for
breach of contract and fraud. The Court dismissed Mr. Thorners breach of contract and fraud
claims, and allowed Mr. Thorner leave to amend his claim for alleged breach of contract with
respect to alleged violations of the Companys reporting requirements that do not flow from the
failure to report the Microsoft Settlement Agreement.
The parties participated in a court-ordered mediation on November 7, 2006, but were not
successful in resolving the matter. The parties are in the process of conducting discovery.
On November 22, 2006, Thorner brought a motion for summary judgment arguing that the Companys
breach of contract claim was barred by the doctrine of judicial estoppel as a result of a statement
made in connection with the Sony Computer Entertainment Rule 60 (b) motion. On January 26, 2007,
the Court held a hearing on Thorners motion. On January 29, 2007, the Court issued an order
denying Thorners summary judgment motion, ruling that the Companys breach of contract claim was
not barred by judicial estoppel. On February 5, 2007, with leave of Court, the Company filed a
First Amended Complaint in the action to add Thorners company, Virtual Reality Feedback
Corporation (VRF), as a party-defendant. On February 9, 2007, Thorner filed an Amended Answer and
Counterclaims. The Amended Counterclaims against the Company dropped the previously-dismissed
counterclaims based on Thorners claims for a share of the Companys settlement with Microsoft, but
alleged other counterclaims for alleged Breach of Contract, Breach of the Implied Covenant of Good
Faith and Fair Dealing, Promissory Fraud, Breach of Fiduciary Duty, Negligent Misrepresentation and
Rescission. Thorner alleged in part that the Company breached its agreement with Thorner by failing
to pay royalties for Vibetonz Studio Software Development Kit (SDK) and Immersion Studio for
Gaming; that the Company breached alleged duties to Thorner to license the 722 patent; and that
Thorners agreement with the Company should be rescinded. Thorners Amended Counterclaim does not
specify an amount of damages sought but alleges that Thorner has been damaged in an amount to be
proven at trial. The Company disputes Thorners allegations and intends to vigorously oppose them.
On June 27, 2007, the parties informed the Court that they had reached an agreement in
principle to resolve the case and requested that the Court vacate dates in the case. The parties
requested a status conference in the event that the matter was not finally resolved. On July 3,
2007, the Court entered an Order approving the stipulation, vacating pending dates in the action,
and setting September 7, 2007 as a date for a further status conference.
Faro Technologies Inc. v. Immersion Corporation
On May 3, 2007, Faro Technologies, Inc. (Faro) sued the Company in the Eastern District of
Pennsylvania. The complaint alleges patent infringement of Faros 5,402,582 patent by the Companys
MicroScribe X product. The Company was not served with the complaint. On August 2, 2007, Faro
filed a voluntary dismissal without prejudice of the complaint.
Microsoft Corporation v. Immersion Corporation
On June 18, 2007, Microsoft filed a complaint against the Company in the U.S. District Court
for the Western District of Washington alleging one claim for breach of a contract. Microsoft
alleges that the Company breached a Sublicense Agreement executed in connection with the parties
settlement of litigation in 2003 (see discussion above regarding the settlement with Microsoft).
The complaint alleges that Microsoft is entitled to a share of the judgment monies and other sums
received from Sony Computer Entertainment. In a letter sent to the Company dated May 1, 2007,
Microsoft stated that it believes the Company owes Microsoft at least $27.5 million. The Company
was served with the complaint on July 6, 2007; its response is due on September 4, 2007.
The Company disputes Microsofts allegations and intends to vigorously defend itself.
Other Contingencies
From time to time, the Company receives claims from third parties asserting that the Companys
technologies, or those of its licensees, infringe on the other parties intellectual property
rights. Management believes that these claims are without merit. Additionally, periodically, the
Company is involved in routine legal matters and contractual disputes incidental to its normal
operations. In managements opinion, the resolution of such matters will not have a material
adverse effect on the Companys consolidated financial condition, results of operations, or
liquidity.
In the normal course of business, the Company provides indemnifications of varying scope to
customers against claims of intellectual property infringement made by third parties arising from
the use of the Companys intellectual property, technology, or products. Historically, costs
related to these guarantees have not been significant, and the Company is unable to estimate the
maximum potential impact of these guarantees on its future results of operations.
22
Table of Contents
As permitted under Delaware law, the Company has agreements whereby it indemnifies its
officers and directors for certain events or occurrences while the officer or director is, or was,
serving at its request in such capacity. The term of the indemnification period is for the
officers or directors lifetime. The maximum potential amount of future payments the Company could
be required to make under these indemnification agreements is unlimited; however, the Company
currently has director and officer insurance coverage that limits its exposure and enables it to
recover a portion of any future amounts paid. Management believes the estimated fair value of these
indemnification agreements in excess of applicable insurance coverage is minimal.
See also Note 6 regarding contingencies relating to the 5% Convertible Debenture.
16. SUBSEQUENT EVENT
On July 27, 2007 the Company announced that it had notified the holders of its 5% Convertible
Debentures, due in 2009, of its intent to redeem all of the 5 % Convertible Debentures in full
pursuant to the Mandatory Redemption provision in its 5% Convertible Debentures discussed in Note
6. Approximately $20.1 million of principal and accrued interest is outstanding under the 5%
Convertible Debentures. Under the terms of the 5% Convertible Debentures, once the closing bid
price of the Companys common stock exceeds $14.053 per share for 20 consecutive trading days, the
Company may redeem the 5% Convertible Debentures at the end of a 30-day notice period. Prior to the
end of the 30-day period, the holders of the 5% Convertible Debenture may elect to convert the
principal and accrued interest outstanding into shares of the Companys common stock at a
conversion price of $7.0265 per share. The 5% Convertible Debentures ceased to accrue further
interest upon the Companys election to effect the Mandatory Redemption.
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. The forward-looking statements involve risks and uncertainties.
Forward-looking statements are identified by words such as anticipates, believes, expects,
intends, may, will, and other similar expressions. However, these words are not the only
way we identify forward-looking statements. In addition, any statements, which refer to
expectations, projections, or other characterizations of future events, or circumstances, are
forward-looking statements. Actual results could differ materially from those projected in the
forward-looking statements as a result of a number of factors, including those set forth below in
Managements Discussion and Analysis of Financial Condition and Results of Operations and Risk
Factors, those described elsewhere in this report, and those described in our other reports filed
with the SEC. We caution you not to place undue reliance on these forward-looking statements,
which speak only as of the date of this report, and we undertake no obligation to update these
forward-looking statements after the filing of this report. You are urged to review carefully and
consider our various disclosures in this report and in our other reports publicly disclosed or
filed with the SEC that attempt to advise you of the risks and factors that may affect our
business.
OVERVIEW
We develop, manufacture, license, and support a wide range of hardware and software
technologies that enhance touch interaction with digital devices. We focus on five application
areas gaming, mobility, 3D, touch interface, and medical. We manage these application areas
under two operating and reportable segments: 1) Immersion Computing, Entertainment, and Industrial,
and 2) Immersion Medical.
In markets where our touch technology is a small piece of a larger system (such as mobile
phones, consumer gaming peripherals, and automotive interfaces), we license our technologies to
third-party manufacturers who integrate our technology into their products and resell it under
their own brand names. In other markets, where our touch technology is a complete system (like
medical simulation systems and three-dimensional and professional products) or electronic
components (like electronic arcade gaming boards, rotary encoders, and lateral actuators for
tactile touchscreens), we manufacture and sell products under our own Immersion brand name, through
direct sales, distributors, and value added resellers. In all market areas, we also engage in
development projects for third parties and government agencies from time to time.
Our objective is to proliferate our technologies across markets, platforms, and applications
so that touch and feel become as necessary as color, graphics, and sound in modern user interfaces.
We and our wholly owned subsidiaries hold more than 600 issued or pending patents in the United
States of America and other countries, covering various aspects of hardware and software
technologies.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
23
Table of Contents
Our discussion and analysis of our financial condition and results of operations are based
upon our condensed consolidated financial statements, which have been prepared in accordance with
GAAP. The preparation of these condensed consolidated financial statements requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues,
expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we
evaluate our estimates and assumptions, including those related to revenue recognition, stock-based
compensation, bad debts, inventory reserves, warranty obligations, patents and intangible assets,
contingencies, and litigation. We base our estimates and assumptions on historical experience and
on various other factors that we believe to be reasonable under the circumstances, the results of
which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results may differ from these estimates and
assumptions.
We believe the following are our most critical accounting policies as they require our
significant judgments and estimates in the preparation of our condensed consolidated financial
statements:
Revenue Recognition We recognize revenues in accordance with applicable accounting
standards, including SAB No. 104, Revenue Recognition, EITF No. 00-21, Accounting for Revenue
Arrangements with Multiple Deliverables, and AICPA SOP 97-2, Software Revenue Recognition, as
amended. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has
occurred or service has been rendered, the fee is fixed and determinable, and collectibility is
probable. We derive our revenues from three principal sources: royalty and license fees, product
sales, and development contracts.
Royalty and license revenue We recognize royalty and license revenue based on royalty
reports or related information received from the licensee as well as time-based licenses of our
intellectual property portfolio. Up-front payments under license agreements are deferred and
recognized as revenue based on either the royalty reports received or amortized over the license
period depending on the nature of the agreement. Advance payments under license agreements that
also require us to provide future services to the licensee are deferred and recognized over the
service period when VSOE related to the value of the services does not exist.
We generally recognize revenue from our licensees under one or a combination of the following
license models:
License revenue model | Revenue recognition | |
Perpetual license of intellectual
property portfolio based on per unit
royalties, no services contracted.
|
Based on royalty reports received from licensees. No further obligations to licensee exist. | |
Time-based license of intellectual
property portfolio with up-front
payments and/or annual minimum
royalty requirements, no services
contracted. Licensees have certain
rights to updates to the intellectual
property portfolio during the
contract period.
|
Based on straight-line amortization of annual minimum/up-front payment recognized over contract period or annual minimum period. | |
Perpetual license of intellectual
property portfolio or technology
license along with contract for
development work.
|
Based on cost-to-cost percentage-of-completion accounting method over the service period. Obligation to licensee exists until development work is complete. | |
License of software or technology, no
modification necessary, no services
contracted.
|
Up-front revenue recognition based on SOP 97-2 criteria or EITF No. 00-21, as applicable. |
Individual contracts may have characteristics that do not fall within a specific license model
or may have characteristics of a combination of license models. Under those circumstances, we
recognize revenue in accordance with SAB No. 104, EITF No. 00-21, and SOP 97-2, as amended, to
guide the accounting treatment for each individual contract. See also the discussions regarding
Multiple element arrangements below. If the information received from our licensees regarding
royalties is incorrect or inaccurate, our revenues in future periods may be adversely affected. To
date, none of the information we have received from our licensees has caused any material reduction
in future period revenues.
Product sales We recognize revenues from product sales when the product is shipped, provided
collection is determined to be probable and no significant obligation remains. We sell the majority
of our products with warranties ranging from three to twenty-four months. We record the estimated
warranty costs during the quarter the revenue is recognized. Historically, warranty-related costs
and related accruals have not been significant. We offer a general right of return on the
MicroScribe product line for
24
Table of Contents
14 days after purchase. We recognize revenue at the time of shipment
of a MicroScribe digitizer and provide an accrual for potential returns based on historical
experience. We offer no other general right of return on our products.
Development contracts and other revenue Development contracts and other revenue is comprised
of professional services (consulting services and/or development contracts), customer support, and
extended warranty contracts. Development contract revenues are recognized under the cost-to-cost
percentage-of-completion accounting method based on physical completion of the work to be
performed. Losses on contracts are recognized when determined. Revisions in estimates are reflected
in the period in which the conditions become known. Customer support and extended warranty contract
revenue is recognized ratably over the contractual period.
Multiple element arrangements We enter into revenue arrangements in which the customer
purchases a combination of patent, technology, and/or software licenses, products, professional
services, support, and extended warranties (multiple element arrangements). When VSOE of fair value
exists for all elements, we allocate revenue to each element based on the relative fair value of
each of the elements.
Our revenue recognition policies are significant because our revenues are a key component of
our results of operations. In addition, our revenue recognition determines the timing of certain
expenses, such as commissions and royalties. Revenue results are difficult to predict, and any
shortfall in revenue or delay in recognizing revenue could cause our operating results to vary
significantly from quarter to quarter and could result in greater or future operating losses.
Stock-based Compensation We account for stock-based compensation in accordance with SFAS No.
123R. We elected the modified-prospective method, under which prior periods are not revised for
comparative purposes. Under the fair value recognition provisions of this statement, stock-based
compensation cost is measured at the grant date based on the fair value of the award and is
recognized as expense on a straight-line basis over the requisite service period, which is the
vesting period.
Valuation and amortization method We use the Black-Scholes model, single-option approach to
determine the fair value of stock options and ESPP shares. All share-based payment awards are
amortized on a straight-line basis over the requisite service periods of the awards, which are
generally the vesting periods. The determination of the fair value of stock-based payment awards on
the date of grant using an option-pricing model is affected by our stock price as well as
assumptions regarding a number of complex and subjective variables. These variables include actual
and projected employee stock option exercise behaviors, our expected stock price volatility over
the term of the awards, risk-free interest rate, and expected dividends.
Expected term We estimate the expected term of options granted by using the simplified
method as prescribed by SAB No. 107.
Expected volatility We estimate the volatility of our common stock taking into consideration
our historical stock price movement, the volatility of stock prices of companies of similar size
with similar businesses, if any, and our expected future stock price trends based on known or
anticipated events.
Risk-free interest rate We base the risk-free interest rate that we use in the option
pricing model on U.S. Treasury zero-coupon issues with remaining terms similar to the expected term
on the options.
Expected dividend We do not anticipate paying any cash dividends in the foreseeable future
and therefore use an expected dividend yield of zero in the option pricing model.
Forfeitures We are required to estimate future forfeitures at the time of grant and revise
those estimates in subsequent periods if actual forfeitures differ from those estimates. We use
historical data to estimate pre-vesting option forfeitures and record stock-based compensation
expense only for those awards that are expected to vest. Changes in estimated forfeitures will be
recognized through a cumulative catch-up adjustment in the period of change and will also impact
the amount of compensation expense to be recognized in future periods.
If factors change and we employ different assumptions for estimating stock-based compensation
expense in future periods, or if we decide to use a different valuation model, the future periods
may differ significantly from what we have recorded in the current period and could materially
affect our operating results.
The Black-Scholes model was developed for use in estimating the fair value of traded options
that have no vesting restrictions and are fully transferable, characteristics not present in our
option grants and ESPP shares. Existing valuation models, including the Black-Scholes and lattice
binomial models, may not provide reliable measures of the fair values of our stock-based
25
Table of Contents
compensation. Consequently, there is a risk that our estimates of the fair values of our
stock-based compensation awards on the grant dates may bear little resemblance to the actual values
realized upon the exercise, expiration, early termination, or forfeiture of those stock-based
payments in the future. Certain stock-based payments, such as employee stock options, may expire
and be worthless or otherwise result in zero intrinsic value as compared to the fair values
originally estimated on the grant date and reported in our financial statements. Alternatively,
value may be realized from these instruments that are significantly higher than the fair values
originally estimated on the grant date and reported in our financial statements. There currently is
no market-based mechanism or other practical application to verify the reliability and accuracy of
the estimates stemming from these valuation models, nor is there a means to compare and adjust the
estimates to actual values.
See Note 9 to the condensed consolidated financial statements for further information
regarding the SFAS No. 123R disclosures.
Accounting for Income Taxes We use the asset and liability method of accounting for income
taxes. Under this method, income tax expense is recognized for the amount of taxes payable or
refundable for the current year. In addition, deferred tax assets and liabilities are recognized
for the expected future tax consequences of temporary differences between the financial reporting
and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards.
Management must make assumptions, judgments, and estimates to determine our current provision for
income taxes and also our deferred tax assets and liabilities and any valuation allowance to be
recorded against a deferred tax asset.
Our judgments, assumptions, and estimates relative to the current provision for income tax
take into account current tax laws, our interpretation of current tax laws and possible outcomes of
current and future audits conducted by foreign and domestic tax authorities. We have established
reserves for income taxes to address potential exposures involving tax positions that could be
challenged by tax authorities. Although we believe our judgments, assumptions, and estimates are
reasonable, changes in tax laws or our interpretation of tax laws and any future tax audits could
significantly impact the amounts provided for income taxes in our condensed consolidated financial
statements.
Our assumptions, judgments, and estimates relative to the value of a deferred tax asset take
into account predictions of the amount and category of future taxable income, such as income from
operations or capital gains income. Actual operating results and the underlying amount and category
of income in future years could render inaccurate our current assumptions, judgments, and estimates
of recoverable net deferred taxes. Any of the assumptions, judgments, and estimates mentioned above
could cause our actual income tax obligations to differ from our estimates, thus materially
impacting our financial position and results of operations.
Long-term Liabilities In 2003, we executed a series of agreements with Microsoft as
described in Note 8 to the condensed consolidated financial statements that provided for settlement
of our lawsuit against Microsoft as well as various licensing, sublicensing, and equity and
financing arrangements. We accounted for the proceeds received under the agreements as a long-term
customer advance based on certain provisions that would result in payment of funds to Microsoft.
Upon Microsofts election to convert its shares of our Series A Preferred Stock into common stock,
we reduced the long-term customer advance from Microsoft to the minimum amount we would be
obligated to pay Microsoft upon a settlement of the Sony Computer Entertainment Lawsuit as set
forth in our agreements with Microsoft. The remainder of the consideration was transferred to
common stock in 2004. Per the conditions as set forth in our agreements with Microsoft, in the
event that we elected to settle the action in the United States District Court for the Northern
District of California entitled Immersion Corporation v. Sony Computer Entertainment of America,
Inc., Sony Computer Entertainment Inc. and Microsoft Corporation, Case No. C02-00710 CW (WDB), as
such action pertains to Sony Computer Entertainment, we would be obligated to pay Microsoft a
minimum of $15.0 million for amounts up to $100.0 million received from Sony Computer Entertainment on account
of our granting certain rights, plus 25% of amounts over $100.0 million up to $150.0 million, and
17.5% of amounts over $150.0 million.
In March 2007, we announced the conclusion of our patent infringement litigation against Sony
Computer Entertainment at the U.S. Court of Appeals for the Federal Circuit. Sony Computer
Entertainment satisfied the District Court judgment against it. As of March 19, 2007, we entered
into a new business agreement with Sony Computer Entertainment. We have determined that the
conclusion of our litigation with Sony Computer Entertainment does not trigger any payment
obligations under our Microsoft agreements. However, on June 18, 2007, Microsoft filed a complaint
against us in the United States District Court for the Western District of Washington alleging
breach of our Sublicense Agreement dated July 25, 2003 and seeks damages, specific performance,
declaratory judgment and attorneys fees and costs. We believe that we are not obligated under the
Sublicense Agreement with Microsoft to make any payment to Microsoft relating to the conclusion
of our litigation with Sony Computer Entertainment. We intend to defend this lawsuit vigorously.
The results of any litigation are inherently uncertain, and there can be no assurance that our
position will prevail.
In December 2004, we executed a series of agreements as described in Note 6 to the condensed
consolidated financial statements that provided for the issuance of 5% Convertible Debentures and
warrants, and that granted certain registration rights
26
Table of Contents
to the holders of the 5% Convertible Debentures. We accounted for the issuance of our 5% Convertible Debentures and related warrants in
accordance with EITF No. 98-5, Accounting for Convertible Securities with Beneficial Conversion
Features or Contingently Adjustable Conversion Ratios and other related accounting guidance. We
estimated the relative fair value of the various instruments included in the agreements entered
into in December 2004 and allocated the relative fair values to be as follows: warrants $1.7
million, Put Option $0.1 million, Registration Rights $0.1 million, issuance costs $1.3
million, 5% Convertible Debentures $16.8 million. The 5% Convertible Debentures are being
accreted to $20.0 million over their five-year life, resulting in additional interest expense. The
value of the warrants is included in Stockholders Equity (Deficit), the value of the Put Option
and Registration Rights are recorded as liabilities and are subject to future value adjustments,
and the value of the 5% Convertible Debentures is recorded as long-term debt. As of July 26, 2007
the closing bid price of our common stock exceeded $14.053 for 20 consecutive trading days and on
July 27, 2007, the holders of the 5% Convertible Debentures were notified that we intend to effect
the Mandatory Redemption of the 5% Convertible Debentures (see Note 16 to the condensed
consolidated financial statements regarding subsequent event).
Long-term Deferred Revenue In addition to normal items of deferred revenue due after one
year, we had included Sony Computer Entertainment compulsory license fees and interest earned
thereon in long-term deferred revenue due to the contingent nature of the court-ordered payments
(see Note 7 to the condensed consolidated financial statements). Upon the conclusion of our patent
litigation at the U.S. Court of Appeals for the Federal Circuit the contingency on these funds
lapsed.
Short-term Investments Our short-term investments consist primarily of highly liquid debt
instruments purchased with an original or remaining maturity at the date of purchase of greater
than 90 days. We classify all debt securities with readily determinable market values as
available-for-sale in accordance with SFAS No. 115, Accounting for Certain Investments in Debt
and Equity Securities. These investments are carried at fair market value with unrealized gains
and losses considered to be temporary in nature reported as a separate component of other
comprehensive income (loss) within stockholders equity (deficit). We review all investments for
reductions in fair value that are other-than-temporary. When such reductions occur, the cost of the
investment is adjusted to fair value through loss on investments on the condensed consolidated
statement of operations. Gains and losses on investments are calculated on the basis of specific
identification.
Recovery of Accounts Receivable We maintain allowances for doubtful accounts for estimated
losses resulting from our review and assessment of our customers ability to make required
payments. If the financial condition of one or more of our customers were to deteriorate, resulting
in an impairment of their ability to make payments, additional allowances might be required. To
date such estimated losses have been within our expectations.
Inventory Reserves We reduce our inventory value for estimated obsolete and slow moving
inventory in an amount equal to the difference between the cost of inventory and the net realizable
value based upon assumptions about future demand and market conditions. If actual future demand and
market conditions are less favorable than those projected by management, additional inventory
write-downs may be required.
Product Return and Warranty Reserves We provide for estimated costs of future anticipated
product returns and warranty obligations based on historical experience when related revenues are
recognized, and we defer warranty-related revenue over the related warranty term.
Intangible Assets We have acquired patents and other intangibles. In addition, we
capitalize the external legal and filing fees associated with patents and trademarks. We assess
the recoverability of our intangible assets, and we must make assumptions regarding estimated future cash flows and other factors to determine the fair value of the
respective assets that affect our consolidated financial statements. If these estimates or related
assumptions change in the future, we may be required to record impairment charges for these assets.
We amortize our intangible assets related to patents and trademarks, once they issue, over their
estimated useful lives, generally 10 years. Future changes in the estimated useful life could
affect the amount of future period amortization expense that we will incur. During the three months
and six months ended June 30, 2007, we capitalized costs associated with patents and trademarks of
$447,000 and $833,000, respectively. Our total amortization expense for the same periods for all
intangible assets was $242,000 and $496,000, respectively.
The above listing is not intended to be a comprehensive list of all of our accounting
policies. In many cases, the accounting treatment of a particular transaction is specifically
dictated by GAAP, with no need for managements judgment in their application. There are also areas
in which managements judgment in selecting any available alternative would not produce a
materially different result.
RESULTS OF OPERATIONS FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2007 AND 2006
Overview
27
Table of Contents
We achieved a 29% increase in revenues during the three months ended June 30, 2007 as
compared to the three months ended June 30, 2006 and an 18% increase in revenues during the six
months ended June 30, 2007 as compared to the six months ended June 30, 2006. The second quarter
revenue growth was primarily due to a 61% increase in royalty and license revenues, primarily
gaming and touch interface product royalties and a 35% increase in product sales, primarily medical
product sales. Our net income was $176,000 for the three months ended June 30, 2007 compared to a
net loss of $2.4 million for the three months ended June 30, 2006, mainly due to an increase in
revenues, income tax benefits, and increased interest income, partially offset by increased
operating expenses. Our net income was $122.6 million for the six months ended June 30, 2007
compared to a net loss of $5.3 million for the six months ended June 30, 2006. The increase in net
income was primarily due to the litigation conclusion and patent license from Sony Computer
Entertainment of $119.9 million and the extinguishment of the liability to Microsoft of $15.0
million.
In March 2007, we announced the conclusion of our patent infringement litigation against Sony
Computer Entertainment at the U.S. Court of Appeals for the Federal Circuit. In satisfaction of
the Amended Judgment, we received funds totaling $97.3 million, inclusive of the award for past
damages for sales and other activities with respect to the infringing Sony PlayStation system
consisting of the PlayStation consoles, Dual Shock controllers, and the 47 games found by the jury
to infringe our patents, pre-judgment interest and costs, and post-judgment interest. Additionally
we retained the $32.4 million of compulsory license fees and interest thereon previously paid to us
by Sony Computer Entertainment pursuant to Court Orders. We also entered into a new business
agreement with Sony Computer Entertainment. In addition, in both March and June 2007, Sony Computer
Entertainment made payments of $1.875 million pursuant to rights under the new business agreement.
During the remainder of 2007, we expect to focus on the execution of sales and marketing plans
in our established businesses to increase revenue and make selected investments in product and
technology development for longer-term new growth areas. In addition, we have budgeted to continue
to protect and defend our extensive intellectual property portfolio across all business segments.
Our continued success could be limited by several factors, including the timely release of our new
products or our licensees products, continued market acceptance of our products and technology,
the introduction of new products by existing or new competitors, and the cost of ongoing
litigation. For a further discussion of these and other risk factors, see the section titled Risk
Factors.
June 30, | Change | |||||||||||
REVENUES | 2007 | 2006 | ||||||||||
($ In thousands) | ||||||||||||
Three months ended: |
||||||||||||
Royalty and license |
$ | 2,747 | $ | 1,702 | 61 | % | ||||||
Product sales |
5,289 | 3,917 | 35 | % | ||||||||
Development contracts and other |
559 | 1,034 | (46 | )% | ||||||||
Total Revenue |
$ | 8,595 | $ | 6,653 | 29 | % | ||||||
Six months ended: |
||||||||||||
Royalty and license |
$ | 4,958 | $ | 3,612 | 37 | % | ||||||
Product sales |
8,879 | 7,283 | 22 | % | ||||||||
Development contracts and other |
1,172 | 1,790 | (35 | )% | ||||||||
Total Revenue |
$ | 15,009 | $ | 12,685 | 18 | % | ||||||
Three Months Ended June 30, 2007 Compared to Three Months Ended June 30, 2006
Total Revenue Our total revenue for the second quarter of 2007 increased by $1.9 million or
29% from the second quarter of 2006.
Royalty and license revenue Royalty and license revenue is comprised of royalties earned on
sales by our TouchSense licensees and license fees charged for our intellectual property portfolio.
Royalty and license revenue for the three months ended June 30, 2007 was $2.7 million, an increase
of $1.0 million or 61% from the three months ended June 30, 2006. The increase in
28
Table of Contents
royalty and license revenue was primarily due to an increase in touch interface product
royalties of $681,000 and an increase in gaming royalties of $444,000.
Touch interface product royalties increased due to increased licensee revenue from the
expansion of the number of products licensed to the automotive market and the recognition of
certain royalty payments in the second quarter of 2007.
The increase in gaming royalties was mainly due to new royalty and license revenue from Sony
Computer Entertainment, a first-party peripheral licensee, during the three months ended June 30,
2007, which offset a decrease in sales by our third-party peripheral licensees of royalty bearing
gaming peripherals compared to last year. Sony Computer Entertainment became a licensee in March
2007, and accordingly there was no license revenue from them in the prior year comparative period.
During the three months ended June 30, 2007, we recognized $749,000 of revenue from Sony Computer
Entertainment. The decrease in revenues of $305,000 from our third-party peripheral licensees was
primarily due to i) the reduced sales of past generation video console systems with the launches of
the next-generation console models from Microsoft (Xbox 360), Sony (PlayStation 3), and Nintendo
(Wii), and ii) the significant decline in third-party market share of aftermarket game console
controllers as market share shifted to first-party peripheral makers due to the launch of the
next-generation console models.
The market share shift to first-party peripheral makers in combination with other actions by
Microsoft, Sony, and Nintendo has caused our gaming revenue from existing third-party peripheral
licensees to decline. Sony announced on May 8, 2006 that the vibration feature that is currently
available on controllers for PlayStation and PlayStation 2 would be removed from the new
PlayStation 3 controller. The PlayStation 3 console system was launched in late 2006 in the United
States and Japan without native vibration or any force feedback capability of any kind. This course
of action by Sony has had material adverse consequences on our current and future gaming royalty
revenues from third-party peripheral licensees since our gaming royalties have primarily been from
licensed third-party controller products with vibration or force feedback capabilities that require
some degree of vibration and/or force feedback support or compatibility in the video console system
to be viable products. In the first quarter of 2007, Sony released an update to the PlayStation 3
that offers limited vibration and force feedback support for some older PS1 and PS2 games and
rumble and force feedback controllers compatible with the PS1 and PS2 console systems. We do not
know if this situation might change at some point in the life of the PlayStation 3 console system,
or whether or to what extent the PlayStation 3 console will be compatible with or support rumble or
force feedback in PS3 games or controllers compatible with the PS3 console system.
Based on our litigation conclusion and new business agreement entered into with Sony Computer
Entertainment in March 2007 (see Note 10 to the condensed consolidated financial statements for
more discussion) we will recognize a minimum of $30.0 million as royalty and license revenue from
March 2007 through March 2017, approximately $750,000 per quarter. For the Microsoft Xbox
360 video console system launched in November 2005, Microsoft has, to date, not broadly licensed
third parties to produce game controllers. Because our gaming royalties come mainly from
third-party manufacturers, unless Microsoft licenses additional third-parties, our gaming royalty
revenue may continue to decline. For the Nintendo Wii video console system launched in December
2006, Nintendo has, to date, not yet broadly licensed third parties to produce game controllers for
its Wii game console. Because our gaming royalties come mainly from third-party manufacturers,
unless Nintendo licenses additional third-party licensees, our gaming royalty revenue may continue
to decline.
Product sales Product sales for the three months ended June 30, 2007 were $5.3 million, an
increase of $1.4 million or 35% as compared to the three months ended June 30, 2006. The increase
in product sales was primarily due to increased medical product sales of $1.4 million, mainly due
to increased sales of our endovascular, endoscopy, and Virtual IV simulator platforms. This
increase in product sales was a result of pursuing a product growth strategy for our medical
business, which includes developing new products, leveraging our industry alliances, and expanding
international sales. In addition, there was an increase in product sales from touch interface
products of $18,000 including increased sales of rotary modules. Touch interface products include
touchscreen and touch panel components, rotary modules, and commercial gaming products. Partially
offsetting this increase was a decrease in product sales of our 3D products of $93,000 primarily
due to decreased sales of our MicroScribe, CyberGrasp®, and CyberGlove® products as a result of
some sales force transitions.
Development contract and other revenue Development contract and other revenue is comprised
of revenue on commercial and government contracts and extended support and warranty contracts.
Development contract and other revenue was $559,000 during the three months ended June 30, 2007, a
decrease of $475,000 or 46% as compared to the three months ended June 30, 2006. Government
contract revenue decreased by $645,000 primarily due to the completion of work performed under a
medical government contract. Partially offsetting this decrease was an increase in commercial
contract revenue of $105,000 mainly due to increased revenue recognized on mobile device
development contracts led by the completion of one mobile device development contract, partially
offset by decreased medical and touch interface product development contract revenue.
We categorize our geographic information into four major regions: North America, Europe, Far
East, and Rest of the World. In the second quarter of 2007, revenue generated in North America,
Europe, Far East, and Rest of the World represented 60%, 18%, 17%, and 5%, respectively, compared
to 73%, 17%, 8%, and 2%, respectively, for the second quarter of 2006. The shift in
29
Table of Contents
revenues among regions was mainly due to an increase in medical product revenue, touch
interface product royalty revenue, and mobile devices royalty and development contract revenue in
the Far East, and an increase in medical product sales in the Rest of the World, offset by a
reduction in revenue from North American gaming licensees and a decrease in government contract
revenue from customers in North America due to the completion of those projects in 2006.
Six Months Ended June 30, 2007 Compared to the Six Months Ended June 30, 2006
Total Revenue Our total revenue for the first six months of 2007 increased by $2.3 million
or 18% from the first six months of 2006.
Royalty and license revenue Royalty and license revenue for the six months ended June 30,
2007 increased by $1.3 million or 37% from the six months ended June 30, 2006. The increase in
royalty and license revenue was primarily due to an increase in gaming royalties of $699,000 and an
increase in touch interface product royalties of $691,000, offset in part by a decrease in medical
license fees of $83,000. The increase in gaming royalties was mainly due to new royalty and license
revenue from Sony Computer Entertainment, a first-party peripheral licensee, during the six months
ended June 30, 2007, which offset a decrease in sales by our third-party peripheral licensees of
royalty bearing gaming peripherals compared to last year. Touch interface product royalties
increased due to the expansion of the number of products licensed to the automotive market and the
recognition of certain royalty payments in the second quarter of 2007. The decrease in medical
royalty and license revenue was primarily due to a decrease in license revenue from our license and
development agreements with Medtronic.
Product sales Product sales for the six months ended June 30, 2007 increased by $1.6 million
or 22% as compared to the six months ended June 30, 2006. The increase in product sales was
primarily due to increased medical product sales of $1.8 million, mainly due to increased sales of
our endovascular, endoscopy, and Virtual IV simulator platforms. In addition, there was an increase
in product sales from touch interface products of $58,000 including increased sales of rotary
modules and commercial gaming products. Partially offsetting this increase was a decrease in
product sales of our 3D products of $270,000 primarily due to decreased sales of our MicroScribe,
CyberGlove, and CyberGrasp, products due to sales force transitions
and quality initiatives.
Development contract and other revenue Development contract and other revenue for the six
months ended June 30, 2007 decreased by $618,000 or 35% as compared to the six months ended June
30, 2006. Government contract work decreased by $1.1 million primarily due to the completion of
work performed under a medical government contract in 2006. Partially offsetting this decrease was
an increase in commercial contract revenue of $355,000 mainly due to increased development contract
revenue from the completion of one mobile device development contract and continued revenue from
another mobile device development contract. In addition, revenue from product repairs increased by
$106,000.
In the first six month of 2007, revenue generated in North America, Europe, Far East, and Rest
of the World represented 63%, 17%, 16%, and 4%, respectively, compared to 72%, 17%, 9%, and 2%,
respectively, for the first six months of 2006. The shift in revenues among regions was mainly due
to an increase in medical product revenue, touch interface product royalty revenue, and mobile
devices royalty and development contract revenue in the Far East, and an increase in medical
product sales in the Rest of the World, offset by a decrease in government contract revenue from
customers in North America due to the completion of those projects in 2006.
June 30, | Change | |||||||||||
COST OF PRODUCT SALES | 2007 | 2006 | ||||||||||
($ In thousands) | ||||||||||||
Three months ended: |
||||||||||||
Cost of product sales |
$ | 2,427 | $ | 1,802 | 35 | % | ||||||
% of total product revenue |
46 | % | 46 | % | ||||||||
Six months ended: |
||||||||||||
Cost of product sales |
$ | 3,970 | $ | 3,157 | 26 | % | ||||||
% of total product revenue |
45 | % | 43 | % |
30
Table of Contents
Cost of Product Sales Our cost of product sales consists primarily of materials, labor, and
overhead. There is no cost of product sales associated with royalty revenue or development contract
revenue. Cost of product sales was $2.4 million, an increase of $625,000 or 35% for the three
months ended June 30, 2007 as compared to the three months ended June 30, 2006. The increase in
cost of product sales was primarily due to increased direct material costs of $368,000 and an
increase of overhead costs of $266,000, offset in part by decreased royalties of $32,000. The
increase in direct material costs was a result of increased product sales. Overhead costs
increased, in part, as a result of increased salary expense primarily due to the costs of programs
to improve quality processes within our manufacturing operations which we anticipate will continue
throughout 2007.
Cost of product sales increased by $813,000 or 26% for the six months ended June 30, 2007 as
compared to the six months ended June 30, 2006. The increase in cost of product sales was primarily
due to increased direct material costs of $519,000, and an increase of overhead costs of $328,000,
offset in part by decreased royalties of $53,000. The increase in direct material costs was a
result of increased product sales and a shift in product mix that included sales of our lower
margin Virtual IV medical simulator. Overhead costs increased, in part, as a result of increased
salary expense primarily due to the costs of programs to improve quality processes within our
manufacturing operations.
31
Table of Contents
June 30, | Change | |||||||||||
OPERATING EXPENSES AND OTHER | 2007 | 2006 | ||||||||||
($ In thousands) | ||||||||||||
Three months ended: |
||||||||||||
Sales and marketing |
$ | 3,030 | $ | 3,009 | 1 | % | ||||||
% of total revenue |
35 | % | 45 | % | ||||||||
Research and development |
$ | 2,513 | $ | 1,802 | 39 | % | ||||||
% of total revenue |
29 | % | 27 | % | ||||||||
General and administrative |
$ | 3,122 | $ | 2,296 | 36 | % | ||||||
% of total revenue |
36 | % | 35 | % | ||||||||
Amortization of intangibles |
$ | 242 | $ | 219 | 11 | % | ||||||
% of total revenue |
3 | % | 3 | % | ||||||||
Litigation conclusions and patent license |
$ | | $ | (400 | ) | * | % | |||||
% of total revenue |
| % | (6 | )% | ||||||||
Six months ended: |
||||||||||||
Sales and marketing |
$ | 5,733 | $ | 6,086 | (6 | )% | ||||||
% of total revenue |
38 | % | 48 | % | ||||||||
Research and development |
$ | 5,056 | $ | 3,531 | 43 | % | ||||||
% of total revenue |
34 | % | 28 | % | ||||||||
General and administrative |
$ | 6,381 | $ | 5,107 | 25 | % | ||||||
% of total revenue |
43 | % | 40 | % | ||||||||
Amortization of intangibles |
$ | 496 | $ | 429 | 16 | % | ||||||
% of total revenue |
3 | % | 3 | % | ||||||||
Litigation conclusions and patent license. |
$ | (134,900 | ) | $ | (1,050 | ) | * | % | ||||
% of total revenue |
(899 | )% | (8 | )% |
* | Percentage not meaningful |
Sales and Marketing Our sales and marketing expenses are comprised primarily of employee
compensation and benefits costs, advertising, public relations, trade shows, brochures, market
development funds, travel, and an allocation of facilities costs. Sales and marketing expenses were
$3.0 million, an increase of $21,000 or 1% in the second quarter of 2007 compared to the comparable
period in 2006. The increase was primarily due to increased salaries, benefits, and overhead
expense of $59,000, an increase in bad debt expense of $39,000, an increase in professional
consulting and license fees of $19,000, and an increase in inventory items used for demonstration
purposes of $11,000, offset in part by decreased advertising and public relations costs of $59,000,
and a decrease in travel expense to support sales and marketing efforts of $49,000 due to timing of
programs and sales meetings. The increased compensation, benefits, and overhead expense was
primarily due to increased variable compensation earned on increased sales and contracts signed
during the period. We expect to continue to focus our sales and marketing efforts on medical,
mobile device, and touchscreen market opportunities to build greater market acceptance for our
touch technologies. We expect to continue to invest in sales and marketing in future
periods to exploit market opportunities for our technology.
32
Table of Contents
Sales and marketing expenses decreased by $353,000 or 6% in the first six months of 2007
compared to the comparable period in 2006. The decrease was mainly the result of decreased
compensation, benefits, and overhead expense of $122,000, decreased advertising and marketing
expenses including, market research, product marketing and public relations costs of $117,000, and
decreased travel expense to support sales and marketing efforts of $104,000. The decreased
compensation, benefits, and overhead expense was primarily due to a reduction in headcount and
decreased stock-based compensation expense offset in part by an increase in variable compensation
earned on increased sales and contracts signed during the period.
Research and Development Our research and development expenses are comprised primarily of
employee compensation and benefits, consulting fees, tooling and supplies, and an allocation of
facilities costs. Research and development expenses were $2.5 million, an increase of $711,000 or
39% in the second quarter of 2007 compared to the same period in 2006. The increase was primarily
due to increased compensation, benefits, and overhead of $514,000, an increase in professional
consulting expense of $116,000 for non-recurring engineering projects, an increase in prototyping
expenses of $64,000, and an increase in travel of $13,000. The increased compensation, benefits,
and overhead expense was primarily due to increased research and development headcount. We believe
that continued investment in research and development is critical to our future success, and we
expect to make targeted investments in areas of product and technology development to support
future growth.
Research and development expenses increased by $1.5 million or 43% in the first six months of
2007 compared to the same period in 2006. The increase was primarily due to increased compensation,
benefits, and overhead of $1.1 million, an increase in professional consulting expense of $230,000
for non-recurring engineering projects, an increase in travel of $77,000 in support of sales
efforts, and an increase in prototyping expenses of $51,000. The increased compensation, benefits,
and overhead expense was primarily due to increased research and development headcount.
Additionally, environmental regulation compliance has caused overall research and development
expenses to increase for the period and we anticipate we will need to expend further costs and
resources to meet new compliance regulations in the future.
General and Administrative Our general and administrative expenses are comprised primarily
of employee compensation and benefits, legal and professional fees, office supplies, travel, and an
allocation of facilities costs. General and administrative expenses were $3.1 million, an increase
of $826,000 or 36% in the second quarter of 2007 compared to the same period in 2006. The increase
was primarily due to increased legal, professional, and license fee expense of $823,000. The
increased legal, professional, and license fee expenses were primarily due to increased audit, tax,
and accounting fees mainly related to the accounting and valuation for Sony Computer Entertainment
litigation conclusion and patent license and income tax related issues, increased general legal and
patent costs, and increased consulting costs. We expect that the dollar amount of general and
administrative expenses to continue to be a significant component of our operating expenses. We
will continue to incur costs related to litigation as we continue to defend our intellectual
property and defend lawsuits brought against us.
General and administrative increased by $1.3 million or 25% in the first six months of 2007
compared to the same period in 2006. The increase was primarily due to increased legal,
professional, and license fee expense of $1.2 million and increased public company expense of
$75,000. The increased legal, professional, and license fee expenses were primarily due to
increased audit, tax, and accounting fees, increased general legal and patent costs, and increased
consulting costs.
Amortization of Intangibles Our amortization of intangibles is comprised primarily of patent
amortization and other intangible amortization. Amortization of intangibles increased by $23,000 or
11% in the second quarter of 2007 compared to the same period in 2006. Amortization of intangibles
increased by $67,000 or 16% in the first six months of 2007 compared to the same period in 2006.
The increases were primarily attributable to the increased cost and number of patents being
amortized offset in part by some intangible assets reaching full amortization.
Litigation Conclusions and Patent License In March 2007, we concluded our patent
infringement litigation against Sony Computer Entertainment at the U.S. Court of Appeals for the
Federal Circuit. In satisfaction of the Amended Judgment, we received funds totaling $97.3
million, inclusive of the award for past damages, pre-judgment interest and costs, and
post-judgment interest. Additionally, we retained $32.4 million of compulsory license fees and
interest thereon previously paid to us by Sony Computer Entertainment pursuant to Court Orders. See
Note 15 to the condensed consolidated financial statements for further discussion of this
litigation. As of March 19, 2007 both parties entered into an agreement whereby we granted Sony
Computer Entertainment and its affiliates a worldwide, non-transferable, non-exclusive license of
our patents for the going-forward use, development, manufacture, sale, lease, importation, and
distribution of its current and past PlayStation and related products. The license does not cover
adult, foundry, medical, automotive, industrial, mobility, or gambling products. We also granted to
Sony Computer Entertainment a license of our patents for the use, development, manufacture, sale,
lease, importation, and distribution, by Sony Computer Entertainment and through third parties, of
haptic game devices for use on those Sony PlayStation consoles. We also granted Sony Computer
Entertainment certain other licenses, an option to obtain licenses in the future with respect to
future gaming consoles, products, certain releases and covenants not to sue. Sony Computer
Entertainment granted us certain covenants not to sue and agreed to pay us twelve quarterly
installments of $1.875 million (for a total of $22.5 million) beginning on March 31, 2007 and
ending on December 31, 2009, and may pay us certain other fees and royalty amounts. In total, we
will
33
Table of Contents
receive a minimum of $152.2 million through the conclusion of the litigation and the separate
patent license. We engaged an independent firm of financial advisors to assist with the
determination of the fair value of all the elements of both the litigation conclusion and patent
license. In accordance with the guidance from EITF No. 00-21, we allocated the present value of the
total payments, equal to $149.9 million, between each element based on their relative fair values.
Under this allocation, we recorded $119.9 million as litigation conclusions and patent license
income and the remaining $30.0 million was allocated to deferred license revenue. We recorded
$749,000 and $856,000, as revenue, respectively, in the three-month and six-month periods ended
June 30, 2007. We will record the remaining $29.1 million as revenue, on a straight-line basis,
over the remaining capture period of the patents licensed, ending March 19, 2017. We have accounted
for future payments in accordance with APB No. 21 Interest on Receivables and Payables. Under
APB No. 21, we determined the present value of the $22.5 million future payments to equal $20.2
million. We will account for the difference of $2.3 million as interest income as each $1.875
million payment installment becomes due.
Under the terms of a series of agreements that we entered into with Microsoft in 2003, in the
event we had elected to settle the action in the United States District Court for the Northern
District of California entitled Immersion Corporation v. Sony Computer Entertainment of America,
Inc., Sony Computer Entertainment Inc. and Microsoft Corporation, Case No. C02-00710 CW (WDB), as
such action pertains to Sony Computer Entertainment, we would be obligated to pay Microsoft a
minimum of $15.0 million for amounts up to $100.0 million received from Sony Computer Entertainment
on account of our granting certain rights, plus 25% of amounts over $100.0 million up to $150.0
million, and 17.5% of amounts over $150.0 million. The patent infringement litigation with Sony
Computer Entertainment was concluded in March 2007 at the U.S. Court of Appeals for the Federal
Circuit without settlement. We have determined that the conclusion of our litigation with Sony
Computer Entertainment does not trigger any payment obligations under our Microsoft agreements.
Accordingly, the liability of $15.0 million that was in the financial statements at December 31,
2006 was extinguished, and we have accounted for this sum as litigation conclusions and patent
license income in the six-month period ended June 30, 2007. However, in a letter sent to us dated
May 1, 2007, Microsoft disputed our position and stated that it believes we owe Microsoft at least
$27.5 million. On June 18, 2007, Microsoft filed a complaint against us in the U.S. District Court
for the Western District of Washington alleging one claim for breach of a contract. We dispute
Microsofts allegations and intend to vigorously defend ourselves. See Contingencies Note 15 to the
condensed consolidated financial statements. The results of any litigation are inherently
uncertain, and there can be no assurance that our position will prevail.
In February 2006, we announced that we had settled our legal differences in our complaint for
patent infringement against Electro Source and that both parties had agreed to dismiss all claims
and counterclaims relating to this matter. In addition to the Confidential Settlement Agreement,
Electro Source entered into a worldwide license to our patents for vibro-tactile devices in the
consumer gaming peripheral field of use. According to the terms of the agreement, Electro Source
will make royalty payments to us based on sales by Electro Source of spinning mass vibro-tactile
gamepads, steering wheels, and other game controllers for dedicated gaming consoles, such as the
Sony PlayStation and PlayStation 2, the Nintendo GameCube, and the Microsoft Xbox and Xbox 360. In
March 2006 and June 2006, Electro Source paid us $650,000 and $400,000, respectively, and we
recorded $400,000 and $1.1 million as litigation conclusions and patent license income during the
three-month and six-month periods ended June 30, 2006, respectively.
Interest and Other Income Interest and other income consists primarily of interest income
and dividend income from cash and cash equivalents and short-term investments. Interest and other
income increased by $1.7 million in the second quarter of 2007 compared to the same period in 2006.
This improvement was primarily the result of increased interest income earned on increased cash,
cash equivalents, and short-term investments invested after the receipt of the judgment from Sony
Computer Entertainment in March 2007. Interest income earned on the payments from Sony Computer
Entertainment up until the judgment
became final had been included in deferred revenue. We expect interest income to increase
throughout the remainder of the year due to interest income earned on our increased cash, cash
equivalent, and short-term investment balances.
Interest and other income increased by $2.0 million in the first six months of 2007 compared
to the same period in 2007. This improvement was the result of increased cash, cash equivalents,
and short-term investments invested for the first six months of 2007 compared to the same period in
2006.
Interest Expense Interest expense consists primarily of interest and accretion expense on
our 5% Convertible Debentures. Interest expense increased by $4,000 in the second quarter of 2007
compared to the same period in 2006. Interest expense increased by $3,000 in the first six months
of 2007 compared to the same period in 2006. See subsequent Note 16 to the condensed consolidated
financial statements with regard to future interest expense on our 5% Convertible Debentures.
Benefit (Provision) for Income Taxes For the second quarter of 2007, we recorded a
benefit for income taxes of $(1.5) million on a pre-tax loss of $1.3 million, yielding an effective
tax rate of 113.3%. For the second quarter of 2006, we recorded a benefit for income taxes of
$(15,000) on a pre-tax loss of $2.4 million, yielding an effective tax rate of 0.6%. During the
second quarter of 2007, we generated a $1.3 million taxable loss. Based on this loss and future
projections, we recorded a benefit for
34
Table of Contents
income taxes for the quarter ended June 30, 2007. Reductions in estimated taxable income
caused us to record a tax benefit for the quarter ended June 30, 2006.
For the six months ended June 30, 2007, we recorded a provision for income taxes of $7.0 on
pre-tax income of $129.6 million, yielding an effective tax rate of 5.4%. For the six months ended
June 30, 2006, we recorded a provision for income taxes of $87,000 on a pre-tax loss of $5.2
million, yielding an effective tax rate of (1.7)%. The provision for income taxes for the six
months ended June 30, 2007 utilized a significant portion of our net operating loss carryforwards
to offset taxable income that were previously fully reserved thereby reducing the overall effective
tax rate. We released $47.0 million of the deferred tax valuation allowance in the six months ended
June 30, 2006 as the income utilized a substantial portion of the deferred tax assets. The
provision for income tax for the six months ended June 30, 2006 was based on federal and state
alternative minimum income tax payable on taxable income. Although we incurred pre-tax losses in
six months ended June 30, 2006, the sums received from Sony Computer Entertainment and interest
thereon included in long term deferred revenue, approximating $6.9 million for the first six months
of 2006 were taxable, giving rise to an overall taxable profit.
SEGMENT RESULTS FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2007 AND 2006
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Revenues: |
||||||||||||||||
Immersion Computing, Entertainment, and Industrial |
$ | 4,474 | $ | 3,229 | $ | 8,232 | $ | 6,677 | ||||||||
Immersion Medical |
4,147 | 3,475 | 6,804 | 6,076 | ||||||||||||
Intersegment eliminations |
(26 | ) | (51 | ) | (27 | ) | (68 | ) | ||||||||
Total |
$ | 8,595 | $ | 6,653 | $ | 15,009 | $ | 12,685 | ||||||||
Net Income (Loss): |
||||||||||||||||
Immersion Computing, Entertainment, and Industrial |
$ | 152 | $ | (2,464 | ) | $ | 123,442 | $ | (5,103 | ) | ||||||
Immersion Medical |
23 | 95 | (839 | ) | (183 | ) | ||||||||||
Intersegment eliminations |
1 | (10 | ) | 6 | 1 | |||||||||||
Total |
$ | 176 | $ | (2,379 | ) | $ | 122,609 | $ | (5,285 | ) | ||||||
* | Segment assets and expenses relating to our corporate operations are not allocated but are included in Immersion Computing, Entertainment, and Industrial as that is how they are considered for management evaluation purposes. As a result the segment information may not be indicative of the financial position or results of operations that would have been achieved had these segments operated as unaffiliated entities. |
Immersion Computing, Entertainment, and Industrial segment Revenues from the Immersion
Computing, Entertainment, and Industrial segment were $4.5 million, an increase of $1.3 million or
39% in the second quarter of 2007 compared to the same period in 2006. Royalty and license revenues
increased by $1.1 million, mainly due to new royalty and license revenue from Sony Computer
Entertainment, a first-party peripheral licensee, which was offset in part by a decrease in royalty
and license revenue from our third-party peripheral licensees of royalty bearing gaming
peripherals, and an increase in touch interface product royalties from the expansion of products
licensed by us in the automotive market and the recognition of certain royalty payments during the
second quarter. Development contract revenues increased by $217,000, primarily due to increased
revenue from mobile device contracts, partially offset by a decrease in touch interface product
development contracts. Product sales decreased by $100,000, mainly due to decreased sales of our 3D
products including our MicroScribe, CyberGrasp, and CyberGlove products, partially offset by an
increase in product sales from touch interface products, including sales of rotary modules. Net
income for the three months ended June 30, 2007 was $152,000, an improvement of $2.6 million
compared to the same period in 2006. The increase was primarily due to an increase in interest and
other income of $1.7 million, an increase in benefit for income taxes $1.5 million, and increased
gross margin of $1.0 million. The increases were partially offset by an increase of general and
administrative expenses of $955,000, the reduction of litigation settlements of $400,000 from
Electro Source in 2006, and an increase in research and development expenses of $138,000.
Revenues for the first six months of fiscal 2007 increased by $1.6 million, or 23% as compared
to the same period last year
35
Table of Contents
for the Immersion Computing, Entertainment, and Industrial segment. Royalty and license
revenue increased by $1.4 million, mainly due to increased gaming royalties and increased royalties
and license fees from our touch interface product licensees as noted above; development contract
revenue increased by $379,000, primarily due to increased revenue from mobile device contracts,
offset in part by a reduction in revenue on touch interface products contracts; and product sales
decreased by $253,000, mainly due to decreased sales of our 3D products partially offset by an
increase in touch interface product sales. Net income for the six months ended June 30, 2007 was
$123.4 million, an improvement of $128.5 million compared to the same period in 2006. The increase
was primarily due to the litigation conclusions and patent license income of $134.9 million (Sony
Computer Entertainment of $119.9 million and from Microsoft of $15.0 million), increased interest
and other income of $2.0 million, increased gross margin of $1.3 million and a decrease in sales
and marketing expenses of $189,000. The increases were partially offset by increased provision for
income taxes of $6.9 million, an increase in general and administrative expenses of $1.4 million,
the reduction of litigation settlements of $1.1 million from Electro Source in 2006, and an
increase of research and development expenses of $367,000.
Immersion Medical segment Revenues from Immersion Medical were $4.1 million, an increase of
$672,000 or 19%, for the second quarter of 2007 compared to the same period in 2006. The increase
was primarily due to an increase of $1.4 million in product sales partially offset by a decrease of
$692,000 in development contract revenue and a decrease in medical license fees of $83,000. Product
sales increased primarily due to increased sales of our endovascular, endoscopy, and Virtual IV
simulators. The product sales increase was a result of pursuing a product growth strategy for our
medical business, which includes developing new products, leveraging our industry alliances, and
expanding international sales. Development contract revenue decreased due to the completion of work
performed under a government contract and a decrease in commercial contract revenue. Net income for
the three months ended June 30, 2007 was $23,000, a decrease of $72,000 or 76% compared to the same
period in 2006. The decline was mainly due to increased operating expenses of $374,000 partially
offset by increased gross margin of $305,000. The increased operating expenses included increased
research and development expenses of $573,000 partially offset by decreased general and
administrative expenses of $129,000 and decreased sales and marketing expenses of $71,000.
Revenues from Immersion Medical were $6.8 million, an increase of $728,000 or 12%, for the
first six months of 2007 compared to the same period in 2006. The increase was primarily due to an
increase of $1.8 million in product sales partially offset by a decrease of $1.0 million in
development contract revenue, and a decrease in medical license fees of $83,000. Product sales
increased primarily due to increased sales of our endovascular, endoscopy, and Virtual IV
simulators. The product sales increase was a result of our continued pursuit of a product growth
strategy for our medical business as noted above. Development contract revenue decreased due to the
completion of work performed under a government contract. Net loss for the six months ended June
30, 2007 was $839,000, an increase of $656,000 compared to the same period in 2006. The increased
loss was mainly due to increased operating expenses of $839,000 partially offset by increased gross
margin of $189,000. The increased operating expenses included increased research and development
expenses of $1.2 million partially offset by decreased sales and marketing expenses of $164,000 and
decreased general and administrative expenses of $155,000.
LIQUIDITY AND CAPITAL RESOURCES
Our cash, cash equivalents, and short-term investments consist primarily of money market funds
and highly liquid debt instruments. All of our cash equivalents and short-term investments are
classified as available-for-sale under the provisions of SFAS No. 115, Accounting for Certain
Investments in Debt and Equity Securities. The securities are stated at market value, with
unrealized gains and losses reported as a component of accumulated other comprehensive income,
within stockholders equity (deficit).
On June 30, 2007 our cash, cash equivalents, and short-term investments totaled $135.5
million, an increase of $103.5 million from $32.0 million on December 31, 2006.
In March 2007, we concluded our patent infringement litigation against Sony Computer
Entertainment at the U.S. Court of Appeals for the Federal Circuit. In satisfaction of the Amended
Judgment, we received funds totaling $97.3 million, inclusive of the award for past damages,
pre-judgment interest and costs, and post-judgment interest. Additionally, we retained $32.4
million of compulsory license fees and interest thereon previously paid to us by Sony Computer
Entertainment pursuant to Court Orders. Furthermore, we entered into a new business agreement.
Under the new business agreement we are to receive twelve quarterly installments of $1.875 million
for a total of $22.5 million beginning on March 31, 2007 and ending on December 31, 2009. As of
June 30, 2007 we have received two of these installments.
We have determined that the conclusion of our litigation with Sony Computer Entertainment does
not trigger any payment obligations under our Microsoft agreements as noted in Note 8 to the
condensed consolidated financial statements. Accordingly, the liability of $15.0 million that was
in the financial statements at December 31, 2006 had been extinguished, and we have accounted for
this sum as litigation conclusions and patent license income in the three-month period ended March
31, 2007. However, in a letter sent to us dated May 1, 2007, Microsoft disputed our position and
stated that it believes we owe Microsoft at least $27.5 million. On June 18, 2007, Microsoft filed
a complaint against us in the U.S. District Court for the Western District of
36
Table of Contents
Washington alleging one claim for breach of a contract. We dispute Microsofts allegations and
intend to vigorously defend ourselves. See Contingencies Note 15 to the condensed consolidated
financial statements. The results of any litigation are inherently uncertain, and there can be no
assurance that our position will prevail.
In December 2004, we issued an aggregate principal amount of $20.0 million of 5% Convertible
Debentures. The 5% Convertible Debentures were due to mature on December 22, 2009. The amount
payable at maturity of each 5% Convertible Debenture was the initial principal plus all accrued but
unpaid interest thereon, to the extent such principal amount and interest has not been converted
into common stock or previously paid in cash. Our 5% Convertible Debentures accrued interest at 5%
per annum. Accordingly, we were required to make interest payments in the amount of $1.0 million
per annum until such time as the 5% Convertible Debentures were either converted to common stock or
matured. If the closing bid price of our common stock was at or above $14.053 for at least 20
consecutive trading days, and certain other conditions are met, we had the right to (i) require the
holder of a 5% Convertible Debenture to convert the 5% Convertible Debenture in whole, including
interest, into shares of our common stock at a price of $7.0265 per common share, as may be
adjusted under the debenture, as set forth and subject to the conditions in the 5% Convertible
Debenture, or (ii) redeem the 5% Convertible Debenture. If we made either of the foregoing
elections with respect to any 5% Convertible Debenture, we must make the same election with respect
to all 5% Convertible Debentures. As of July 26, 2007, the closing bid price of our common stock
exceeded $14.053 for 20 consecutive trading days and the holders of the 5% Convertible Debentures
were notified that we intended to effect the Mandatory Redemption. The 5% Convertible Debentures
ceased to accrue further interest upon our election to effect the Mandatory Redemption. See Note 16
to the condensed consolidated statements regarding subsequent event.
Net
cash provided by operating activities during the six months ended
June 30, 2007 was $93.8
million, a change of $90.4 million from the $3.4 million provided during the six months ended June
30, 2006. Cash provided by operations during the six months ended June 30, 2007 was primarily the
result of our net income of $122.6 million, an increase of $7.3 million due to a change in income
taxes payable, an increase of $464,000 due to a change in accrued compensation and other current
liabilities, and an increase of $269,000 due to a change in prepaid expenses and other current
assets. These increases were offset by a $28.9 million decrease due to a change in deferred revenue
and customer advances mainly related to the conclusion of our patent litigation with Sony Computer
Entertainment and the extinguishment of the customer advance from Microsoft, a decrease of $5.4
million due to a change in deferred income taxes, an decrease of $1.5 million due to a change in
accounts receivable, a decrease of $1.2 million due to a change in accounts payable due to the
timing of payments to vendors and a decrease of $425,000 due to a change in inventories. Cash
provided by operations during the six months ended June 30, 2007 was also impacted by noncash
charges and credits of $613,000, including a credit of
$1.9 million from excess tax benefits
from stock-based compensation, partially offset by $1.2 million of noncash stock-based
compensation, $496,000 in amortization of intangibles, $430,000 in depreciation, and $316,000 in
accretion expenses on our 5% Convertible Debentures.
Net cash used in investing activities during the six months ended June 30, 2007 was $26.4
million, compared to the $1.3 million used in investing activities during three months ended June
30, 2006, an increase of $25.1 million. Net cash used in investing activities during the period
consisted of an increase in purchases of short-term investments of $24.9 million, an $833,000
increase in other assets, primarily due to capitalization of external patent filing and application
costs, and $656,000 used to purchase capital equipment.
Net
cash provided by financing activities during the six months ended
June 30, 2007 was $10.3
million compared to $571,000 provided during the six months ended
June 30, 2006, or a $9.8 million
increase from the prior year. Net cash provided by financing activities for the period consisted
primarily of issuances of common stock and exercises of stock options in the amount of $8.5
million, and an increase of $1.9 million from excess tax benefits from tax deductible stock-based
compensation.
We believe that our cash and cash equivalents will be sufficient to meet our working capital
needs for at least the next twelve months. We will continue to protect and defend our extensive
intellectual property portfolio across all business segments. We anticipate that capital
expenditures for the year ended December 31, 2007 will total approximately $1.5 million in
connection with anticipated maintenance and upgrades to operations and infrastructure.
Additionally, if we acquire one or more businesses, patents, or products, our cash or capital
requirements could increase substantially. In the event of such an acquisition, or should any
unanticipated circumstances arise that significantly increase our capital requirements, we may
elect to raise additional capital through debt or equity financing. Any of these events could
result in substantial dilution to our stockholders. Although we expect to be able to raise
additional capital if necessary, there is no assurance that such additional capital will be
available on terms acceptable to us, if at all.
SUMMARY DISCLOSURES ABOUT CONTRACTUAL OBLIGATIONS AND COMMERCIAL COMMITMENTS
The following table reflects a summary of our contractual cash obligations and other
commercial commitments as of December 31, 2006, excluding our 5% Convertible Debenture:
37
Table of Contents
2008 and | 2010 and | |||||||||||||||
Contractual Obligations | Total | 2007 | 2009 | 2011 | ||||||||||||
(In thousands) | ||||||||||||||||
Operating leases |
$ | 2,951 | $ | 994 | $ | 1,638 | $ | 319 | ||||||||
As of December 31, 2006 we had contractual obligations for outstanding principal and
interest of $23.0 million due on our 5% Convertible Debentures. On July 27, 2007 we announced that
we had notified the holders of the 5% Convertible Debentures, due in 2009, of our intent to redeem
all of the 5 % Convertible Debentures in full as per the Mandatory Redemption of 5% Convertible
Debentures discussed in Note 6 to the condensed consolidated financial statements. Approximately
$20.1 million of principal and accrued interest is outstanding under the 5% Convertible Debentures.
Under the terms of the 5% Convertible Debentures, once the closing bid price of our common stock
exceeds $14.053 per share for 20 consecutive trading days, we may redeem the 5% Convertible
Debentures at the end of a 30-day notice period. Prior to the end of the 30-day period, the holders
of the 5% Convertible Debenture may elect to convert the principal and accrued interest outstanding
into shares of our common stock at a conversion price of $7.0265 per share.
RECENT ACCOUNTING PRONOUNCEMENTS
In June 2006, the FASB issued FIN 48, Accounting for Uncertainty in Income Taxes. FIN 48
clarifies the accounting for uncertainty in income taxes recognized in an enterprises financial
statements in accordance with SFAS No. 109, Accounting for Income Taxes. FIN 48 prescribes a
two-step process to determine the amount of benefit to be recognized. First, the tax position must
be evaluated to determine the likelihood that it will be sustained upon examination. If the tax
position is deemed more-likely-than-not to be sustained, the tax position is then measured to
determine the amount of benefit to recognize in the financial statements. The tax position is
measured at the largest amount of benefit that is greater than 50 percent likely of being realized
upon ultimate settlement. We adopted the provisions of FIN 48 on January 1, 2007. The adoption of
FIN 48 resulted in no adjustment to beginning retained earnings as we had a full valuation
allowance on the deferred tax asset as of the adoption date.
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. SFAS No. 157
establishes a framework for measuring fair value by providing a standard definition of fair value
as it applies to assets and liabilities. SFAS No. 157, which does not require any new fair value
measurements, clarifies the application of other accounting pronouncements that require or permit
fair value measurements. The effective date for us is January 1, 2008. We are currently evaluating
the effect that the adoption of SFAS No. 157 will have on our financial position and results of
operations.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets
and Financial Liabilities. The new Statement allows entities to choose, at specified election
dates, to measure eligible financial assets and liabilities at fair value in situations in which
they are not otherwise required to be measured at fair value. If a company elects the fair value
option for an eligible item, changes in that items fair value in subsequent reporting periods must
be recognized in current earnings. SFAS No. 159 also establishes presentation and disclosure
requirements designed to draw comparison between entities that elect different measurement
attributes for similar assets and liabilities. SFAS No. 159 is effective for fiscal years beginning
after November 15, 2007. Early adoption is permitted subject to specific requirements outlined in
the new Statement. We are currently evaluating the effect that the adoption of SFAS No. 159 will
have on our financial position and results of operations.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We have limited exposure to financial market risks, including changes in interest rates. The
fair value of our investment portfolio or related income would not be significantly impacted by a
100 basis point increase or decrease in interest rates due mainly to the short-term nature of the
major portion of our investment portfolio. An increase or decrease in interest rates would not
significantly increase or decrease interest expense on debt obligations due to the fixed nature of
our debt obligations. Our foreign operations are limited in scope and thus we are not materially
exposed to foreign currency fluctuations.
As of June 30, 2007, we had outstanding $20.0 million of fixed rate long-term convertible
debentures. The holder of a 5% Convertible Debenture had the right to convert the outstanding
principal amount, and accrued and unpaid interest, in whole or in part into our common stock at a
price of $7.0265 per common share, the Conversion Price. In the event of a change of control, a
holder could require us to redeem all or a portion of their 5% Convertible Debenture. This is
referred to as the Put Option. The
38
Table of Contents
redeemed portion shall be redeemed at a price equal to the redeemed amount multiplied by 100%
of the principal amount of the 5% Convertible Debenture. If the closing bid price of our common
stock was at or above $14.053 for at least 20 consecutive trading days and certain other conditions
are met, we had the right to (i) require the holder of a 5% Convertible Debenture to convert the
debenture in whole, including interest, into shares of our common stock at a price of $7.0265 per
common share, as may be adjusted under the debenture, as set forth and subject to the conditions in
the 5% Convertible Debenture, or (ii) redeem the 5% Convertible Debenture. If we made either of the
foregoing elections with respect to any 5% Convertible Debenture, we must make the same election
with respect to all 5% Convertible Debentures. As of July 26, 2007 the closing bid price of our
common stock exceeded $14.053 for 20 consecutive trading days and on July 27, 2007, the holders of
the 5% Convertible Debentures were notified that we intended to effect the Mandatory Redemption
(see Note 16 to the condensed consolidated statements regarding subsequent event).
ITEM 4. CONTROLS AND PROCEDURES
Based on their evaluation as of June 30, 2007, our management with the participation of our
Chief Executive Officer and Chief Financial Officer, have concluded that our disclosure controls
and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of
1934, as amended) were sufficiently effective to ensure that the information required to be
disclosed by us in this quarterly report on Form 10-Q was recorded, processed, summarized and
reported within the time periods specified in the SECs rules for Form 10-Q.
There were no changes to internal controls over financial reporting during the quarter ended
June 30, 2007 that have materially affected or are reasonably likely to materially affect our
internal control over financial reporting.
Our management, including our Chief Executive Officer and Chief Financial Officer, does not
expect that our disclosure controls and procedures or our internal controls will prevent all error
and all fraud. A control system, no matter how well conceived and operated, can provide only
reasonable, not absolute assurance that the objectives of the control system are met. Further, the
design of a control system must reflect the fact that there are resource constraints, and the
benefits of controls must be considered relative to their costs. Because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any within Immersion, have been detected.
PART II
OTHER INFORMATION
OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
In re Immersion Corporation
We are involved in legal proceedings relating to a class action lawsuit filed on November 9,
2001, In re Immersion Corporation Initial Public Offering Securities Litigation, No. Civ. 01-9975
(S.D.N.Y.), related to In re Initial Public Offering Securities Litigation, No. 21 MC 92
(S.D.N.Y.). The named defendants are Immersion and three of our current or former officers or
directors (the Immersion Defendants), and certain underwriters of our November 12, 1999 initial
public offering (IPO). Subsequently, two of the individual defendants stipulated to a dismissal
without prejudice.
The operative amended complaint is brought on purported behalf of all persons who purchased
our common stock from the date of our IPO through December 6, 2000. It alleges liability under
Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934, on the grounds that the registration statement for the IPO did not disclose
that: (1) the underwriters agreed to allow certain customers to purchase shares in the IPO in
exchange for excess commissions to be paid to the underwriters; and (2) the underwriters arranged
for certain customers to purchase additional shares in the aftermarket at predetermined prices. The
complaint also appears to allege that false or misleading analyst reports were issued. The
complaint does not claim any specific amount of damages.
Similar allegations were made in other lawsuits challenging over 300 other initial public
offerings and follow-on offerings conducted in 1999 and 2000. The cases were consolidated for
pretrial purposes. On February 19, 2003, the Court ruled on all defendants motions to dismiss. The
motion was denied as to claims under the Securities Act of 1933 in the case involving us as well as
in all other cases (except for 10 cases). The motion was denied as to the claim under Section 10(b)
as to us, on the basis that the complaint alleged that we had made acquisition(s) following the
IPO. The motion was granted as to the claim under Section 10(b), but denied as to the claim under
Section 20(a), as to the remaining individual defendant.
39
Table of Contents
We and most of the issuer defendants have settled with the plaintiffs. In this settlement,
plaintiffs have dismissed and released all claims against the Immersion Defendants, in exchange for
a contingent payment by the insurance companies collectively responsible for insuring the issuers
in all of the IPO cases, and for the assignment or surrender of certain claims we may have against
the underwriters. The Immersion Defendants will not be required to make any cash payments in the
settlement, unless the pro rata amount paid by the insurers in the settlement exceeds the amount of
the insurance coverage, a circumstance which we believe is remote. The settlement will require
approval of the Court, which cannot be assured, after class members are given the opportunity to
object to the settlement or opt out of the settlement.
In September 2005, the Court granted preliminary approval of the settlement. The Court held a
hearing to consider final approval of the settlement on April 24, 2006, and took the matter under
submission. Before the Court issued a final decision on the settlement, on December 5, 2006 the
United States Court of Appeals for the Second Circuit vacated the class certification of
plaintiffs claims against the underwriters in six cases designated as focus or test cases. Miles
v. Merrill Lynch & Co. (In re Initial Public Offering Securities Litigation). Thereafter, on
December 14, 2006, the Court ordered a stay of all proceedings in all of the lawsuits pending the
outcome of plaintiffs petition to the Second Circuit Court of Appeals for a rehearing en banc and
resolution of the class certification issue. On April 6, 2007, the Second Circuit Court of Appeals
denied plaintiffs petition for a rehearing, but clarified that the plaintiffs may seek to certify
a more limited class. Accordingly, the plaintiffs and issuers have stated that they are prepared
to discuss how the settlement might be amended or renegotiated to comply with the decision of the
Second Circuit Court of Appeals. On April 30, 2007, Plaintiffs stated that they intend to present
a proposed redefined class to the Court. If the settlement is not amended or renegotiated and then
approved by the Court, we cannot be assured that we will prevail in the lawsuit.
Immersion Corporation vs. Microsoft Corporation, Sony Computer Entertainment Inc. and Sony
Computer Entertainment of America, Inc.
On February 11, 2002, we filed a complaint against Microsoft Corporation, Sony Computer
Entertainment, Inc., and Sony Computer Entertainment of America, Inc. in the U.S. District Court
for the Northern District Court of California alleging infringement of U.S. Patent Nos. 5,889,672
and 6,275,213. On July 28, 2003, we announced that we had settled our legal differences with
Microsoft, and both parties agreed to dismiss all claims and counterclaims relating to this matter
as well as assume financial responsibility for their respective legal costs with respect to the
lawsuit between us and Microsoft.
On September 21, 2004, after a trial, the jury returned its verdict in favor of us. The jury
found all the asserted claims of the patents valid and infringed. The jury awarded us damages in
the amount of $82.0 million. On March 24, 2005, Judge Wilken entered judgment in our favor and
awarded us $82.0 million in past damages, and pre-judgment interest in the amount of $8.9 million,
for a total of $90.9 million. We were also awarded certain court costs. Court costs do not include
attorneys fees. Additionally, the Court issued a permanent injunction against the manufacture,
use, sale, or import into the United States of the infringing Sony PlayStation system consisting of
the PlayStation consoles, Dual Shock controllers, and the 47 games found by the jury to infringe
our patents. The Court stayed the permanent injunction pending appeal to the United States Court of
Appeals for the Federal Circuit. The Court further ordered Sony Computer Entertainment to pay a
compulsory license fee at the rate of 1.37% for the duration of the stay of the permanent
injunction at the same rate and conditions as previously awarded in its interim January 10, 2005
and February 9, 2005 Orders. On April 7, 2005, pursuant to a stipulation of the parties, the Court
entered an Amended Judgment to clarify that the Judgment in favor of us and against Sony Computer
Entertainment also encompassed Sony Computer Entertainments counterclaims for declaratory relief
on invalidity and unenforceability, as well as non-infringement.
On March 1, 2007, Sony Computer Entertainment withdrew and moved to dismiss its appeals from
the District Courts April 7, 2005 Amended Judgment (and all interlocutory orders merged in the
Amended Judgment). On March 2, 2007, Sony Computer Entertainment withdrew and moved to dismiss its
appeal from the District Courts March 8, 2006 order denying Sony Computer Entertainments motion
for relief from final judgment under Rule 60(b) of the Federal Rules of Civil Procedure. On March
8, 2007, the Federal Circuit dismissed the Sony Computer Entertainment Rule 60(b) appeal. On March
14, 2007 the Federal Circuit dismissed the Sony Computer Entertainment appeal of Amended Judgment
(and all interlocutory orders merged in the Amended Judgment). In accordance with the Amended
Judgment, we received funds totaling $97.3 million in satisfaction of the judgment for past damages
for sales and other activities with respect to the infringing Sony PlayStation system consisting of
the PlayStation consoles, Dual Shock controllers, and the 47 games found by the jury to infringe
our patents, pre-judgment interest and costs, and post-judgment interest. Additionally, we retained
$32.4 million of compulsory license fees and interest thereon previously paid to us by Sony
Computer Entertainment ($27.9 million in long-term deferred revenue on December 31, 2006 and $4.5
million received subsequent to year end.) On March 19, 2007, we lodged with the court a Notice of
Satisfaction of Judgment, indicating that Sony Computer Entertainment had satisfied and discharged
the judgment that the court had entered. On March 19, 2007, pursuant to a Stipulation lodged with
the court, Judge Wilken entered an order dissolving the permanent injunction.
On May 17, 2005, Sony Computer Entertainment filed a Request for Inter Partes Reexamination of
the 333 Patent with the United States Patent and Trademark Office (PTO). On May 19, 2005, Sony
Computer Entertainment filed a similar Request for
40
Table of Contents
reexamination of the 213 Patent. On March 27, 2007, we filed a petition to terminate the
inter partes reexamination on the grounds that the District Court judgment was final and
non-appealable. On June 5, 2007, the USPTO granted our petition to terminate the inter partes
proceedings.
Internet Services LLC Litigation
On October 20, 2004, Internet Services LLC (ISLLC) filed claims against us in our lawsuit
against Sony Computer Entertainment, alleging that we breached a contract with ISLLC by suing Sony
Computer Entertainment for patent infringement relating to haptically-enabled software whose topics
or images are allegedly age-restricted, for judicial apportionment of damages between ISLLC and us
of the damages awarded by the jury, and for a judicial declaration with respect to ISLLCs rights
and duties under agreements with us. On December 29, 2004, the Court issued an order dismissing
ISLLCs claims against Sony Computer Entertainment with prejudice and dismissing ISLLCs claims
against us without prejudice to ISLLC filing a new complaint if it can do so in good faith without
contradicting, or repeating the deficiency of, its complaint.
On January 12, 2005, ISLLC filed Amended Cross-Claims and Counterclaims against us that
contained similar claims. ISLLC also realleged counterclaims against Sony Computer Entertainment.
On January 28, 2005, we filed a motion to dismiss ISLLCs Amended Cross-Claims and a motion to
strike ISLLCs Counterclaims against Sony Computer Entertainment. On March 24, 2005 the Court
issued an order dismissing ISLLCs claims with prejudice as to ISLLCs claim seeking a declaratory
judgment that it is an exclusive licensee under the 213 and 333 patents and as to ISLLCs claim
seeking judicial apportionment of the damages verdict in the Sony Computer Entertainment case.
The Courts order further dismissed ISLLCs claims without prejudice as to ISLLCs breach of
contract and unjust enrichment claims.
ISLLC filed a notice of appeal of the District Court orders with the United States Court of
Appeals for the Federal Circuit on April 18, 2005. On April 4, 2007, the Federal Circuit issued its
opinion, affirming the District Court orders.
On February 8, 2006, ISLLC filed a lawsuit against us in the Superior Court of Santa Clara
County. ISLLCs complaint seeks a share of the damages awarded to us in the March 24, 2005 Judgment
and of the Microsoft settlement proceeds, and generally restates the claims already adjudicated by
the District Court. On March 16, 2006, we answered the complaint, cross claimed for breach of
contract by ISLLC and rescission of the contract, and removed the lawsuit to federal court. The
case was assigned to Judge Wilken as a case related to the previous proceedings involving Sony
Computer Entertainment and ISLLC. ISLLC filed its answer to our cross claims on April 27, 2006.
ISLLC also moved to remand the case to Superior Court. On July 10, 2006, Judge Wilken issued an
order denying ISLLCs motion to remand. On September 5, 2006, Judge Wilken granted the stipulated
request by the parties to stay discovery and other proceedings in the case pending the disposition
of ISLLCs appeal from the Courts previous orders. The case was stayed from December 1, 2006
pending the Federal Circuits disposition on the appeal. As noted above, the Federal Circuit issued
its opinion on April 4, 2007, and entered a judgment affirming the District Courts previous
orders. On April 23, 2007, ISLLC filed in the Federal Circuit a Petition for Panel Rehearing and a
Motion to Extend Time. ISLLC argued that the Court should rehear the matter or correct and/or
clarify the April 4, 2007 opinion. On May 7, 2007, the Federal Circuit denied ISLLCs petition.
On May 10, 2007, ISLLC filed a motion in the District Court to remand its latest action to the
Superior Court or in the alternative for leave to file an amended complaint to remove the
declaratory relief claim. Immersion opposed ISLLCs motion, and cross-moved for judgment on the
pleadings on the grounds that ISLLCs claims are barred by res judicata and collateral estoppel.
On June 26, 2007, the Court ruled on the motions, denying ISLLCs motion to remand or for leave to
file an amended complaint, and granting in part Immersions motion for judgment on the pleadings.
The Court dismissed ISLLCs claim for declaratory relief. ISLLCs claims for breach of contract,
promissory fraud, and constructive trust, to the extent not inconsistent with the Courts previous
rulings, remain.
We intend to defend ourselves vigorously against ISLLCs allegations. The parties participated
in a court ordered mediation on March 12, 2007, but were unsuccessful in resolving the matter.
Immersion Corporation vs. Thorner
On March 24, 2006, we filed a lawsuit against Mr. Craig Thorner in Santa Clara
County Superior Court. The complaint alleges claims for breach of contract with respect to
Thorners license to a third party of U.S. Patent No. 5,684,722, which we have alleged is in
violation of contractual obligations to it. The case was removed to federal court by Mr. Thorner,
and has been assigned to Judge Jeremy Fogel. On May 1, 2006, Mr. Thorner filed an answer to our
claims and asserted counterclaims against us seeking, among other things, a portion of the proceeds
from our license with Microsoft, under theories of alleged breach of contract, breach of the
implied covenant of good faith and fair dealing, fraud, promissory fraud, breach of fiduciary duty,
and negligent misrepresentation. On July 28, 2006, we filed a motion for judgment on the pleadings
seeking the dismissal of Mr. Thorners breach of contract and fraud claims which allege a right to
a portion of the proceeds from our license with Microsoft. On September 1, 2006, the Court held a
hearing on our motion. On September 12, 2006, the Court issued an order granting our
41
Table of Contents
motion for judgment on the pleadings as to Mr. Thorners alleged claims for breach of contract
and fraud. The Court dismissed Mr. Thorners breach of contract and fraud claims, and allowed Mr.
Thorner leave to amend his claim for alleged breach of contract with respect to alleged violations
of our reporting requirements that do not flow from the failure to report the Microsoft Settlement
Agreement.
The parties participated in a court-ordered mediation on November 7, 2006, but were not
successful in resolving the matter. The parties are in the process of conducting discovery.
On November 22, 2006, Thorner brought a motion for summary judgment arguing that our breach of
contract claim was barred by the doctrine of judicial estoppel as a result of a statement made in
connection with the Sony Computer Entertainment Rule 60 (b) motion. On January 26, 2007, the Court
held a hearing on Thorners motion. On January 29, 2007, the Court issued an order denying
Thorners summary judgment motion, ruling that our breach of contract claim was not barred by
judicial estoppel. On February 5, 2007, with leave of Court, we filed a First Amended Complaint in
the action to add Thorners company, Virtual Reality Feedback Corporation (VRF), as a
party-defendant. On February 9, 2007, Thorner filed an Amended Answer and Counterclaims. The
Amended Counterclaims against us dropped the previously-dismissed counterclaims based on Thorners
claims for a share of our settlement with Microsoft, but alleged other counterclaims for alleged
Breach of Contract, Breach of the Implied Covenant of Good Faith and Fair Dealing, Promissory
Fraud, Breach of Fiduciary Duty, Negligent Misrepresentation and Rescission. Thorner alleged in
part that we breached our agreement with Thorner by failing to pay royalties for Vibetonz Studio
SDK and Immersion Studio for Gaming; that we breached alleged duties to Thorner to license the 722
patent; and that Thorners agreement with us should be rescinded. Thorners Amended Counterclaim
does not specify an amount of damages sought but alleges that Thorner has been damaged in an amount
to be proven at trial. We dispute Thorners allegations and intend to vigorously oppose them.
On June 27, 2007, the parties informed the Court that they had reached an agreement in
principle to resolve the case and requested that the Court vacate dates in the case. The parties
requested a status conference in the event that the matter was not finally resolved. On July 3,
2007, the Court entered an Order approving the stipulation, vacating pending dates in the action,
and setting September 7, 2007 as a date for a further status conference.
Faro Technologies Inc. v. Immersion Corporation
On May 3, 2007, Faro sued us in the Eastern District of Pennsylvania. The complaint alleges
patent infringement of Faros 5,402,582 patent by our
MicroScribe X product. We were not served with the complaint.
On August 2, 2007, Faro filed a voluntary dismissal without prejudice of
the complaint.
Microsoft Corporation v. Immersion Corporation.
On June 18, 2007, Microsoft filed a complaint against us in the U.S. District Court for the
Western District of Washington alleging one claim for breach of a contract. Microsoft alleges that
we breached a Sublicense Agreement executed in connection with the parties settlement of
litigation in 2003 (see discussion above regarding settlement with Microsoft). The complaint
alleges that Microsoft is entitled to a share of the judgment monies and other sums received from
Sony Computer Entertainment. In a letter sent to us dated May 1, 2007, Microsoft stated that it
believes we owe Microsoft at least $27.5 million. We were served with the complaint on July 6,
2007; its response is due on September 4, 2007. We dispute Microsofts allegations and
intend to vigorously defend ourselves.
ITEM 1A. RISK FACTORS
Company Risks
WE HAD AN ACCUMULATED DEFICIT OF $15 MILLION AS OF JUNE 30, 2007, HAVE A HISTORY OF LOSSES, MAY
EXPERIENCE LOSSES IN THE FUTURE, AND MAY NOT ACHIEVE OR MAINTAIN PROFITABILITY IN THE FUTURE.
Since
1997, we have incurred losses in all but the two most recent quarters. We need to generate
significant ongoing revenue to maintain profitability. We anticipate that our expenses will
increase in the foreseeable future as we:
42
Table of Contents
| continue to develop our technologies; | ||
| attempt to expand the market for touch-enabled technologies and products; | ||
| protect and enforce our intellectual property; | ||
| pursue strategic relationships; and | ||
| increase our sales and marketing efforts. |
If our revenues grow more slowly than we anticipate or if our operating expenses exceed our
expectations, we may not achieve or maintain profitability.
LITIGATION REGARDING INTELLECTUAL PROPERTY RIGHTS COULD BE EXPENSIVE, DISRUPTIVE, AND TIME
CONSUMING; COULD RESULT IN THE IMPAIRMENT OR LOSS OF PORTIONS OF OUR INTELLECTUAL PROPERTY; AND
COULD ADVERSELY AFFECT OUR BUSINESS.
Intellectual property litigation, whether brought by us or by others against us, has caused us
to expend, and may cause us to expend in future periods, significant financial resources as well as
divert managements time and efforts. From time to time, we initiate claims against third parties
that we believe infringe our intellectual property rights. We intend to enforce our intellectual
property rights vigorously and may initiate litigation against parties that we believe are
infringing our intellectual property rights if we are unable to resolve matters satisfactorily
through negotiation. Litigation brought to protect and enforce our intellectual property rights
could be costly, time-consuming, and distracting to management and could result in the impairment
or loss of portions of our intellectual property. In addition, any litigation in which we are
accused of infringement may cause product shipment delays, require us to develop non-infringing
technologies, or require us to enter into royalty or license agreements even before the issue of
infringement has been decided on the merits. If any litigation were not resolved in our favor, we
could become subject to substantial damage claims from third parties and indemnification claims
from our licensees. We and our licensees could be enjoined from the continued use of the
technologies at issue without a royalty or license agreement. Royalty or license agreements, if
required, might not be available on acceptable terms, or at all. If a third party claiming
infringement against us prevailed, and we could not develop non-infringing technologies or license
the infringed or similar technologies on a timely and cost-effective basis, our expenses would
increase and our revenues could decrease.
We attempt to avoid infringing known proprietary rights of third parties. However, third
parties may hold, or may in the future be issued, patents that could be infringed by our products
or technologies. Any of these third parties might make a claim of infringement against us with
respect to the products that we manufacture and the technologies that we license. From time to
time, we have received letters from companies, several of which have significantly greater
financial resources than we do, asserting that some of our technologies, or those of our licensees,
infringe their intellectual property rights. Certain of our licensees may receive similar letters
from these or other companies from time to time. Such letters or subsequent litigation may
influence our licensees decisions whether to ship products incorporating our technologies. In
addition, such letters may cause a dispute between our licensees and us over indemnification for
the infringement claim. Any of these notices, or additional notices that we or our licensees could
receive in the future from these or other companies, could lead to litigation against us, either
regarding the infringement claim or the indemnification claim.
We have acquired patents from third parties and also license some technologies from third
parties. We must rely upon the owners of the patents or the technologies for information on the
origin and ownership of the acquired or licensed technologies. As a result, our exposure to
infringement claims may increase. We generally obtain representations as to the origin and
ownership of acquired or licensed technologies and indemnification to cover any breach of these
representations. However, representations may not be accurate and indemnification may not provide
adequate compensation for breach of the representations. Intellectual property claims against our
licensees, or us, whether or not they have merit, could be time-consuming to defend, cause product
shipment delays, require us to pay damages, harm existing license arrangements, or require us or
our licensees to cease utilizing the technologies unless we can enter into licensing agreements.
Licensing agreements might not be available on terms acceptable to us or at all. Furthermore,
claims by third parties against our licensees could also result in claims by our licensees against
us under the indemnification provisions of our licensees agreements with us.
The legal principles applicable to patents and patent licenses continue to change and evolve.
Decisions that make it easier for patent licensees to challenge the validity, enforceability, or
infringement of patents, or make it more difficult for patent licensors to obtain a permanent
injunction, obtain enhanced damages for willful infringement, or to obtain or enforce patents, may
43
Table of Contents
adversely affect our business and the value of our patent portfolio. Furthermore, our prospects
for future revenue growth through our royalty and licensing based businesses could be diminished.
MICROSOFT DISPUTES OUR ASSESSMENT THAT WE ARE NOT OBLIGATED UNDER OUR AGREEMENT WITH THEM TO MAKE
ANY PAYMENT TO THEM RELATING TO THE CONCLUSION OF OUR LITIGATION WITH SONY COMPUTER ENTERTAINMENT.
DEFENDING OUR POSITION MAY BE EXPENSIVE, DISRUPTIVE, AND TIME CONSUMING, AND REGARDLESS OF WHETHER
WE ARE SUCCESSFUL, COULD ADVERSELY AFFECT OUR BUSINESS.
In 2003, we executed a series of agreements with Microsoft as described in Note 8 to the
condensed consolidated financial statements that provided for settlement of our lawsuit against
Microsoft as well as various licensing, sublicensing, and equity and financing arrangements under
the Microsoft sublicensing agreement. In the event that we elected to settle the action in the
United States District Court for the Northern District of California entitled Immersion Corporation
v. Sony Computer Entertainment of America, Inc., Sony Computer Entertainment Inc. and Microsoft
Corporation, Case No. C02-00710 CW (WDB), as such action pertains to Sony Computer Entertainment,
we would be obligated to pay Microsoft a minimum of $15.0 million for amounts up to $100 million
received from Sony Computer Entertainment on account of our granting certain rights, plus 25% of
amounts over $100.0 million up to $150.0 million, and 17.5% of amounts over $150.0 million. In
March 2007, we announced the conclusion of our patent infringement litigation against Sony Computer
Entertainment at the U.S. Court of Appeals for the Federal Circuit. Sony Computer Entertainment
satisfied the District Court judgment against it. As of March 19, 2007, we and Sony Computer
Entertainment entered into a new business agreement. We have determined that we are not obligated
under our agreements with Microsoft to make any payment to Microsoft relating to the conclusion of
our litigation with Sony Computer Entertainment. However, in a letter sent to us dated May 1, 2007,
Microsoft disputed our position and stated that it believes we owe Microsoft at least $27.5
million. Further, on June 18, 2007, Microsoft filed a complaint against us in the U.S. District
Court for the Western District of Washington alleging we are in breach of our contract with
Microsoft and that Microsoft is entitled to a share of the judgment monies and other sums we
received from Sony. We dispute Microsofts allegations and intend to vigorously defend ourselves in
the lawsuit. The results of any litigation are inherently uncertain, and there can be no assurance
that our position will prevail.
OUR CURRENT LITIGATION UNDERTAKINGS ARE EXPENSIVE, DISRUPTIVE, AND TIME CONSUMING, AND WILL
CONTINUE TO BE, UNTIL RESOLVED, AND REGARDLESS OF WHETHER WE ARE ULTIMATELY SUCCESSFUL, COULD
ADVERSELY AFFECT OUR BUSINESS.
We are involved in litigation with ISLLC involving claims for breach of contract and
rescission against ISLLC in the U.S. District Court for the Northern District of California.
We are involved in litigation with Mr. Craig Thorner in the U.S. District Court for the
Northern District of California relating to our allegations of breach of contract with respect to
Thorners license to a third party of U.S. Patent No. 5,684,722 and his allegations of breach of
contract, breach of the implied covenant of good faith and fair dealing, promissory fraud, breach
of fiduciary duty, negligent misrepresentation, and rescission.
We are also involved in litigation against Microsoft. Microsofts complaint against us
alleges that we are in breach of the Sublicense Agreement executed in support of the parties
settlement of litigation in 2003. The complaint alleges that Microsoft is entitled to a share of
the judgment monies and other sums received from Sony Computer Entertainment at the conclusion of
our patent litigation against Sony Computer Entertainment.
Due to the inherent uncertainties of litigation, we cannot accurately predict how these cases
will ultimately be resolved. We anticipate that the litigation will continue to be costly, and
there can be no assurance that we will be able to recover the costs we incur in connection with the
litigation. We expense litigation costs as incurred, and only accrue for costs that have been
incurred but not paid to the vendor as of the financial statement date. Litigation has diverted,
and is likely to continue to divert, the efforts and attention of some of our key management and
personnel. As a result, until such time as it is resolved, litigation could adversely affect our
business. Further, any unfavorable outcome could adversely affect our business. For additional
background on litigation, please see Note 15 to the condensed consolidated financial statements and
the section titled Item 1. Legal Proceedings.
THE TERMS IN OUR AGREEMENTS MAY BE CONSTRUED BY OUR LICENSEES IN A MANNER THAT IS INCONSISTENT
WITH THE RIGHTS THAT WE HAVE GRANTED TO OTHER LICENSEES, OR IN A MANNER THAT MAY REQUIRE US TO
INCUR SUBSTANTIAL COSTS TO RESOLVE CONFLICTS OVER LICENSE TERMS.
44
Table of Contents
We have entered into, and we expect to continue to enter into, agreements pursuant to
which our licensees are granted rights under our technology and intellectual property. These rights
may be granted in certain fields of use, or with respect to certain market sectors or product
categories, and may include exclusive rights or sublicensing rights. We refer to the license terms
and restrictions in our agreements, including, but not limited to, field of use definitions, market
sector, and product category definitions, collectively as License Provisions.
Due to the continuing evolution of market sectors, product categories, and licensee business
models, and to the compromises inherent in the drafting and negotiation of License Provisions, our
licensees may, at some time during the term of their agreements with us, interpret License
Provisions in their agreements in a way that is different from our interpretation of such License
Provisions, or in a way that is in conflict with the rights that we have granted to other
licensees. Such interpretations by our licensees may lead to (a) claims that we have granted rights
to one licensee which are inconsistent with the rights that we have granted to another licensee,
and/or (b) claims by one licensee against another licensee that may result in our incurring
indemnification or other obligations or liabilities.
In addition, after we enter into an agreement, it is possible that markets and/or products, or
legal and/or regulatory environments, will evolve in a manner that we did not foresee or was not
foreseeable at the time we entered into the agreement. As a result, in any agreement, we may have
granted rights that will preclude or restrict our exploitation of new opportunities that arise
after the execution of the agreement.
PRODUCT LIABILITY CLAIMS COULD BE TIME-CONSUMING AND COSTLY TO DEFEND AND COULD EXPOSE US TO LOSS.
Our products or our licensees products may have flaws or other defects that may lead to
personal or other injury claims. If products that we or our licensees sell cause personal injury,
property injury, financial loss, or other injury to our or our licensees customers, the customers
or our licensees may seek damages or other recovery from us. Any claims against us would be
time-consuming, expensive to defend, and distracting to management, and could result in damages and
injure our reputation, the reputation of our technology and services, and/or the reputation of our
products, or the reputation of our licensees or their products. This damage could limit the market
for our and our licensees products and harm our results of operations.
In the past, manufacturers of peripheral products including certain gaming products such as
joysticks, wheels, or gamepads, have been subject to claims alleging that use of their products has
caused or contributed to various types of repetitive stress injuries, including carpal tunnel
syndrome. We have not experienced any product liability claims to date. Although our license
agreements typically contain provisions designed to limit our exposure to product liability claims,
existing or future laws or unfavorable judicial decisions could limit or invalidate the provisions.
IF THE SETTLEMENT ON OUR CURRENT CLASS ACTION LAWSUIT FALLS THROUGH, THE CONTINUING LAWSUIT COULD
BE EXPENSIVE, DISRUPTIVE, AND TIME CONSUMING TO DEFEND AGAINST, AND IF WE ARE NOT SUCCESSFUL, COULD
ADVERSELY AFFECT OUR BUSINESS.
We are involved in legal proceedings relating to a class action lawsuit filed on November 9,
2001, related to In re Initial Public Offering Securities Litigation. The named defendants are
Immersion and three of our current or former officers or directors and certain underwriters of our
November 12, 1999 IPO. Subsequently, two of the individual defendants stipulated to a dismissal
without prejudice. We and most of the issuer defendants have settled with the plaintiffs. However,
the settlement requires approval by the Court, which cannot be assured, after class members are
given the opportunity to object to the settlement or opt out of the settlement.
IF OUR FACILITIES WERE TO EXPERIENCE CATASTROPHIC LOSS, OUR OPERATIONS WOULD BE SERIOUSLY HARMED.
Our facilities could be subject to a catastrophic loss such as fire, flood, earthquake, power
outage, or terrorist activity. A substantial portion of our research and development activities,
manufacturing, our corporate headquarters, and other critical business operations are located near
major earthquake faults in San Jose, California, an area with a history of seismic events. An
earthquake at or near our facilities could disrupt our operations, delay production and shipments
of our products or technologies, and result in large expenses to repair and replace the facility.
While we believe that we maintain insurance sufficient to cover most long-term potential losses at
our facilities, our existing insurance may not be adequate for all possible losses. In addition,
California has experienced problems with its power supply in recent years. As a result, we have
experienced utility cost increases and may experience unexpected interruptions in our power supply
that could have a material adverse effect on our sales, results of operations, and financial
condition.
45
Table of Contents
Industry and Technology Risks
WE HAVE LITTLE OR NO CONTROL OR INFLUENCE ON OUR LICENSEES DESIGN, MANUFACTURING, PROMOTION,
DISTRIBUTION, OR PRICING OF THEIR PRODUCTS INCORPORATING OUR TOUCH-ENABLING TECHNOLOGIES, UPON
WHICH WE GENERATE ROYALTY REVENUE.
A key part of our business strategy is to license our intellectual property to companies that
manufacture and sell products incorporating our touch-enabling technologies. Sales of those
products generate royalty and license revenue for us. For the three months ended June 30, 2007 and
2006, 32% and 26%, respectively, of our total revenues were royalty and license revenues. For the
six months ended June 30, 2007 and 2006, 33% and 28%, respectively, of our total revenues were
royalty and license revenues. However, we do not control or influence the design, manufacture,
quality control, promotion, distribution, or pricing of products that are manufactured and sold by
our licensees. In addition, we generally do not have commitments from our licensees that they will
continue to use our technologies in current or future products. As a result, products incorporating
our technologies may not be brought to market, meet quality control standards, achieve commercial
acceptance, or generate meaningful royalty revenue for us. For us to generate royalty revenue,
licensees that pay us per-unit royalties must manufacture and distribute products incorporating our
touch-enabling technologies in a timely fashion and generate consumer demand through marketing and
other promotional activities. Products incorporating our touch-enabling technologies are generally
more difficult to design and manufacture, which may cause product introduction delays or quality
control problems. If our licensees fail to stimulate and capitalize upon market demand for products
that generate royalties for us, or if products are recalled because of quality control problems,
our revenues will not grow and could decline. Alternatively, if a product that incorporates our
touch-enabling technologies achieves widespread market acceptance, the product manufacturer may
elect to stop making it rather than pay us royalties based on sales of the product.
Peak demand for products that incorporate our technologies, especially in the video console
gaming and computer gaming peripherals market, typically occurs in the fourth calendar quarter as a
result of increased demand during the year-end holiday season. If our licensees do not ship
products incorporating our touch-enabling technologies in a timely fashion or fail to achieve
strong sales in the fourth quarter of the calendar year, we may not receive related royalty and
license revenue.
A significant proportion of our gaming royalty revenues come from third-party peripheral
makers who make licensed gaming products designed for use with popular video game console systems
from Microsoft, Sony, and Nintendo. Video game console systems are closed, proprietary systems,
and video game console system makers typically impose certain requirements or restrictions on
third-party peripheral makers who wish to make peripherals that will be compatible with a
particular video game console system. These requirements and restrictions could be in the form of
hardware technical specifications, software technical specifications, security specifications or
other security mechanisms, component vendor specifications, licensing terms and conditions, or
other forms. If third-party peripheral makers cannot or are not allowed to obtain or satisfy these
requirements or restrictions, our gaming royalty revenues could be significantly reduced.
Furthermore, should a significant video game console maker choose to omit touch-enabling
capabilities from its console system or somehow restrict or impede the ability of third parties to
make touch-enabling peripherals, it may very well lead our gaming licensees to stop making products
with touch-enabling capabilities, thereby significantly reducing our gaming royalty revenues. Sony
announced on May 8, 2006 that the vibration feature that is currently available on controllers for
PlayStation and PlayStation 2 would be removed from the new PlayStation 3 controller. The
PlayStation 3 console system was launched in late 2006 in the United States and Japan without
native vibration or any force feedback capability of any kind. This course of action by Sony has
had material adverse consequences on our current and future gaming royalty revenues since our
gaming royalties have primarily been from licensed third-party controller products with vibration
or force feedback capabilities that require some degree of vibration and/or force feedback support
or compatibility in the video console system to be viable products. Sony has since released an
update to the PlayStation 3 that offers limited vibration and force feedback support for some older
PS1 and PS2 games and PS1 and PS2 rumble and force feedback controllers only. We do not know if
this situation might change at some point in the life of the PlayStation 3 console system, or
whether or to what extent the PlayStation 3 console will be compatible with or support rumble or
force feedback in PS3 games or PS3 controllers.
Both the recently launched Microsoft Xbox 360 and Nintendo Wii include touch-enabling
capabilities. For the Microsoft Xbox 360 video console system launched in November 2005, Microsoft
has, to date, not yet broadly licensed third parties to produce peripherals for its Xbox 360 game
console. To the extent Microsoft does not fully license third parties, Microsofts share of all
aftermarket game controller sales will likely remain high or increase, which we expect will limit
our gaming royalty revenue. Additionally, Microsoft is now making touch-enabled wheels covered by
their royalty-free, perpetual, irrevocable license to our worldwide portfolio of patents that are
in competition with our licensees products for which we earn per unit royalties.
46
Table of Contents
BECAUSE WE HAVE A FIXED PAYMENT LICENSE WITH MICROSOFT, OUR ROYALTY REVENUE FROM LICENSING IN THE
GAMING MARKET AND OTHER CONSUMER MARKETS HAS AND MAY FURTHER DECLINE IF MICROSOFT INCREASES ITS
VOLUME OF SALES OF TOUCH-ENABLED GAMING PRODUCTS AND CONSUMER PRODUCTS AT THE EXPENSE OF OUR OTHER
LICENSEES.
Under the terms of our present agreement with Microsoft, Microsoft receives a royalty-free,
perpetual, irrevocable license to our worldwide portfolio of patents. This license permits
Microsoft to make, use, and sell hardware, software, and services, excluding specified products,
covered by our patents. We will not receive any further revenues or royalties from Microsoft under
our current agreement with Microsoft. Microsoft has a significant share of the market for
touch-enabled console gaming computer peripherals and is pursuing other consumer markets such as
mobile phones, PDAs, and portable music players Microsoft has significantly greater financial,
sales, and marketing resources, as well as greater name recognition and a larger customer base than
some of our other licensees. In the event that Microsoft increases its share of these markets, our
royalty revenue from other licensees in these market segments might decline.
WE GENERATE REVENUES FROM TOUCH-ENABLING COMPONENTS THAT ARE SOLD AND INCORPORATED INTO THIRD-
PARTY PRODUCTS. WE HAVE LITTLE OR NO CONTROL OR INFLUENCE OVER THE DESIGN, MANUFACTURE, PROMOTION,
DISTRIBUTION, OR PRICING OF THOSE THIRD- PARTY PRODUCTS.
Part of our business strategy is to sell components that provide touch feedback capability in
products that other companies design, manufacture, and sell. Sales of these components generate
product revenue. However, we do not control or influence the design, manufacture, quality control,
promotion, distribution, or pricing of products that are manufactured and sold by those customers
that buy these components. In addition, we generally do not have commitments from customers that
they will continue to use our components in current or future products. As a result, products
incorporating our components may not be brought to market, meet quality control standards, or
achieve commercial acceptance. If the customers fail to stimulate and capitalize upon market demand
for their products that include our components, or if products are recalled because of quality
control problems, our revenues will not grow and could decline.
LAERDAL MEDICAL CORPORATION (LAERDAL) ACCOUNTS FOR A SIGNIFICANT PORTION OF OUR REVENUES AND A
REDUCTION IN SALES TO LAERDAL MAY REDUCE OUR TOTAL REVENUE.
Laerdal accounts for a significant portion of our revenue. For the three months ended June 30,
2007 and 2006, 12% and 8%, respectively, of our total revenues were derived from Laerdal. For the
six months ended June 30, 2007 and 2006, 12% and 4%, respectively, of our total revenues were
derived from Laerdal. If our product sales to Laerdal decline, then our total revenue may decline.
MEDTRONIC ACCOUNTS FOR A SIGNIFICANT PORTION OF OUR REVENUES AND A REDUCTION IN SALES TO MEDTRONIC,
OR A REDUCTION IN DEVELOPMENT WORK FOR MEDTRONIC, MAY REDUCE OUR TOTAL REVENUE.
Medtronic accounts for a significant portion of our revenue. For the three months ended June
30, 2007 and 2006, 11% and 9%, respectively, of our total revenues were derived from Medtronic. For
the six months ended June 30, 2007 and 2006, 9% and 8%, respectively, of our total revenues were
derived from Medtronic. If our product sales to Medtronic decline, and/or Medtronic reduces the
development activities we perform, then our total revenue may decline.
TOUCH INTERFACE PRODUCT ROYALTIES WILL BE REDUCED IF BMW WERE TO ABANDON ITS IDRIVE SYSTEM OR
REMOVE OUR TECHNOLOGY FROM THE IDRIVE.
Our largest royalty stream from touch interface products is currently from BMW for its iDrive
controller. Press reviews of this system have been largely negative and critical of the systems
complex user interface, which we did not design. Nevertheless, this negative press may cause BMW to
abandon the iDrive controller or to redesign it and/or remove our technology from it at any time.
If our technology is not incorporated in the BMW vehicles our business may suffer.
WE DEPEND ON THIRD-PARTY SUPPLIERS, AND OUR REVENUE AND/OR RESULTS OF OPERATIONS COULD SUFFER IF WE
FAIL TO MANAGE SUPPLIER ISSUES PROPERLY.
Our operations depend on our ability to anticipate our needs for components and products for a
wide variety of systems, products, and services, and on our suppliers ability to deliver
sufficient quantities of quality components, products, and services at reasonable prices in time
for us to meet critical schedules. We may experience a shortage of, or a delay in receiving,
certain
47
Table of Contents
supplies as a result of strong demand, capacity constraints, supplier financial weaknesses,
disputes with suppliers, other problems experienced by suppliers, or problems faced during the
transition to new suppliers. If shortages or delays persist, the price of these supplies may
increase, we may be exposed to quality issues, or the supplies may not be available at all. We may
not be able to secure enough supplies at reasonable prices or of acceptable quality to build
products or provide services in a timely manner in the quantities or according to the
specifications needed. We could lose time-sensitive sales, incur additional freight costs, or be
unable to pass on price increases to our customers. If we cannot adequately address supply issues,
we might have to reengineer some products or service offerings, resulting in further costs and
delays. We intend to purchase certain products from a limited source in China. If the supply of
these products were to be delayed or constrained, or of insufficient quality, we may be unable to
find a new supplier on acceptable terms, or at all, or our ability to ship these new products could
be delayed, any of which could harm our business, financial condition, and operating results.
Additionally, our use of single source suppliers for certain components could exacerbate our
supplier issues. We obtain a significant number of components from single sources due to
technology, availability, price, quality, or other considerations. In addition, new products that
we introduce may use custom components obtained from only one source initially, until we have
evaluated whether there is a need for additional suppliers. The performance of such single source
suppliers may affect the quality, quantity, and price of supplies to us. Accordingly, our revenue
and/or results of operations could be adversely impacted by such events.
COMPLIANCE WITH NEW DIRECTIVES THAT RESTRICT THE USE OF CERTAIN MATERIALS MAY INCREASE OUR COSTS
AND LIMIT OUR REVENUE OPPORTUNITIES.
On July 1, 2006, the European Unions RoHS Directive became effective. This Directive
eliminates most uses of lead, cadmium, hexavalent-chromium, mercury, and certain fire retardants in
electronics placed on the market after the effective date. Since the introduction of the European
Unions RoHS Directive, other regions of the world have announced or implemented similar
regulations. In order to sell products into regions that adopt these or similar regulations, we
have to assess each product and determine whether they comply with the requirements of the
regulations or whether they are exempt from meeting the requirements of the regulations. If we
determine that a product is not exempt and does not comply with adopted regulations, we will have
to make changes to the product or its documentation if we want to sell that product into the region
once the regulations become effective. Making such changes may be costly to perform and may have a
negative impact on our results of operations. In addition, there can be no assurance that the
national enforcement bodies of the regions adopting such regulations will agree with our assessment
that certain of our products and documentation comply with or are exempt from the regulations. If
products are determined not to be compliant or exempt, we will not be able to ship them in the
region that adopts such regulations until such time that they are compliant, and this may have a
negative impact on our revenue and results of operations.
In addition, our products or packaging may not meet all safety, electrical, labeling, marking
or other requirements of all countries into which we ship products directly or our resellers sell
our products. We attempt to comply with all known laws and regulations governing product sales into
the countries we ship products. However, if products are determined not to be compliant or exempt,
we will not be able to ship them in the region that has such regulations until such time that they
are compliant, and this may have a negative impact on our revenue and results of operations. There
is also the possibility of fines and legal costs as well as costs associated with a product recall
if products or packaging is found not to meet the requirements.
BECAUSE PERSONAL COMPUTER PERIPHERAL PRODUCTS THAT INCORPORATE OUR TOUCH-ENABLING TECHNOLOGIES
CURRENTLY MUST WORK WITH MICROSOFTS OPERATING SYSTEM SOFTWARE, OUR COSTS COULD INCREASE AND OUR
REVENUES COULD DECLINE IF MICROSOFT MODIFIES ITS OPERATING SYSTEM SOFTWARE.
Our hardware and software technologies for personal computer peripheral products that
incorporate our touch-enabling technologies are currently compatible with Microsofts Windows 2000,
Windows Me, and Windows XP operating systems, including DirectX, Microsofts entertainment API.
Modifications and new versions of Microsofts operating system and APIs (including DirectX and the
Windows Vista launched in early 2007) may require that we and/or our licensees modify the
touch-enabling technologies to be compatible with Microsofts modifications or new versions, and
this could cause delays in the release of products by our licensees. If Microsoft modifies its
software products in ways that limit the use of our other licensees products, our costs could
increase and our revenues could decline.
REDUCED SPENDING BY CORPORATE OR UNIVERSITY RESEARCH AND DEVELOPMENT DEPARTMENTS MAY ADVERSELY
AFFECT SALES OF OUR THREE-DIMENSIONAL PRODUCTS.
Any economic downturn could lead to a reduction in corporate or university budgets for
research and development in sectors, including the automotive and aerospace sectors, which use our
three-dimensional and professional products. Sales of our three-
48
Table of Contents
dimensional and professional products, including our CyberGlove line of whole-hand sensing
gloves and our MicroScribe line of digitizers, could be adversely affected by cuts in corporate
research and development budgets.
COMPETITION BETWEEN OUR PRODUCTS AND OUR LICENSEES PRODUCTS MAY REDUCE OUR REVENUE.
Rapid technological change, short product life cycles, cyclical market patterns, declining
average selling prices, and increasing foreign and domestic competition characterize the markets in
which we and our licensees compete. We believe that competition in these markets will continue to
be intense and that competitive pressures will drive the price of our products and our licensees
products downward. These price reductions, if not offset by increases in unit sales or
productivity, will cause our revenues to decline.
We face competition from unlicensed products as well. Our licensees or other third parties may
seek to develop products using our intellectual property or develop alternative designs that
attempt to circumvent our intellectual property, which they believe do not require a license under
our intellectual property. These potential competitors may have significantly greater financial,
technical, and marketing resources than we do, and the costs associated with asserting our
intellectual property rights against such products and such potential competitors could be
significant. Moreover, if such alternative designs were determined by a court not to require a
license under our intellectual property rights, competition from such unlicensed products could
limit or reduce our revenues.
WE HAVE EXPERIENCED SIGNIFICANT CHANGE IN OUR BUSINESS, AND OUR FAILURE TO MANAGE THE COMPLEXITIES
ASSOCIATED WITH THE CHANGING ECONOMIC ENVIRONMENT AND TECHNOLOGY LANDSCAPE COULD HARM OUR BUSINESS.
Any future periods of rapid economic and technological change may place significant strains on
our managerial, financial, engineering, and other resources. Our failure to effectively manage
these resources during periods of rapid economic or technological change may harm our business.
THE MARKET FOR CERTAIN TOUCH-ENABLING TECHNOLOGIES AND TOUCH-ENABLED PRODUCTS IS AT AN EARLY STAGE
AND IF MARKET DEMAND DOES NOT DEVELOP, WE MAY NOT ACHIEVE OR SUSTAIN REVENUE GROWTH.
The market for certain of our touch-enabling technologies and certain of our licensees
touch-enabled products is at an early stage. If we and our licensees are unable to develop demand
for touch-enabling technologies and touch-enabled products, we may not achieve or sustain revenue
growth. We cannot accurately predict the growth of the markets for these technologies and products,
the timing of product introductions, or the timing of commercial acceptance of these products.
Even if our touch-enabling technologies and our licensees touch-enabled products are
ultimately widely adopted, widespread adoption may take a long time to occur. The timing and amount
of royalties and product sales that we receive will depend on whether the products marketed achieve
widespread adoption and, if so, how rapidly that adoption occurs.
We expect that we will need to pursue extensive and expensive marketing and sales efforts to
educate prospective licensees, component customers, and end users about the uses and benefits of
our technologies and to persuade software developers to create software that utilizes our
technologies. Negative product reviews or publicity about our products, our licensees products,
haptic features, or haptic technology in general could have a negative impact on market adoption,
our revenue, and/or our ability to license our technologies in the future.
IF WE FAIL TO INCREASE SALES OF OUR MEDICAL SIMULATION DEVICES, OUR FINANCIAL CONDITION AND
OPERATIONS MAY SUFFER.
Many medical institutions do not budget for simulation devices. To increase sales of our
simulation devices, we must, in addition to convincing medical institution personnel of the
usefulness of the devices, persuade them to include a significant expenditure for the devices in
their budgets. If these medical institutions are unwilling to budget for simulation devices or
reduce their budgets as a result of cost-containment pressures or other factors, we may not be able
to increase or maintain sales of medical simulators at a satisfactory rate. A decrease in sales or
any failure to increase sales of our medical simulation products will harm our business.
49
Table of Contents
IF WE ARE UNABLE TO ENTER INTO NEW LICENSING ARRANGEMENTS WITH OUR EXISTING LICENSEES, AND WITH
ADDITIONAL THIRD-PARTY MANUFACTURERS FOR OUR TOUCH-ENABLING TECHNOLOGIES, OUR ROYALTY REVENUE MAY
NOT GROW.
Our revenue growth is significantly dependent on our ability to enter into new licensing
arrangements. Our failure to enter into new or renewal of licensing arrangements will cause our
operating results to suffer. We face numerous risks in obtaining new licenses on terms consistent
with our business objectives and in maintaining, expanding, and supporting our relationships with
our current licensees. These risks include:
| the lengthy and expensive process of building a relationship with potential licensees; | ||
| the fact that we may compete with the internal design teams of existing and potential licensees; | ||
| difficulties in persuading product manufacturers to work with us, to rely on us for critical technology, and to disclose to us proprietary product development and other strategies; | ||
| difficulties with persuading potential licensees who may have developed their own intellectual property or licensed intellectual property from other parties in areas related to ours to license our technology versus continuing to develop their own or license from other parties; | ||
| challenges in demonstrating the compelling value of our technologies in new applications like mobile phones, portable devices, and touchscreens; | ||
| difficulties in persuading existing and potential licensees to bear the development costs and risks necessary to incorporate our technologies into their products; | ||
| difficulties in obtaining new automotive licensees for yet-to-be commercialized technology because their suppliers may not be ready to meet stringent quality and parts availability requirements; | ||
| inability to sign new gaming licensees if the video console makers choose not to license third parties to make peripherals for their new consoles; | ||
| difficulty in signing new gaming licensees given the fact that Sony has included only limited support for vibration features in the PlayStation 3 or related products; and | ||
| reluctance of content developers, mobile phone manufacturers, and service providers to sign license agreements without a critical mass of other such inter-dependent supporters of the mobile phone industry also having a license, or without enough phones in the market that incorporate our technologies. |
A majority of our current royalty revenue has been derived from the licensing of our portfolio
of touch-enabling technologies for video game console and personal computer gaming peripherals,
such as gamepads, joysticks, and steering wheels. Though substantially smaller than the market for
dedicated gaming console peripherals, the market for gamepads, joysticks, and steering wheels for
use with personal computers is declining and is characterized by declining average selling prices.
If the console peripheral market also experiences declines in sales and selling prices, we may not
achieve royalty revenue growth.
IF WE FAIL TO PROTECT AND ENFORCE OUR INTELLECTUAL PROPERTY RIGHTS, OUR ABILITY TO LICENSE OUR
TECHNOLOGIES AND GENERATE REVENUES WOULD BE IMPAIRED.
Our business depends on generating revenues by licensing our intellectual property rights and
by selling products that incorporate our technologies. We rely on our significant patent portfolio
to protect our proprietary rights. If we are not able to protect and enforce those rights, our
ability to obtain future licenses or maintain current licenses and royalty revenue could be
impaired. In addition, if a court or the patent office were to limit the scope, declare
unenforceable, or invalidate any of our patents, current licensees may refuse to make royalty
payments, or they may choose to challenge one or more of our patents. It is also possible that:
| our pending patent applications may not result in the issuance of patents; | ||
| our patents may not be broad enough to protect our proprietary rights; and |
50
Table of Contents
| effective patent protection may not be available in every country in which we or our licensees do business. |
We also rely on licenses, confidentiality agreements, other contractual agreements, and copyright,
trademark, and trade secret laws to establish and protect our proprietary rights. It is possible
that:
| laws and contractual restrictions may not be sufficient to prevent misappropriation of our technologies or deter others from developing similar technologies; and | ||
| policing unauthorized use of our patented technologies, trademarks, and other proprietary rights would be difficult, expensive, and time-consuming, particularly outside of the United States of America. |
CERTAIN TERMS OR RIGHTS GRANTED IN OUR LICENSE AGREEMENTS OR OUR DEVELOPMENT CONTRACTS MAY LIMIT
OUR FUTURE REVENUE OPPORTUNITIES.
While it is not our general practice to sign license agreements that provide exclusive rights
for a period of time with respect to a technology, field of use, and/or geography, or to accept
similar limitations in product development contracts, we have entered into such agreements and may
in the future. Although additional compensation or other benefits may be part of the agreement, the
compensation or benefits may not adequately compensate us for the limitations or restrictions we
have agreed to as that particular market develops. Over the life of the exclusivity period,
especially in markets that grow larger or faster than anticipated, our revenue may be limited and
less than what we could have achieved in the market with several licensees or additional products
available to sell to a specific set of customers.
IF WE ARE UNABLE TO CONTINUALLY IMPROVE AND REDUCE THE COST OF OUR TECHNOLOGIES, COMPANIES MAY NOT
INCORPORATE OUR TECHNOLOGIES INTO THEIR PRODUCTS, WHICH COULD IMPAIR OUR REVENUE GROWTH.
Our ability to achieve revenue growth depends on our continuing ability to improve and reduce
the cost of our technologies and to introduce these technologies to the marketplace in a timely
manner. If our development efforts are not successful or are significantly delayed, companies may
not incorporate our technologies into their products and our revenue growth may be impaired.
IF WE FAIL TO DEVELOP NEW OR ENHANCED TECHNOLOGIES FOR NEW APPLICATIONS AND PLATFORMS, WE MAY NOT
BE ABLE TO CREATE A MARKET FOR OUR TECHNOLOGIES OR OUR TECHNOLOGIES MAY BECOME OBSOLETE, AND OUR
ABILITY TO GROW AND OUR RESULTS OF OPERATIONS MIGHT BE HARMED.
Our initiatives to develop new and enhanced technologies and to commercialize these
technologies for new applications and new platforms may not be successful. Any new or enhanced
technologies may not be favorably received by consumers and could damage our reputation or our
brand. Expanding our technologies could also require significant additional expenses and strain our
management, financial, and operational resources. Moreover, technology products generally have
relatively short product life cycles and our current products may become obsolete in the future.
Our ability to generate revenues will be harmed if:
| we fail to develop new technologies or products; | ||
| the technologies we develop infringe on third-party patents or other third-party rights; | ||
| our new technologies fail to gain market acceptance; or | ||
| our current products become obsolete or no longer meet new regulatory requirements. |
WE HAVE LIMITED ENGINEERING, QUALITY ASSURANCE AND MANUFACTURING RESOURCES TO DESIGN AND FULFILL
TIMELY PRODUCT DELIVERABLES AND DELIVER SUFFICIENT LEVELS OF QUALITY IN SUPPORT OF OUR DIFFERENT
PRODUCT AREAS. PRODUCTS AND SERVICES MAY NOT BE DELIVERED IN A TIMELY WAY, WITH SUFFICIENT LEVELS
OF QUALITY, OR AT ALL, WHICH MAY REDUCE OUR REVENUE.
51
Table of Contents
Engineering, quality assurance, and manufacturing resources are deployed against a variety of
different projects and programs to provide sufficient levels of quality necessary for channels and
customers. Success in various markets may depend on timely deliveries and overall levels of
sustained quality. Failure to provide product and program deliverables and quality levels in a
timely way, or at all, may disrupt channels and customers and reduce our revenues.
THE HIGHER COST OF PRODUCTS INCORPORATING OUR TOUCH-ENABLING TECHNOLOGIES MAY INHIBIT OR PREVENT
THEIR WIDESPREAD ADOPTION.
Personal computer and console gaming peripherals, mobile devices, touchscreens, and automotive
and industrial controls incorporating our touch-enabling technologies can be more expensive than
similar competitive products that are not touch-enabled. Although major manufacturers, such as ALPS
Electric Co., BMW, LG Electronics, Logitech, Microsoft, Samsung, Sony, and Nokia have licensed our
technologies, the greater expense of development and production of products containing our
touch-enabling technologies may be a significant barrier to their widespread adoption and sale.
THIRD-PARTY VALIDATION STUDIES MAY NOT DEMONSTRATE ALL THE BENEFITS OF OUR MEDICAL TRAINING
SIMULATORS, WHICH COULD AFFECT CUSTOMER MOTIVATION TO BUY.
In medical training, validation studies are generally used to confirm the usefulness of new
techniques, devices, and training methods. For medical training simulators, several levels of
validation are generally tested: content, concurrent, construct, and predictive. A validation study
performed by a third party, such as a hospital, a teaching institution, or even an individual
healthcare professional, could result in showing little or no benefit for one or more types of
validation for our medical training simulators. Such validation study results published in medical
journals could impact the willingness of customers to buy our training simulators, especially new
simulators that have not previously been validated. Due to the time generally required to complete
and publish additional validation studies (usually more than a year), the negative impact on sales
revenue could be significant.
MEDICAL LICENSING AND CERTIFICATION AUTHORITIES MAY NOT RECOMMEND OR REQUIRE USE OF OUR
TECHNOLOGIES FOR TRAINING AND/OR TESTING PURPOSES, SIGNIFICANTLY SLOWING OR INHIBITING THE MARKET
PENETRATION OF OUR MEDICAL SIMULATION TECHNOLOGIES.
Several key medical certification bodies, including the American Board of Internal Medicine
(ABIM) and the American College of Cardiology (ACC), have great influence in recommending
particular medical methodologies, including medical training and testing methodologies, for use by
medical professionals. In the event that the ABIM and the ACC, as well as other, similar bodies, do
not endorse medical simulation products in general, or our products in particular, as a training
and/or testing tool, market penetration for our products could be significantly and adversely
affected.
WE HAVE LIMITED DISTRIBUTION CHANNELS AND RESOURCES TO MARKET AND SELL OUR MEDICAL SIMULATORS,
TOUCH INTERFACE PRODUCTS, AND THREE-DIMENSIONAL SIMULATION AND DIGITIZING PRODUCTS, AND IF WE ARE
UNSUCCESSFUL IN MARKETING AND SELLING THESE PRODUCTS, WE MAY NOT ACHIEVE OR SUSTAIN PRODUCT REVENUE
GROWTH.
We have limited resources for marketing and selling medical simulation, touch interface, or
three-dimensional simulation and digitizing products, either directly or through distributors. To
achieve our business objectives, we must build a balanced mixture of sales through a direct sales
channel and through qualified distribution channels. The success of our efforts to sell medical
simulation, touch interface, and three-dimensional simulation products will depend upon our ability
to retain and develop a qualified sales force and effective distribution channels. We may not be
successful in attracting and retaining the personnel necessary to sell and market our products. A
number of our distributors represent small, specialized companies and may not have sufficient
capital or human resources to support the complexities of selling and supporting our products.
There can be no assurance that our direct selling efforts will be effective, distributors or OEMs
will market our products successfully or, if our relationships with distributors or OEMs terminate,
that we will be able to establish relationships with other distributors or OEMs on satisfactory
terms, if at all. Any disruption in the distribution, sales, or marketing network for our products
could have a material adverse effect on our product revenues.
COMPETITION IN THE MEDICAL MARKET MAY REDUCE OUR REVENUE.
If the medical simulation market develops as we anticipate, we believe that we will have
increased competition. As in many developing markets, acquisitions, or consolidations may occur
that could lead to larger competitors with more resources or
52
Table of Contents
broader market penetration. This increased competition may result in the decline of our
revenue and may cause us to reduce our selling prices.
COMPETITION IN THE MOBILITY OR TOUCHSCREEN MARKETS MAY INCREASE OUR COSTS AND REDUCE OUR REVENUE.
If the mobility or touchscreen markets develop as we anticipate, we believe that we will face
a greater number of competitors, possibly including the internal design teams of existing and
potential OEM customers. These potential competitors may have significantly greater financial and
technical resources than we do, and the costs associated with competing with such potential
competitors could be significant. Additionally, increased competition may result in the reduction
of our market share and/or cause us to reduce our prices, which may result in a decline in our
revenue.
AUTOMOBILES INCORPORATING OUR TOUCH-ENABLING TECHNOLOGIES ARE SUBJECT TO LENGTHY PRODUCT
DEVELOPMENT PERIODS, MAKING IT DIFFICULT TO PREDICT WHEN AND WHETHER WE WILL RECEIVE PER UNIT
AUTOMOTIVE ROYALTIES.
The product development process for automobiles is very lengthy, sometimes longer than four
years. We do not earn per unit royalty revenue on our automotive technologies unless and until
automobiles featuring our technologies are shipped to customers, which may not occur until several
years after we enter into an agreement with an automobile manufacturer or a supplier to an
automobile manufacturer. Throughout the product development process, we face the risk that an
automobile manufacturer or supplier may delay the incorporation of, or choose not to incorporate,
our technologies into its automobiles, making it difficult for us to predict the per unit
automotive royalties we may receive, if any. After the product launches, our royalties still depend
on market acceptance of the vehicle or the option packages if our technology is an option (for
example, a navigation unit), which is likely to be determined by many factors beyond our control.
WE MIGHT BE UNABLE TO RETAIN OR RECRUIT NECESSARY PERSONNEL, WHICH COULD SLOW THE DEVELOPMENT AND
DEPLOYMENT OF OUR TECHNOLOGIES.
Our ability to develop and deploy our technologies and to sustain our revenue growth depends
upon the continued service of our management and other key personnel, many of whom would be
difficult to replace. Management and other key employees may voluntarily terminate their employment
with us at any time upon short notice. The loss of management or key personnel could delay product
development cycles or otherwise harm our business.
We believe that our future success will also depend largely on our ability to attract,
integrate, and retain sales, support, marketing, and research and development personnel.
Competition for such personnel is intense, and we may not be successful in attracting, integrating,
and retaining such personnel. Given the protracted nature of if, how, and when we collect royalties
on new design contracts, it may be difficult to craft compensation plans that will attract and
retain the level of salesmanship needed to secure these contracts. Our stock option program is a
long-term retention program that is intended to attract, retain, and provide incentives for
talented employees, officers and directors, and to align stockholder and employee interests.
Additionally some of our executive officers and key employees hold stock options with exercise
prices above the current market price of our common stock. Each of these factors may impair our
ability to retain the services of our executive officers and key employees. Our technologies are
complex and we rely upon the continued service of our existing engineering personnel to support
licensees, enhance existing technologies, and develop new technologies.
Investment Risks
OUR QUARTERLY REVENUES AND OPERATING RESULTS ARE VOLATILE, AND IF OUR FUTURE RESULTS ARE BELOW THE
EXPECTATIONS OF PUBLIC MARKET ANALYSTS OR INVESTORS, THE PRICE OF OUR COMMON STOCK IS LIKELY TO
DECLINE.
Our revenues and operating results are likely to vary significantly from quarter to quarter
due to a number of factors, many of which are outside of our control and any of which could cause
the price of our common stock to decline.
These factors include:
| the establishment or loss of licensing relationships; | ||
| the timing and recognition of payments under fixed and/or up-front license agreements; |
53
Table of Contents
| the timing of work performed under development agreements; | ||
| the timing of our expenses, including costs related to litigation, stock-based awards, acquisitions of technologies, or businesses; | ||
| the timing of introductions and market acceptance of new products and product enhancements by us, our licensees, our competitors, or their competitors; | ||
| our ability to develop and improve our technologies; | ||
| our ability to attract, integrate, and retain qualified personnel; and | ||
| seasonality in the demand for our products or our licensees products. |
ISSUANCE OF THE SHARES OF COMMON STOCK UPON CONVERSION OF DEBENTURES, EXERCISE OF STOCK OPTIONS,
AND EXERCISE OF WARRANTS WILL DILUTE THE OWNERSHIP INTEREST OF EXISTING STOCKHOLDERS AND COULD
ADVERSELY AFFECT THE MARKET PRICE OF OUR COMMON STOCK.
The issuance of shares of common stock in the following circumstances will dilute the
ownership interest of existing stockholders: (i) upon conversion of some or all of the convertible
debentures (ii) upon exercise of some or all of the stock options, and (iii) upon exercise of some
or all of the warrants. Any sales in the public market of the common stock issuable upon such
conversion or upon such exercises, respectively, could adversely affect prevailing market prices of
our common stock. In addition, the existence of these convertible debentures, stock options, and
warrants may encourage short selling by market participants.
OUR STOCK PRICE MAY FLUCTUATE REGARDLESS OF OUR PERFORMANCE.
The stock market has experienced extreme volatility that often has been unrelated or
disproportionate to the performance of particular companies. These market fluctuations may cause
our stock price to decline regardless of our performance. The market price of our common stock has
been, and in the future could be, significantly affected by factors such as: actual or anticipated
fluctuations in operating results; announcements of technical innovations; announcements regarding
litigation in which we are involved; changes by game console manufacturers to not include
touch-enabling capabilities in their products; new products or new contracts; sales or the
perception in the market of possible sales of large number of shares of our common stock by
insiders or others; changes in securities analysts recommendations; changing circumstances
regarding competitors or their customers; governmental regulatory action; developments with respect
to patents or proprietary rights; inclusion in or exclusion from various stock indices; and general
market conditions. In the past, following periods of volatility in the market price of a companys
securities, securities class action litigation has been initiated against that company, such as the
suit currently pending against us.
OUR MAJOR STOCKHOLDERS RETAIN SIGNIFICANT CONTROL OVER US, WHICH MAY LEAD TO CONFLICTS WITH OTHER
STOCKHOLDERS OVER CORPORATE GOVERNANCE MATTERS AND COULD ALSO AFFECT THE VOLATILITY OF OUR STOCK
PRICE.
We currently have, have had in the past, and may have in the future, stockholders who retain
greater than 10%, or in some cases greater than 20%, of our outstanding stock. Acting together,
these stockholders would be able to exercise significant influence over matters that our
stockholders vote upon, including the election of directors and mergers or other business
combinations, which could have the effect of delaying or preventing a third party from acquiring
control over or merging with us. Further, if any individuals in this group elect to sell a
significant portion or all of their holdings of our common stock, the trading price of our common
stock could experience volatility.
PROVISIONS IN OUR CHARTER DOCUMENTS AND DELAWARE LAW COULD PREVENT OR DELAY A CHANGE IN CONTROL,
WHICH COULD REDUCE THE MARKET PRICE OF OUR COMMON STOCK.
Provisions in our certificate of incorporation and bylaws may have the effect of delaying or
preventing a change of control or changes in our management. In addition, certain provisions of
Delaware law may discourage, delay, or prevent someone from acquiring or merging with us. These
provisions could limit the price that investors might be willing to pay in the future for shares.
54
Table of Contents
WE MAY ENGAGE IN ACQUISITIONS THAT COULD DILUTE STOCKHOLDERS INTERESTS, DIVERT MANAGEMENT
ATTENTION, OR CAUSE INTEGRATION PROBLEMS.
As part of our business strategy, we have in the past and may in the future, acquire
businesses or intellectual property that we feel could complement our business, enhance our
technical capabilities, or increase our intellectual property portfolio. If we consummate
acquisitions through cash and/or an exchange of our securities, our stockholders could suffer
significant dilution. Acquisitions could also create risks for us, including:
| unanticipated costs associated with the acquisitions; | ||
| use of substantial portions of our available cash to consummate the acquisitions; | ||
| diversion of managements attention from other business concerns; | ||
| difficulties in assimilation of acquired personnel or operations; and | ||
| potential intellectual property infringement claims related to newly acquired product lines. |
Any acquisitions, even if successfully completed, might not generate significant additional
revenue or provide any benefit to our business.
FAILURE TO MAINTAIN EFFECTIVE INTERNAL CONTROLS IN ACCORDANCE WITH SECTION 404 OF THE
SARBANES-OXLEY ACT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS AND STOCK PRICE.
If we fail to maintain the adequacy of our internal controls, as standards are modified,
supplemented, or amended from time to time, we may not be able to ensure that we can conclude on an
ongoing basis that we have effective internal controls over financial reporting in accordance with
Section 404 of the Sarbanes-Oxley Act. Failure to maintain an effective internal control
environment could have a material adverse effect on our business and stock price.
LEGISLATIVE ACTIONS, HIGHER INSURANCE COST, AND POTENTIAL NEW ACCOUNTING PRONOUNCEMENTS ARE LIKELY
TO IMPACT OUR FUTURE FINANCIAL POSITION AND RESULTS OF OPERATIONS.
There have been regulatory changes and new accounting pronouncements including the
Sarbanes-Oxley Act of 2002, and the recently enacted SFAS No. 123R, Share-Based Payment, which
have had an effect on our financial position and results of operations. Under SFAS No. 123R, we
have been required since January 1, 2006, to adopt a different method of determining the
compensation expense of our employee stock options. SFAS No. 123R has had a significant adverse
effect on our reported financial conditions and may impact the way we conduct our business.
There may potentially be new accounting pronouncements or additional regulatory rulings that
also have an impact on our future financial position and results of operations. These and other
potential changes could materially increase the expenses we report under generally accepted
accounting principles, and adversely affect our operating results.
AUDITS FROM TAXING AUTHORITIES SUCH AS THE INTERNEL REVENUE SERVICE COULD IMPACT OUR FUTURE
FINANCIAL POSITION AND RESULTS OF OPERATIONS.
Our fiscal 2004 income tax return is currently under a routine examination by the Internal
Revenue Service. The results of this audit or other audits could adversely affect our financial
position or operating results.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
We held our annual meeting of stockholders (the Annual Meeting) on June 6, 2007, to consider
and vote on the following proposals to: (i) elect two members of the Board of Directors to serve
for a three-year term as Class II Directors (Proposal 1); (ii) to ratify the appointment of
Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year
ending December 31, 2007 (Proposal 2); and (iii) to consider and vote upon the approval of the
Immersion Corporation 2007 Equity Incentive Plan (Proposal 3).
55
Table of Contents
Proposal 1: The stockholders elected the two nominees for Class II directors to our Board of
Directors. The votes were as follows:
Number of | Withheld | |||||||
Nominees | Votes For | Authority | ||||||
Jonathan Rubinstein |
22,131,348 | 436,626 | ||||||
Robert Van Naarden |
22,362,320 | 205,654 |
Mr. Rubinsteins and Mr. Van Naardens terms will expire at the 2010 annual meeting. The
following directors terms of office continue until the annual meeting indicated: John Hodgman and
Emily Liggett (Class III term expires at the 2008 annual meeting) and Anne DeGheest, Jack Saltich
and Victor Viegas (Class I term expires at the 2009 annual meeting).
Proposal 2: The ratification of Deloitte & Touche LLP as our independent registered public
accounting firm for the fiscal year ending December 31, 2007:
Number of | Number of | Number of | |||||||||||||||
Votes For | Votes Against | Votes Abstained | |||||||||||||||
21,451,415 | 1,102,150 | 14,409 |
Proposal 3: To consider and vote upon the approval of the Immersion Corporation 2007 Equity
Incentive Plan:
Number of | Number of | Number of | Number of | ||||||||||||||
Votes For | Votes Against | Votes Abstained | Broker Non-votes | ||||||||||||||
5,768,625 | 3,550,881 | 124,132 | 13,124,336 |
ITEM 6. EXHIBITS
The following exhibits are filed herewith:
Exhibit | ||
Number | Description | |
31.1
|
Certification of Victor Viegas, President, Chief Executive Officer, and Director, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2
|
Certification of Stephen Ambler, Chief Financial Officer and Vice President, Finance, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1
|
Certification of Victor Viegas, President, Chief Executive Officer, and Director, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2
|
Certification of Stephen Ambler, Chief Financial Officer and Vice President, Finance, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
56
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 8, 2007
IMMERSION CORPORATION |
||||
By | /s/ Stephen Ambler | |||
Stephen Ambler | ||||
Chief Financial Officer and Vice President, Finance |
57
Table of Contents
EXHIBIT INDEX
Exhibit | |||
Number | Description | ||
31.1
|
Certification of Victor Viegas, President, Chief Executive Officer, and Director, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2
|
Certification of Stephen Ambler, Chief Financial Officer and Vice President, Finance, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32.1
|
Certification of Victor Viegas, President, Chief Executive Officer, and Director, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
32.2
|
Certification of Stephen Ambler, Chief Financial Officer and Vice President, Finance, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |